<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart4.xsd">

<DOCUMENT-NAME ACODE="11013">분기보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20240412">5.6</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01399071">주식회사 고바이오랩</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="RPT_TP" AFEATURE="BOTH">1</EXTRACTION>
<EXTRACTION ACODE="IFRS_YN" AFEATURE="BOTH">Y</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">110111-5487437</EXTRACTION>
</SUMMARY>


<BODY ATOCID="78">

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER" ATOCID="1">분 기 보 고 서</COVER-TITLE>
<P></P>
<P USERMARK="F-16">                                    (제 11 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20240101">2024년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2024년      05월     03일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">주식회사 고바이오랩</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">고광표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="53">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="53">서울특별시 관악구 관악로1 220동 745-1호(신림동, 서울대학교종합연구동)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 02-888-9964</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.kobiolabs.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 경영지원본부장   (성  명) 임현규</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 02-888-9964</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TITLE ATOC="N">목     차</TITLE>
<P></P>
<PGBRK></PGBRK>


<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT" ATOCID="2">【 대표이사 등의 확인 】</TITLE>

<IMAGE>
<IMG WIDTH="600" HEIGHT="609" ALIGN="CENTER" HSPACE="0">대표이사 등의 확인서.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사 등의 확인서</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" ATOCID="3">I. 회사의 개요</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0" ATOCID="4">1. 회사의 개요</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<P></P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0" ATOCID="5">2. 회사의 연혁</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<P></P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0" ATOCID="6">3. 자본금 변동사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0" ATOCID="7">4. 주식의 총수 등</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0" ATOCID="8">5. 정관에 관한 사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0" ATOCID="9">II. 사업의 내용</TITLE>
<P></P>

<LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-1-L1" ATOCID="43">1. 사업의 개요</TITLE>
<P></P>

<P>인체 마이크로바이옴은 인체에 자연적으로 존재하는 세균, 바이러스, 곰팡이 등의 모든 미생물군의 집합체를 의미하며, 인체 건강에 직간접적으로 큰 영향을 미칩니다. 인체 마이크로바이옴의 중요성이 강조됨에 따라, 현재 글로벌 제약/바이오 산업계의인체 마이크로바이옴에 대한 관심이 매우 높은 상황이며, 주요한 보건의료 이슈로 부상하여 전세계적으로 활발한 연구개발이 진행되고 있습니다. 이러한 마이크로바이옴에 대한 관심 증가와 우호적인 연구 환경은 관련한 논문의 비약적인 증가와 특허의 증가로 이어지고 있습니다.마이크로바이옴 분야는 치료제, 진단, 화장품, 농업, 수의학까지 다양한 산업 전반에 광범위하게 응용되고 있습니다. 글로벌 마이크로바이옴 치료제 시장은 
<SPAN USERMARK=" I">C. difficile </SPAN>감염증 타깃 치료제가 최초 허가를 받은 2023년을 기점으로  급속한 성장이 전망됩니다. 치료제 시장은 2030년도 기점 10억 달러 규모로 예측되며, 규모 면에는 미국 지역이 가장 큰 시장이나 시장의 성장성 측면에서는 유럽 지역이 가장 돋보일 것으로 보입니다. 특히 전 세계적으로 마이크로바이옴을 다양한 미충족 수요가 존재하는 질환 군에 적용하기 위한 접근이 계속되고 있어, 시장이 보다 빠르게 확장될 수 있습니다.                                    [마이크로바이옴의 활용 분야]
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="349" ALIGN="CENTER" HSPACE="0">마이크로바이옴의 활용 분야.jpg</IMG>
<IMG-CAPTION ATOC="N">출처: 삼정 KPMG 경제연구원, 2020</IMG-CAPTION>
</IMAGE>
<P>마이크로바이옴 치료제는 기존의 합성의약품 및 바이오의약품들과 대비하여  안전성이 우수하여 신약 개발 성공 가능성이 높고, 개발 비용 및 기간이 비교적 짧아 개발 리스크가 작으며 다양한 질병에 대한 적용 가능성이 높아 파이프라인의 확장성 측면에서 이점이 있습니다. 개발 중인 치료제의 질환 분야는 감염질환, 피부질환, 위장관 질환, 대사질환에서 신경질환, 암 및 희귀 질환까지 매우 포괄적이고 다양합니다.고바이오랩은 마이크로바이옴 원천기술과 신약개발 역량을 통합적으로 갖춘 글로벌 혁신 바이오 기업입니다. 당사는 글로벌 수준의 마이크로바이옴 연구진과 신약개발 전문 경영진을 기반으로 기초 연구부터 임상개발까지 전 과정을 아우르는 통합적인 마이크로바이옴 신약개발 역량을 보유하고 있습니다. 독자적으로 구축한 신약개발 플랫폼 기술을 바탕으로 면역, 대사 및 뇌 질환을 대상으로 경쟁력 있는 파이프라인을 구축했고, 국내 최초로 마이크로바이옴 신약의 글로벌 임상 시험을 개시하여 마이크로바이옴 신약개발 선도 회사로서의 지위를 공고히 했습니다. 당사는 차세대 유망 바이오 분야에서 핵심 경쟁력을 갖춘 '글로벌 선도 마이크로바이옴 회사'로 성장하고 있습니다.고바이오랩은 인체 마이크로바이옴 기반 후보물질의 발굴부터 임상 시험, 제품화 단계에 이르기까지의 전 과정을 자체적으로 진행하며, 이를 기반으로 마이크로바이옴 신약[큐어바이오틱스(CUREbiotics)] 개발 파이프라인을 보유하고 있습니다. 또한 혁신적인 마이크로바이옴 치료제 개발을 위하여 파이프라인 확장성 및 임상 성공 가능성이 높은 신약 개발 플랫폼인 Smartiome(스마티옴)을 구축하였습니다. 현재 면역질환 치료용 기능성 소재 2종에 대해 국내 최초로 글로벌 임상시험을 진행하는 등 다양한 신약 파이프라인에 대한 개발을 본격적으로 진행하고 있습니다.</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="284" ALIGN="CENTER" HSPACE="0">파이프라인 업데이트.jpg</IMG>
<IMG-CAPTION ATOC="N">고바이오랩 마이크로바이옴 치료제 파이프라인</IMG-CAPTION>
</IMAGE>
<P></P>
<P>위바이옴은 2022년 3월 국내 최고의 마이크로바이옴 기반 바이오벤처인 고바이오랩과 확고한 유통채널을 갖춘 이마트가 함께 출자하여 설립한 건강기능식품 자회사입니다. 현재 여성건강, 면역력, 대사질환 및 정신건강 등 주요 타깃 기능성에 맞춘 고기능성 미생물 소재를 지속 발굴하고 있으며, 홈쇼핑 및 온라인 등의 유통 채널을 통하여 빠른 매출액 성장을 보이고 있습니다. 개별인정형 소재 확보가 건강기능식품 시장에 주는 파급력이 매우 높은 만큼 향후 적극적인 인체적용시험 진행을 통해 기능성을 담보할 계획이며, 확고한 유통망을 지닌 전략적 파트너인 이마트와 초기 상품 개발 시점부터 적극적으로 협력하여 상업성을 갖춘 제품을 시장에 제시하고 있습니다. 위바이옴은 뛰어난 미생물 관련 기술력을 십분 반영한 프로바이오틱스 공장을 국가식품클러스터 내에 준공 완료하였습니다.</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="394" ALIGN="CENTER" HSPACE="0">위바이옴_사진.jpg</IMG>
<IMG-CAPTION ATOC="N">위바이옴 프로바이오틱스 공장</IMG-CAPTION>
</IMAGE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-2-L1" ATOCID="44">2. 주요 제품 및 서비스</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 주요 제품 등의 현황</SPAN>
</P>
<P>당사의 주요 제품 등의 현황은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="1119" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="711"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">구분 </TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">품목 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">생산(판매) 개시일 </TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">매출액(원)
<SPAN USERMARK=" 0X0000FF"></SPAN>
</TD>
<TD WIDTH="720" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">제품 설명 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="624">CUREbiotics</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">KBLP-001 </TD>
<TD ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="267">2021년 10월</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="145">7,066,503(0.001%)</TD>

<TD WIDTH="720" VALIGN="MIDDLE" HEIGHT="145">면역 피부질환 치료제로 개발 중입니다. 아토피 피부염 및 건선 비임상 동물모델 시험에서 우수한 치료효과 및 면역 관련 바이오 마커의 개선을 확인했습니다. 호주 글로벌 임상 1상에서 안전성 및 약물 동태를 확인 후 미국 FDA로부터 중등도 건선 환자를 대상으로 하는 글로벌 임상 2상 IND 승인을 받았습니다. 
<SPAN></SPAN>
<SPAN>현재 임상 2상 투약을 완료하여 Topline Data를 수취하였으며, 바이오마커 분석을 진행하고 있습니다. 전</SPAN>
<SPAN>임</SPAN>상 및 임상 결과를 바탕으로 SPH Sine Pharmaceutical Laboratories Co., Ltd., 에 기술이전하여 계약금을 수취하였습니다.
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">KBLP-002 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="122">97,665(0.001%)</TD>
<TD WIDTH="720" HEIGHT="122">알레르기 질환 치료제로 개발 중입니다. 천식 및 아토피 피부염 비임상 동물모델 시험에서 우수한 치료효과 및 알레르기 염증 관련 바이오마커의 개선을 확인 했습니다. 호주 글로벌 임상 1상에서 안전성 및 약물 동태를 확인하였으며, 향후 적용증을 확정하여 미국 FDA 임상 2상 IND 신청을 진행할 계획입니다. 전임상 및 임상 결과를 바탕으로 SPH Sine Pharmaceutical Laboratories Co., Ltd., 에 기술이전하여 계약금을 수취하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBLP-004 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">- </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">-</TD>
<TD WIDTH="720" HEIGHT="76">마이크로바이옴 유래 물질을 이용하여 대사질환 치료제로 개발 중인 과제입니다. 비임상 동물 모델 시험을 통하여 체중감소 및 대사질환 바이오마커의 개선을 확인했습니다 GLP-1 유도를 통해 비만 등 다양한 대사질환에서 효과를 보일 것으로 기대하고 있습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBLP-005</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">- </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">-</TD>
<TD WIDTH="720" HEIGHT="76">생균 및 유효물질을 이용하여 항암치료제로 개발중인 과제입니다. 현재 비임상 동물모델 수준에서 후보균주 및 유효물질을 탐색하고 있으며, 이후 면역항암제 및 병용투여용 항암보조제 등으로 확장하여 빠른 추가 비임상 및 임상시험에 진입할 수 있도록 준비하고 있습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">KBLP-006</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020년 11월</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>

<TD WIDTH="720" HEIGHT="53">염증성 장질환 치료제로 개발 중입니다. 염증성 장질환 비임상 동물모델 시험에서 우수한 치료효과 및 면역 관련 바이오 마커의 개선을 확인하였으며,
<SPAN> 임상시험 진입 등을 고려하고 있습니다.</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBLP-009</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">- </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">-</TD>
<TD WIDTH="720" HEIGHT="76">간질환(MAFLD) 치료제로 개발 중인 마이크로바이옴 치료제입니다. 알코올성 동물 모델 시험에서 증상 개선 및 장벽 기능 강화 등의 바이오마커 개선을 확인하였습니다. 알코올성 간질환 및 비알콜성 간질환에서 효과를 기대하고 있습니다. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBLP-010 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">- </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">-</TD>
<TD WIDTH="720" HEIGHT="76">자폐 스펙트럼 장애 치료제로 개발 중인 마이크로바이옴 치료제입니다. 비임상 시험을 통하여 우울 및 불안 등의 정신 신경성 증상의 개선 및 뇌내 세로토닌 증가 염증성 사이토카인의 감소 등을 확인하였습니다. 치료제 옵션이 제한적인 자폐 스펙트럼 장애 환자에서 치료 효과를 기대하고 있습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">CAREbiotics(건강기능식품 등 포함)</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">- </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">14,766,488,911(99.04%)</TD>
<TD WIDTH="720" HEIGHT="76">인체 마이크로바이옴 기반 고기능성 프로바이오틱스를 발굴하여, 장 및 피부 건강 개선 등 다양한 효능을 확인하고 관련 지식재산권을 확보 중입니다. 이전한 균주들에 대한 선급 라이선스 기술료를 수취하였으며, 후속 연구개발 과정 등에 따른 경상기술료 취득 역시 예정되어 있습니다. </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">나. 주요 제품 등의 가격변동 추이</SPAN>당사의 주요 사업 영역인 인체 마이크로바이옴 치료제는 현재 개발 중으로, 별도의 관련 가격변동추이가 없습니다.위바이옴은 2022년 3월에 창업한 회사로, 현재까지 의미있는 제품 가격 변동 추이는 없습니다.
</P>
<P></P>
<P USERMARK=" B">다. 주요 제품의 경쟁요소</P>
<P>다양한 질병들 및 마이크로바이옴 사이의 유의한 상관관계가 밝혀짐에 따라, 다수의 마이크로바이옴 치료제 개발이 진행 중입니다. 각 마이크로바이옴 치료제들에 대한 장단점을 살펴보면 다음과 같습니다.</P>
<P>1) 분변 이식은 다양한 임상적 연구를 통해 PoC(proof of concept)가 확립되었으며 장 정착성이 높아 치료효과가 지속되는 장점이 있으나, 공여자에 따른 효능 차이가 심하고 병원균 오염 등에 따른 안전성 이슈가 있습니다.</P>
<P>2) 혼합 균주는 다양한 기능성 및 병원균 오염 배제가 가능하나, 제조공정이 복잡하고 품질관리 난이도가 높을 것으로 예상되고 있습니다.</P>
<P>3) 단일 균주는 제조 및 품질관리가 용이하고 안전성이 매우 높으나, 제한적인 기능성 및 낮은 장 정착성으로 효능 지속 기간이 짧아 기능성이 높은 균주 선택이 중요합니다.</P>
<P>4) 유전자 변형 균주는 유전자 조작을 통한 타깃 물질의 발현 및 전달을 개선하여 효능 및 안정성을 높일 것으로 기대되나, 안전성 이슈가 있으며 허가 가이드라인이 부재하여 개발상의 어려움이 있을 것으로 예상됩니다.</P>
<P>5) 유효 물질은 작용기전 입증이 용이하고 전통적인 신약 개발 요건에 따른 명확한 개발 경로가 장점인 반면, 다른 마이크로바이옴 치료제 대비 개발 기간 및 비용이 높은 단점이 있는 것으로 판단됩니다.6) 프리바이오틱스는 균주의 생장을 돕는 물질로써 기존 신약 개발과 유사하나, 투여량이 많고 작용기전 입증이 쉽지 않다는 단점을 가지고 있습니다.</P>
<P> </P>
<P>당사는 자체 구축한 스마티옴 플랫폼을 기반으로, 마이크로바이옴 경쟁업체 대비 고도화된 기술들을 적용하고 연관 분야와의 기술적 융합을 실시하는 등 독창적인 치료제 개발 방식을 구현하고 있습니다. 특히 쌍둥이 코호트를 활용하여 인간 유전정보, 생활습관, 식이 등의 다양한 메타데이터 정보 기반 환경적 교란 요인의 보정 등 오류를 최소화한 분석을 진행하고 있으며, 면역체 및 대사체 등의 추가 정보를 활용하여 과학적 타당성이 높은 질환-마이크로바이옴 상관 관계를 도출하고 있습니다. 아울러 축적된 배양기술 노하우를 바탕으로 난배양성/고기능 균주의 동정 및 공배양 기술을 활용한 최적의 균주 후보 도출 과정을 자체적으로 수행하고 있습니다. 이러한 배양기술 노하우는 개발 및 상업화를 위한 생산 최적화 등에도 역시 적용함으로써 보다 고품질의 제품 생산을 안정적으로 실시할 수 있습니다. 또한 당사는 단백질 공학, 유전체 공학, 분석 화학, 면역학 등 인접 영역의 기술을 적극 활용하여 마이크로바이옴 유래 기능성 소재에 대한 통합적 기전 연구를 실시하며, 예비 유효성 임상시험을 선행하여 임상개발 성공률을 극대화하는 등의 전략 역시 적용하고 있습니다.</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="296" ALIGN="CENTER" HSPACE="0">스마티옴.jpg</IMG>
<IMG-CAPTION ATOC="N">마이크로바이옴 치료제 개발 플랫폼 - 스마티옴</IMG-CAPTION>
</IMAGE>
<P>국내 1위 건강기능식품인 홍삼의 시장점유율이 점차 떨어지고 있는 반면 프로바이오틱스는 꾸준히 성장하고 있다는 점을 볼 때, 향후 프로바이오틱스 시장 잠재력은 상당한 수준에 이르렀습니다. 그러나 현재 장기능 개선 기능성을 주장하는 프로바이오틱스 제품들은 매우 많으며, 제약사, 식품기업 및 바이오기업 등이 출시한 다양한 브랜드가 시장에 난립되어 있습니다. 프로바이오틱스 브랜드의 배타적 경쟁력을 확보하기 위해서는 탄탄한 지식재산권 및 개별인정 등을 통해 독점적인 지위를 확보할 필요성이 있으며, 위바이옴은 지속적인 연구 개발과 신규 설비 도입 등을 통해 이러한 준비를 착실히 수행해 나가고 있습니다. 특히 프로바이오틱스의 다양한 기능성에 대한 연구 결과들이 제시됨에 따라, 규제기관인 식품의약품안전처의 개별인정을 받는 프로바이오틱스 소재들 역시 점차 증가하고 있습니다. 따라서, 향후 장기능 개선 외 별도의 건강 기능성을 주장할 수 있는 프로바이오틱스 소재들이 건강기능식품 시장에서 경쟁력 있는 지위를 확보할 것으로 예측됩니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-3-L1" ATOCID="45">3. 원재료 및 생산설비</TITLE>
<P></P>
<P USERMARK=" B">가. 사업영역에 따른 원재료 매입</P>
<P>당사의 주요 사업 영역은 인체 마이크로바이옴 치료제 개발로 first-in-class 또는 best-in-class 신약후보물질의 기술이전을 주된 사업화 모델로 삼고 있습니다. 당사는 현재 치료제에 대한 임상시험 등 개발과정에 주력하고 있으며, 제품 제조를 위한 별도 원재료 매입은 없습니다.</P>
<P>위바이옴은 인체 마이크로바이옴 기반 건강기능식품 및 식품을 주된 사업영역으로 삼고 있으며,식품용 원료 등을 매입하여 프로바이오틱스 대량 생산을 진행합니다.1) 매입현황프로바이오틱스 대량 생산에 소요되는 주요 원료들의 당 분기 가격 추이는 하기와 같습니다.</P>

<TABLE WIDTH="560" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="551"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="560" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="678" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="309"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" ALIGN="CENTER" WIDTH="318" USERMARK=" BC0XD7D7D7" HEIGHT="60">
<P>품 목</P>
</TD>

<TD ALIGN="CENTER" WIDTH="120" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>2024년 1분기</P>
</TD>

<TD ALIGN="CENTER" WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2023년</P>
</TD>
<TD ALIGN="CENTER" WIDTH="120" USERMARK=" BC0XD7D7D7" HEIGHT="30">2022년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="120" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>(제11기 1분기)</P>
</TD>

<TD ALIGN="CENTER" WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(제10기)</P>
</TD>
<TD ALIGN="CENTER" WIDTH="120" USERMARK=" BC0XD7D7D7" HEIGHT="30">(제9기)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="318" HEIGHT="30">소이펩톤(Soy peptone)(원/kg)</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">40,784</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30"> 43,079</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">43,079</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="318" HEIGHT="30">트레할로스(Trehalose)(원/kg)</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">5,818</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">5,899</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">13,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="318" HEIGHT="30">효모추출물(Yeast extract)(원/kg)</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">5,537</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">13,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="318" HEIGHT="30">L-아르지닌(L-arginine)(원/kg)</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">16,000</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">20,727</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">36,052</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>2) 원재료 가격변동추이국제 원재료 가격 변동 및 유효기간 경과 원료의 환불에 따라 일부 원료의 매입가격이 변동되었습니다.</P>

<P>
<SPAN USERMARK=" B">나. 생산설비</SPAN>현재 임상시험용 의약품을 국내에서 생산할 수 있는 의약품 GMP 업체가 부재하여, 전량 해외 위탁생산전문업체(CMO)를 통하여 생산하고 있습니다.위바이옴 익산공장은 프로바이오틱스 원료를 생산하는 목적으로 2023년 준공을 완료하였으며, 동년 12월 중 건강기능식품 GMP 인증을 받았습니다. 발효 및 균체분리, 동결건조에 이르기까지 프로바이오틱스 원료 생산 전 과정 중 오염을 최소화할 수 있는 자동식 시스템을 갖추어 연간 20톤 이상의 고품질 프로바이오틱스 원료를 생산할 수 있습니다.
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-4-L1" ATOCID="46">4. 매출 및 수주상황</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 매출상황</SPAN>
</P>
<P>1) 매출실적</P>

<TABLE BORDER="0" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 개, 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="147"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>매출유형</P>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">

<P>2024년 1분기
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
</TD>

<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2023년</P>
</TD>

<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2022년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제11기 1분기)</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제10기)</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(제9기)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기술이전</TD>

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수 출</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,164,168</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">564,221,248</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">933,235,418</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내 수</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,066,314</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">306,275,660</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,149,522</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">73,230,482</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">870,496,908</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,033,384,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">제품매출</TD>

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수 출</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내 수</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,766,488,911</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,231,756,526</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,566,449,926</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,766,488,911</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,231,756,526</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,566,449,926</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">용역매출</TD>

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수 출</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내 수</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,000,000</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,783,629</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,741,814</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,000,000</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,783,629</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,741,814</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">합계</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,164,168</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">564,221,248</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">933,235,418</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내 수</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,902,555,225</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,573,815,815</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,672,341,262</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,909,719,393</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,138,037,063</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,605,576,680</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 제품매출액은 계약부채-고객충성제도 및 반품충당부채 평가금액을 반영한 금액입니다. </P>
<P></P>
<P>2) 판매경로가) 판매조직</P>
<P>당사가 개발하고 있는 마이크로바이옴 관련 기술을 임상 단계 중 라이선스 아웃(license-out; L/O) 하는 것을 주된 사업전략으로 삼고 있습니다. 해당 분야에 대한 높은 이해도 및 전문성, 풍부한 경험을 가진 조직인 사업개발본부를 자체 구성하여 국내/글로벌 제약사와의 제휴, 업무협약 및 기술이전 전반을 담당하고 있습니다.위바이옴은 마케팅본부를 구성하여 홈쇼핑 및 온라인 채널을 이용한 건강기능식품 판매를 중점적으로 진행하고 있습니다.</P>
<P>나) 판매전략</P>
<P>인체 마이크로바이옴 치료제 및 기능성 후보 물질을 대상으로 한 고바이오랩의 L/O 전략 방향은, 높은 제휴 가치를 실현할 수 있는 시점에(right time), 추가적인 과제 가치를 구현할 수 있는 파트너와(value-added partner), 사업의 연속성을 보장할 수 있는 계약을 체결하여(sustainable business) 과제 가치를 극대화하는 것입니다.</P>
<P>당사의 L/O프로세스는 연구개발 성과의 사업적 연속성을 확보하고 과제 가치를 극대화하여 조기에 사업 성과를 달성하는 것을 주된 목적으로 삼습니다. 제휴 논의 초기부터 과학 및 사업적 전문성을 보유한 핵심 기업들과의 협의를 통해 최대한의 정보를 취득하고, 이를 반영하여 과제 방향을 적절히 설정합니다. 이후 사업가치를 극대화할 수 있도록 엄선한 제휴 후보사들과의 후속 협상을 진행하되, 당사 전략 방향에 맞추어 계약의 조건을 적절히 설정하는 것을 목표로 하고 있습니다.마이크로바이옴 치료제의 안전성은 상당 수준 인정이 되고 있어, 효능에서 확증적인 결과를 보일 경우 글로벌 제약사의 관심 유도 및 높은 과제 가치를 인정받을 수 있을 것으로 판단됩니다. 기전 연구 기반 유효 물질의 경우, 작용 기전의 잠재력 및 신규성을 바탕으로 연구/전임상 단계에서 제휴를 추진하여 개발/상업화 효율성을 제고할 계획입니다. 우선적으로 고려하는 제휴 대상사는 질환 분야에 대한 개발 및 상업화 역량이 충분한 글로벌 제약사이며, 면역 질환 등 질환 전문 제약사와의 연구개발 및 상업화 역량이 높은 전문 제약사와의 제휴를 우선적으로 고려하고 있습니다. 마이크로바이옴 분야에 대한 높은 이해도 및 개발 역량을 보이는 마이크로바이옴 전문사와의 제휴 역시 고려 대상입니다.고바이오랩은 글로벌 2상까지는 직접 수행하는 것이 가능하나 글로벌 3상 및 상업화 등을 직접 수행하기는 어려워, 이러한 부족한 역량을 제휴를 통해 보완하고자 합니다. 따라서 임상 2상 종료 시점까지 적합한 파트너와의 제휴를 1차적으로 추진하고자 하며, 임상 2상 완료 이후에도 제휴가 어려운 경우 비교적 저렴한 국내 임상 3상을 진행하여 각 파이프라인의 가치 증진 및 사업/제휴 매력도를 유지할 계획입니다.위바이옴의 주요 매출은 건강기능식품이며, 연구개발 외에는 모두 위탁 생산/외주 가공을 통해 제품 생산을 실시하고 있습니다. 특히 위바이옴은 고바이오랩에서 확보한 고기능성 마이크로바이옴 기반 건강기능식품 소재의 개발 및 개별인정형 인체적용시험 진행에 박차를 가하여, 향후 배타적인 시장 지위를 획득하기 위해 노력하고 있습니다. 특히 개별인정형 인체적용시험을 통해 개발한 특정 신규 기능성 건강기능식품은 현재까지 시장에 제시된 것이 없는만큼, 유통망과 마케팅이 적절히 갖추어졌을 경우 충분한 선점효과를 누릴 수 있을 것으로 사료됩니다.</P>

<P>
<SPAN USERMARK=" B">나. 수주상황</SPAN>
</P>
<P>수주상황과 관련된 사항은「II. 사업의 내용 → 6. 주요계약 및 연구개발활동 → 가.경영상의 주요 계약」을 참조하시기 바랍니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-5-L1" ATOCID="47">5. 위험관리 및 파생거래</TITLE>
<P></P>
<P USERMARK=" B">가. 시장위험과 위험관리</P>
<P>1) 재무위험관리요소</P>
<P>위험관리는 이사회에서 승인한 정책에 따라 재무부서의 주관으로 이루어지고 있습니다. 재무부서는 관련부서들과의 긴밀한 협조하에 재무위험을 식별하고 평가하고 관리합니다. 이사회는 전반적인 위험관리에 대한 원칙과 외환위험, 이자율 위험, 신용 위험, 파생금융상품과 비파생금융상품의 이용 및 유동성을 초과하는 투자와 같은 특정 분야에 관한 정책을 문서화된 정책을 검토하고 승인합니다.</P>
<P>가) 신용 위험신용위험은 기업 및 개인 고객에 대한 신용거래 및 채권 뿐 아니라 현금성자산, 채무상품의 계약 현금흐름, 유리한 파생상품 및 예치금 등에서도 발생합니다.</P>
<P> </P>
<P>나) 유동성 위험</P>

<P>당사는 유동부채를 적정 수준으로 유지하고, 영업 자금 수요를 충족시키기 위해 유동성에 대한 예측을 항시 모니터링하고 있습니다. 유동성을 예측하는데 있어 연결회사의 자금조달 계획, 약정 준수, 당사 내부의 목표재무비율 및 통화에 대한 제한과 같은 외부법규나 법률 요구사항도 고려하고 있습니다.2) 자본위험 관리당사의 자본 관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 보호하고 자본 비용을 절감하기 위해 최적의 자본 구조를 유지하는 것입니다.
<SPAN USERMARK=" B">나. 파생상품 및 풋백옵션 등 거래현황</SPAN>
<SPAN></SPAN>
<SPAN>파생상품 및 풋백옵션 등 거래현황에 관한 사항은「III. 재무에 관한 사항 → 3. 연결재무제표 주석 → 31. 우발상황 및 약정사항」을 참조하시기 바랍니다. </SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-6-L1" ATOCID="48">6. 주요계약 및 연구개발활동</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 경영상의 주요 계약</SPAN>1) 공동 연구개발 관련 주요 계약
</P>

<TABLE BORDER="1" WIDTH="951" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="241"></COL>
<COL WIDTH="154"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약상대방</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약일(기간)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약목적 및 내용</TD>
<TD WIDTH="250" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약금액 또는대금수주방법(기준) 등</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">광동제약</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.04.21.(2021.04.21. ~ 2024.03.31.)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">개별인정형 건강기능식품 개발 및 상업화</TD>
<TD ROWSPAN="2" WIDTH="250" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="129">주1)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">주식회사 셀트리온</TD>

<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<SPAN>2022.03.23.(2022.03.23. ~ 2024.03.22.)주2)</SPAN>
</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">과민성대장증후군(IBS)/아토피피부염(AD) 치료 후보물질 발굴 목적 공동연구</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2차 연구비/라이선스 옵션비 수취</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 계약 세부내용은 영업기밀이므로 기재하지 않았습니다.주2) 상기 계약기간은 공동연구기간이며 그 진행 현황에 따라 변동가능합니다.</P>
<P></P>
<P>2) 라이선스 인(License-in) 계약</P>
<P>당사는 설립 이후 국내 및 해외 특허 등과 관련해 특허 이전 또는 전용실시권 허여 계약(당사가 계약상대방으로부터 기술을 도입), 노하우계약 등을 체결한 바 있으며, 상세 내역은 아래와 같습니다.</P>

<TABLE BORDER="1" WIDTH="1120" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="261"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>계약 상대방</P>
</TD>

<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>계약체결일</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">계약의 내용</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">관련특허</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">향후 계획</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">양수도 대금주1)</TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>기타 투자판단에 참고할 사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>서울대학교 기술지주회사</P>
</TD>

<TD ROWSPAN="5" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>2015.07.</P>
</TD>
<TD ROWSPAN="5" WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">'인유두종바이러스 감염 및 자궁경부암 진단용 조성물' 등 관련 계약기술 특허 양수도</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국 특허 공개번호 2014-0114698</TD>
<TD ROWSPAN="5" WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">플랫폼 구축/건강기능식품 상품화</TD>
<TD ROWSPAN="6" WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="249">지급완료,본 계약건 외의 별도 기술료 지급 없음</TD>

<TD ROWSPAN="5" WIDTH="202" VALIGN="MIDDLE" HEIGHT="150">
<P>1) 해당 특허권들에 대한 국내/국외 전체 연관권리 확보2) 계약기간: 계약일 ~ 특허존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국 특허 등록번호 1445243</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT 출원번호 PCT/KR2015/000440</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국 특허 출원번호 201510140419.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국 특허 출원번호 10-2015-0053702</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>서울대학교 산학협력단</P>
</TD>

<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2018.11.</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">한국인 인체 시료에서 확보한 유익균 미생물 군집 정보에 대한 노하우</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">플랫폼 구축</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">1) 계약기간: 계약일 ~ 2028.11.30.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="440">
<P>서울대학교 산학협력단</P>
</TD>

<TD ROWSPAN="7" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="440">
<P>2019.11.</P>
</TD>
<TD ROWSPAN="7" WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="440">'국내특허출원 제10-2017-0122608호' 등 계약기술 특허 양수도</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">국내특허출원 제10-2017-0122608호 및 국제특허출원 PCT/KR2019/002114</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">플랫폼 구축</TD>
<TD ROWSPAN="21" WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="1543">주2)</TD>

<TD ROWSPAN="7" WIDTH="202" VALIGN="MIDDLE" HEIGHT="440">
<P>1) 선급기술료/자체개발 또는 기술이전시에 따른 기술료 지급 구조</P>
<P>2) 해당 특허에 대한 국내/국외 전체 연관권리 확보3) 계약기간: 계약일 ~ 특허존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">국내특허출원 제10-2018-0013466호 및 국제특허출원 PCT/KR/2019/001525</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBLP-010/건강기능식품 상품화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">국내특허출원 제10-2018-0053279호 및 국제특허출원 PCT/KR/2019/005553</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">KBLP-006/기술이전</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">국내특허출원 제10-2018-0058568호 및 국제특허출원 PCT/KR/2019/006232</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">KBLP-001/기술이전</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">국내특허출원 제10-2018-0058569호 및 국제특허출원 PCT/KR/2019/006231</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">KBLP-002/기술이전</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">국내특허출원 제10-2018-0115823호 및 국제특허출원 PCT/KR/2018/011564</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBLP-009/건강기능식품 상품화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">국내특허출원 제10-2018-0121137호 및 국제특허출원 PCT/KR/2019/013402</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBLP-004/건강기능식품 상품화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="348">
<P>서울대학교 산학협력단</P>
</TD>

<TD ROWSPAN="7" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="348">
<P>2019.11.</P>
</TD>
<TD ROWSPAN="7" WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="348">'미국특허출원 US 14/905,327' 등 계약기술 전용실시권 허여</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국특허출원 US 14/905,327</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">플랫폼 구축</TD>

<TD ROWSPAN="7" WIDTH="202" VALIGN="MIDDLE" HEIGHT="348">
<P>1) 선급기술료/자체개발 또는 기술이전시에 따른 기술료 지급 구조</P>
<P>2) 해당 특허에 대한 국내/국외 전체 연관권리 확보3) 계약기간: 계약일 ~ 특허존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">국내특허출원 제10-2015-0162111호</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">플랫폼 구축/건강기능식품 상품화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내특허출원 제10-2016-0094299호</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">플랫폼 구축</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내특허출원 제10-2016-0124109호</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">플랫폼 구축</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">국내특허출원 제10-2017-0122620호 및 국제특허출원 PCT/KR/2019/002115</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">플랫폼 구축</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">국내특허출원 제10-2017-0158315호 및 국제특허출원 PCT/KR/2017/013498</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">플랫폼 구축/건강기능식품 상품화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">국내특허출원 제10-2018-0045772호 및 국제특허출원 PCT/KR/2019/004790</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">플랫폼 구축</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>서울대학교 산학협력단,서울대학교병원</P>
</TD>

<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>2020.03.</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">'국내특허출원 제10-2019-0092689호'등 계약기술 양도</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">국내특허출원 제10-2019-0092689호</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">플랫폼 구축</TD>

<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="168">
<P>1) 선급기술료/자체개발 또는 기술이전시에 따른 기술료 지급 구조</P>
<P>2) 해당 특허에 대한 국내/국외 전체 연관권리 확보3) 계약기간: 계약일 ~ 특허존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>경희대학교 산학협력단</P>
</TD>

<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2020.06.</P>
</TD>

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">1종 균주(
<SPAN USERMARK=" I">Ruminococcus faecis)</SPAN>에 대한 노하우 기술
</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">플랫폼 구축</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">1) 계약기간: 계약일 ~  </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>서울대학교 산학협력단</P>
</TD>

<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>2020.09.</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">기능성 프로바이오틱스에 대한 서울대학교 상표의 사용계약(통상사용권)</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">-</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">건강기능식품 상품화</TD>

<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="145">
<P>1) 상호 합의하 만료일 이후 연장 가능2) 계약기간: 계약일 ~ 2024. 08.31.3) 사용주체: 주식회사 위바이옴 (건강기능식품 자회사)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">서울대학교 산학협력단</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">2020.11.</TD>
<TD ROWSPAN="2" WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">'국내특허출원 제10-2020-0066313호'등 계약기술 양도</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내특허출원 제10-2020-0066313호</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">KBLP-004 </TD>

<TD ROWSPAN="2" WIDTH="202" VALIGN="MIDDLE" HEIGHT="168">
<P>1) 선급기술료/자체개발 또는 기술이전시에 따른 기술료 지급 구조</P>
<P>2) 해당 특허에 대한 국내/국외 전체 연관권리 확보3) 계약기간: 계약일 ~ 특허존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="138">국내특허출원 제10-2020-0102564호</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="138">기술이전</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">연세대학교 산학협력단</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">2021.12.</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">'국내특허출원 제10-2019-0122531'등 계약기술 양도</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">국내특허출원 제10-2019-0122531호 및 국제특허출원 PCT/KR2020/013379</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">건강기능식품 상품화</TD>
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="99">1) 정액기술료 지급 구조2) 해당 특허에 대한 국내/국외 전체 연관관리 확보3) 계약기간: 계약일 ~ </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">서울대학교 산학협력단</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">2024.02.</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">'국내특허출원 제10-2023-0020133' 계약기술 양도</TD>
<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">국내특허출원 제10-2023-0020133호</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">건강기능식품 상품화</TD>

<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="99">
<P>1) 선급기술료/마일스톤 기술료 지급 구조</P>
<P>2) 계약기간: 계약일 ~ 특허존속기간 만료일</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 계약 세부내용은 영업기밀이므로 기재하지 않았습니다.주2) 선급기술료는 무형자산(특허권)으로 인식하고 있습니다.</P>
<P></P>
<P>가) 품목 : '인유두종바이러스 감염 및 자궁경부암 진단용 조성물' 등</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>서울대학교 기술지주회사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>계약대상기술 특허에 대한 일체의 권리(국내 및 국제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>계약체결일: 2015.07.29.</P>
<P>계약종료일: 특허 존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="168" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="489" HEIGHT="168">
<P>- 인유두종바이러스 감염 및 자궁경부암 진단용 조성물(국내특허출원 제 10-2014-0114698)</P>
<P>- 장내세균의 군집과 기능의 변화를 이용한 대사성 및 염증성 질환의 조기진단(국내특허등록 1445243 및 국제특허출원 PCT/KR2015/000440, 중국특허출원 제 201510140419.1)</P>
<P>- 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 분리균주(국내특허출원 제 10-2015-0053702)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="489" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>나) 품목 : 한국인 인체시료에서 확보한 유익균 미생물 군집 정보에 대한 노하우</P>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="481"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="490" HEIGHT="30">
<P>서울대학교 산학협력단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="490" HEIGHT="30">
<P>계약대상 노하우에 대한 통상실시권 허여</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="490" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="490" HEIGHT="76">
<P>계약체결일: 2018.11.23.</P>
<P>계약일부변경일: 2020.05.06.</P>
<P>계약종료일: 2028.11.30.주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="490" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="490" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>

<TD WIDTH="490" VALIGN="MIDDLE" HEIGHT="30">
<P>계약당사자와의 합의에 따른 미공개</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="490" VALIGN="MIDDLE" HEIGHT="30">기술료 지급 시 경상연구개발비 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="490" HEIGHT="76">
<P>- 한국인 인체 시료에서 확보한 유익균 미생물 군집 정보에 대한 노하우 (연령 및 건강 상태별 한국인 인체 시료 관련 임상 라이브러리와 미생물 유전체 군집 라이브러리 정보)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="490" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 계약 연장에 대한 별도의 서면 합의가 없을 경우 계약이 만료됩니다.</P>
<P>다) 품목 : '클로스트리디움 디피실레 성장 억제 효과를 갖는 클로스트리디움 신덴스 균주' 등</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>서울대학교 산학협력단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>계약대상기술 특허에 대한 일체의 권리(국내 및 국제) 주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>계약체결일: 2019.11.13.</P>
<P>계약종료일: 특허 존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>

<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="53">
<P>선급기술료 지급 및 임상단계에 따른 마일스톤 기술료 지급계약제품 매출발생시 매출에 따른 경상기술료 지급</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="398" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="489" HEIGHT="398">
<P>- 클로스트리디움 디피실레 성장 억제 효과를 갖는 클로스트리디움 신덴스 균주(국내특허출원 제10-2017-0122608 및 국제특허출원 PCT/KR2019/002114)</P>
<P>- 락토바실러스 플란타럼 KBL396 균주 및 그 용도(국내특허출원 제10-2018-0013366 및 국제특허출원 PCT/KR/2019/001525)</P>
<P>- 락토바실러스 파라카제이 균주 및 그 용도(국내특허출원 제10-2018-0053279 및 국제특허출원 PCT/KR/2019/005553)</P>
<P>- 락토바실러스 가세리 KBL697균주 및 그 용도(국내특허출원 제10-2018-0058568 및 국제특허출원 PCT/KR/2019/006232)</P>
<P>- 락토바실러스 크리스파투스 KBL693 균주 및 그 용도(국내특허출원 제10-2018-0058569 및 국제특허출원 PCT/KR/2019/006231)</P>
<P>- 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물(국내특허출원 제10-2018-0115823 및 국제특허출원 PCT/KR/2018/011564)</P>
<P>- 아커만시아 뮤시니필라를 유효성분으로 포함하는 식욕억제 또는 대사성 질환 치료 또는 예방용 약학적 조성물(국내특허출원 제10-2018-0121137 및 국제특허출원 PCT/KR/2019/013402)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="53">
<P>고바이오랩이 제3자에게 대상기술의 기술 이전으로 인한 기술이전대가 수취시 10% 이내의 경상기술료 지급</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 출원 중인 지식재산권 및 이들과 우선권 기초출원이 동일한 국내외 지식재산권 전부에 대한 권리를 의미합니다.</P>
<P>라) 품목 : 'Composition for evaluating or predicting patients therapeutic response to metformin' 등</P>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="479"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="488" HEIGHT="30">
<P>서울대학교 산학협력단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="488" HEIGHT="30">
<P>계약대상기술 특허에 대한 전용실시권 허여(국내 및 국제) 주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="488" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="488" HEIGHT="53">
<P>계약체결일: 2019.11.13.</P>
<P>계약종료일: 특허 존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="488" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="488" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="53">
<P>선급기술료 지급 및 임상단계에 따른 마일스톤 기술료 지급계약제품 매출발생시 매출에 따른 경상기술료 지급</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="352" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="352">
<P>- Composition for evaluating or predicting patients therapeutic response to metformin (미국특허출원 US 14/905,327)</P>
<P>- 항 노로바이러스 활성을 갖는 락토바실러스 속 균주 및 이를 포함하는 항바이러스 조성물(국내특허출원 제10-2015-0162111)</P>
<P>- 구강 세균의 군집을 이용한 대사성 질환 진단용 바이오마커(국내특허출원 제10-2016-0094299)</P>
<P>- 질내 미생물을 포함하는 조성물(국내특허출원 제10-2016-0124109)</P>
<P>- 클로스트리디움 디피실레 성장 억제 효과를 갖는 락토바실러스 균주(국내특허출원 제10-2017-012262 및 국제특허출원 PCT/KR/2019/002115)</P>
<P>- 락토바실러스 퍼멘텀 KBL375균주 및 그 용도(국내특허출원 제10-2017-0158315 및 국제특허출원 PCT/KR/2017/013498)</P>

<P>- 신규한 
<SPAN USERMARK=" I">Bacteroides vulgatus </SPAN>균주 및 이를 유효 성분으로 하는 면역 및 대사성 질환 예방 또는 치료용 조성물(국내특허출원 제10-2018-0045772 및 국제특허출원 PCT/KR/2019/004790)
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>
<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="53">고바이오랩이 제3자에게 대상기술의 기술 이전으로 인한 기술이전대가 수취시 10% 이내의 경상기술료 지급</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 출원 중인 지식재산권 및 이들과 우선권 기초출원이 동일한 국내외 지식재산권 전부에 대한 권리를 의미합니다.마) 품목 : 비알코올성 지방간 질환의 예측 및 진단용 조성물, 및 그의 예방 또는 치료용 약학적 조성물</P>

<TABLE BORDER="1" WIDTH="623" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="476"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="485" HEIGHT="30">
<P>서울대학교 산학협력단, 서울대학교 병원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="485" HEIGHT="30">
<P>계약대상기술 특허에 대한 일체의 권리(국내 및 국제) 주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="485" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="485" HEIGHT="53">
<P>계약체결일: 2020.03.04.</P>
<P>계약종료일: 특허 존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="485" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="485" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="53">
<P>선급기술료 지급 및 임상단계에 따른 마일스톤 기술료 지급계약제품 매출발생시 매출에 따른 경상기술료 지급</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="485" HEIGHT="53">
<P>- 비알코올성 지방간 질환의 예측 및 진단용 조성물, 및 그의 예방 또는 치료용 약학적 조성물(국내특허출원 제10-2019-0092689호)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>
<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="53">고바이오랩이 제3자에게 대상기술의 기술 이전으로 인한 기술이전대가 수취시 10% 이내의 경상기술료 지급</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 출원 중인 지식재산권 및 이들과 우선권 기초출원이 동일한 국내외 지식재산권 전부에 대한 권리를 의미합니다.</P>

<P>바) 품목 : 1종 균주(
<SPAN USERMARK=" I">Ruminococcus faecis</SPAN>)에 대한 노하우 기술
</P>

<TABLE BORDER="1" WIDTH="596" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="449"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="458" HEIGHT="30">
<P>경희대학교 산학협력단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="458" HEIGHT="30">
<P>계약대상 노하우에 대한 노하우 기술 일체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="458" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="458" HEIGHT="30">
<P>계약체결일: 2020.06.25.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="458" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="458" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>
<TD WIDTH="458" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="458" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="458" VALIGN="MIDDLE" HEIGHT="30">

<P>1종 균주(
<SPAN USERMARK=" I">Ruminococcus faecis</SPAN>)에 대한 노하우 기술
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="458" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>사) 품목 : 기능성 프로바이오틱스 및 건강기능식품에 대한 서울대학교 상표 사용계약</P>

<TABLE BORDER="1" WIDTH="596" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="449"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="458" HEIGHT="30">
<P>서울대학교 산학협력단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="458" HEIGHT="53">
<P>기능성 프로바이오틱스 및 건강기능식품에 대한 서울대학교 상표 사용 계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="458" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="458" HEIGHT="53">
<P>계약체결일: 2022.09.01.</P>
<P>계약종료일: 2024.08.31. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="458" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="458" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>
<TD WIDTH="458" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>

<TD WIDTH="458" VALIGN="MIDDLE" HEIGHT="30">
<P>상표사용료 지급시 지급수수료 회계처리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="458" HEIGHT="76">
<P>당사의 기능성 프로바이오틱스 및 건강기능식품에 대해, 제품 포장 및 TV(홈쇼핑 포함). 온라인, 오프라인, 신문, 라디오광고 등에 서울대학교 상표 사용을 허여</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>
<TD WIDTH="458" VALIGN="MIDDLE" HEIGHT="30">사용주체: 주식회사 위바이옴(고바이오랩의 건강기능식품 자회사)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>아) 품목 : 'ICAM-2에 결합하는 물질을 유효성분으로 포함하는 대사질환 예방 또는 치료용 조성물' 등</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>서울대학교 산학협력단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>계약대상기술 특허에 대한 일체의 권리(국내 및 국제) 주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>계약체결일: 2020.11.11.</P>
<P>계약종료일: 특허 존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>

<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="53">
<P>선급기술료 지급 및 임상단계에 따른 마일스톤 기술료 지급계약제품 매출발생시 매출에 따른 경상기술료 지급</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="489" HEIGHT="99">
<P>- ICAM-2에 결합하는 물질을 유효성분으로 포함하는 대사질환 예방 또는 치료용 조성물(국내특허출원 제10-2020-0066313)</P>
<P>- 염증성 장질환의 예방 또는 치료용 조성물(국내특허출원 제10-2020-0102564)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="53">
<P>고바이오랩이 제3자에게 대상기술의 기술 이전으로 인한 기술이전대가 수취시 10% 이내의 경상기술료 지급</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 출원 중인 지식재산권 및 이들과 우선권 기초출원이 동일한 국내외 지식재산권 전부에 대한 권리를 의미합니다.</P>
<P>자) 품목 : '락토바실러스 애시도필러스 KBL409 균주 및 그 용도' 특허</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>
<TD WIDTH="489" HEIGHT="30">연세대학교 산학협력단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>계약대상기술 특허에 대한 일체의 권리(국내 및 국제) 주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>계약체결일: 2021.12.30.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">정액기술료 지급</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>- 락토바실러스 애시도필러스 KBL409 균주 및 그 용도(국내특허출원 제10-2019-0122531 및 국제특허출원 PCT/KR/2020/013379)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 출원 중인 지식재산권 및 이들과 우선권 기초출원이 동일한 국내외 지식재산권 전부에 대한 권리를 의미합니다.</P>
<P></P>
<P>차) 품목 : '리모실락토바실러스 루테리 균주 및 이의 면역 증진 용도' 특허</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>서울대학교 산학협력단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>계약대상기술 특허에 대한 일체의 권리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>계약체결일: 2024.02.05.</P>
<P>계약종료일: 특허 존속기간 만료일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 지급금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>

<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="53">
<P>선급기술료 지급 및 마일스톤 기술료 지급계약제품 매출발생시 매출에 따른 경상기술료 지급</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 회계처리방법</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">무형자산(특허권) 회계처리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑨ 대상기술</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>- 라모실락토바실러스 루테리 균주 및 이의 면역 증진 용도(국내특허출원 제10-2023-0020133)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="53">
<P>고바이오랩이 제3자에게 대상기술의 기술 이전으로 인한 기술이전대가 수취시 10%의 경상기술료 지급</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>3) 라이선스 아웃(L/O) 계약 주1)</P>

<TABLE BORDER="1" WIDTH="1010" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="265"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>계약 상대방</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>계약체결일</P>
</TD>

<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>계약의 내용</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>대상지역</P>
</TD>

<TD WIDTH="274" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>총계약금액</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>수취금액</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">SPH Sine Pharmaceutical LaboratoriesCo., Ltd.,</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2021.10.</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">마이크로바이옴 신약 후보 KBL697 및 KBL693 관련 기술이전</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">중국 등 지역(중국, 홍콩, 마카오, 대만)</TD>
<TD WIDTH="274" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">USD 107,250,000(계약금: USD 2,500,000, 마일스톤USD 104,750,000)</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">USD 2,500,000</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">임상 1,2상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">(주)위바이옴</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2022.04.</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">KBL375외 4종 균주 및 균주 관련 기술에 대한 라이선스 이전</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">대한민국을 포함한 전세계 주2)</TD>
<TD COLSPAN="2" WIDTH="387" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">주3)</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">건강기능식품 개발</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 임상단계, 허가, 상업화 등 단계별 수령 예정이며, 경상기술료(royalty)는 별도입니다. 수익배분(profit sharing)은 합의된 조건에 따라 진행할 계획입니다.주2) 식품 또는 건강기능식품에 한정합니다.주3) 총 계약금액(선급기술료 및 경상기술료)은 영업기밀이므로 기재하지 않았습니다.</P>
<P>가) 품목 : 마이크로바이옴 신약 후보 KBL697 및 KBL693 관련 기술</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>
<TD WIDTH="489" HEIGHT="30">SPH Sine Pharmaceutical Laboratories Co., Ltd.,</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>계약대상기술(특허)에 대한 일체의 권리(국내 및 국제)주1)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>
<TD WIDTH="489" HEIGHT="30">중국 등 지역(중국, 홍콩, 마카오, 대만)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>계약체결일: 2021.10.28.</P>
<P>계약종료일: 계약체결일 ~ 제품 발매 후 20년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">USD 107,250,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 수취금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약금 USD 2,500,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="99">- 계약금 : USD 1,250,000[(계약후 영업일 60일 이내 USD 1,250,000, 최초 물질 전달(initial material transfer) 후 영업일 60일 이내 USD 1,250,000)]- 마일스톤 : USD 104,750,000 주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>⑧ 대상기술</P>
</TD>

<TD WIDTH="489" HEIGHT="99">
<P>- 락토바실러스 가세리 KBL697균주 및 그 용도(국내특허출원 제10-2018-0058568 및 국제특허출원 PCT/KR/2019/006232)</P>
<P>- 락토바실러스 크리스파투스 KBL693 균주 및 그 용도(국내특허출원 제10-2018-0058569 및 국제특허출원 PCT/KR/2019/006231)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑨ 기타사항</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="53">- 임상단계, 허가, 상업화 등 단계별 수령 예정이며, 경상기술료는 별도- 수익배분은 합의된 조건에 따라 진행할 계획</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 출원 중인 지식재산권 및 이들과 우선권 기초출원이 동일한 국내외 지식재산권 전부에 대한 권리를 의미합니다.주2) 임상단계, 허가 및 상업화 등 단계별로 수령 예정입니다. 계약당사자와의 합의에 따라 세부사항은 공개하지 않습니다.</P>
<P>나) 품목 : KBL375외 4종 균주 및 균주 관련 기술에 대한 라이선스 이전</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>① 계약상대방</P>
</TD>
<TD WIDTH="489" HEIGHT="30">(주)위바이옴</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>② 계약내용</P>
</TD>

<TD WIDTH="489" HEIGHT="76">
<P>계약대상기술(특허)를 사용한, 균주들을 유효성분으로 하는 식품 또는 건강기능식품의 원료, 반제품, 완제품을 (주)위바이옴 단독 및 제3자와 공동 또는 위탁하여 생산할 수 있는 일체의 권리(국내 및 국제)주1)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③ 대상지역</P>
</TD>
<TD WIDTH="489" HEIGHT="30">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>④ 계약기간</P>
</TD>

<TD WIDTH="489" HEIGHT="76">
<P>계약체결일: 2022.04.15.</P>
<P>계약종료일: 계약체결일로부터 20년 또는 특허권의 존속 기간 만료일 중 일찍 도래하는 날</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤ 총 계약금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥ 수취금액</P>
</TD>
<TD WIDTH="489" HEIGHT="30">계약당사자와의 합의에 따른 미공개 주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦ 계약조건</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="30">계약당사자와의 합의에 따른 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="260" USERMARK=" BC0XD7D7D7">
<P>⑧ 대상기술</P>
</TD>
<TD WIDTH="489" HEIGHT="260">- 락토바실러스 퍼멘텀 KBL375 균주 및 그 용도(국내특허출원 제10-2017-0158315 및 국제특허출원 PCT/KR/2017/013498)- 락토바실러스 플란타럼 KBL396 균주 및 그 용도(국내특허출원 제10-2018-0115823 및 국제특허출원 PCT/KR/2019/001525)- 락토바실러스 애시도필러스 KBL409 균주 및 그 용도(국내특허출원 제10-2019-0122531 및 국제특허출원 PCT/KR/2020/013379)- 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 분리균주(국내특허출원 제 10-2018-0003582)- 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물(국내특허출원 제10-2018-0115823 및 국제특허출원 PCT/KR/2018/011564)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>⑨ 기타사항</P>
</TD>
<TD WIDTH="489" VALIGN="MIDDLE" HEIGHT="76">- 개별인정형 인체적용시험, 허가, 상업화 등 단계별 수령 예정이며, 경상기술료는 별도- 수익배분은 합의된 조건에 따라 진행할 계획</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 출원 중인 지식재산권 및 이들과 우선권 기초출원이 동일한 국내외 지식재산권 전부에 대한 권리를 의미합니다.주2) 5개의 대상 균주(KBL375, KBL396, KBL409, KBL674, KBL982) 및 균주 관련 기술문서를 이전하여 반환의무가 없는 선급기술료를 수취하였습니다.</P>
<P>4) 합작투자계약당사는 2022년 중 위바이옴의 지분 49%를 보유한 이마트와 위바이옴의 소유 및 지배구조 등에 대한 합작투자계약을 체결하였습니다. 동 계약에 따라, 각 당사자는 일정 기간 동안 주식처분이 제한되어 있으며, 주식처분제한 기간 이후 거래상대방의 지분 양도 시 회사는 이에 대한 우선매수권을 가집니다. 거래상대방인 이마트는 교착상태 또는 합작회사의 설립일로부터 10년이 경과된 경우, 보유 지분에 대하여 회사에 매수청구권을 행사할 수 있습니다.</P>

<P>
<SPAN USERMARK=" B">나. 연구개발활동</SPAN>
</P>
<P>1) 연구개발활동 개요</P>
<P>당사의 연구개발조직은 연구소 외 총 3개 본부로 구성되어 있습니다. 기술연구인력은 총 44명으로, 박사 12명, 석사 25명, 학사 7명 등입니다.</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="404" ALIGN="CENTER" HSPACE="0">연구개발조직.jpg</IMG>
<IMG-CAPTION ATOC="N">고바이오랩 조직도(기준일: 2024년 3월 31일)</IMG-CAPTION>
</IMAGE>
<P></P>
<P>2) 연구개발 담당조직가) 연구인력현황</P>

<TABLE BORDER="0" WIDTH="619" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="619" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="72"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD COLSPAN="4" WIDTH="401" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>인원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>박사</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>석사</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>학사</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>합계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임원</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>사업개발본부</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>의약개발본부</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>PD팀</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>RA/QA팀</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상팀</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>연구소</P>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Microbiome 센터</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PharmaBiotics 센터</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">R&D기술관리팀</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동기술개발 T/F</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나) 핵심 연구개발 인력</P>

<TABLE BORDER="1" WIDTH="1131" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="754"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>직책</P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>성명</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>담당업무</P>
</TD>

<TD WIDTH="763" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>약력</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">부사장(COO)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">이한승</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">CMC/임상/개발업무 총괄</TD>
<TD WIDTH="763" VALIGN="MIDDLE" HEIGHT="214">1987 ~ 1991 서울대학교 화학공학 학사1992 ~ 1994 University of California Irvine 생물화학공학 석사1994 ~1998 University of California Irvine 생물화학공학 박사1999 ~ 2005 LG생명과학 배양공정 연구팀장2005 ~ 2011 LG생명과학 히알루론산 연구팀장2011 ~ 2017 LG생명과학 HA사업부장2017 ~ 2019 LG화학 바이오시밀러 사업부장2019 ~ 2022 와이바이오로직스 개발본부장 부사장2023 ~ 현 재 ㈜고바이오랩 COO</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="201">연구소장(CTO)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="201">임상균</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="201">연구분야 총괄주)</TD>
<TD WIDTH="763" VALIGN="MIDDLE" HEIGHT="201">1994 ~ 2001 서울대학교 미생물학 학사2001 ~ 2006 University of Wisconsin-Madison 종양생물학 박사2007 ~ 2011 UT Southwestern Medical Center Postdoctoral Fellow2011 ~ 2016 UT Southwestern Medical Center Instructor2016 ~ 2018 Harvard Medical School 책임연구원2018 ~ 2019 Vivid Biosciences 수석연구원2019 ~ 2023 Kanaph Therapeutics 상무이사2023 ~ 현 재 (주)고바이오랩 CTO</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>CMC본부장</P>
</TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>신용원</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>CMC업무 총괄</P>
</TD>

<TD WIDTH="763" VALIGN="MIDDLE" HEIGHT="168">
<P>1992 ~ 1996 경북대학교 유전공학 학사</P>
<P>1996 ~ 1998 경북대학교 유전공학 석사</P>
<P>2013 ~ 2018 경희대학교 의과학 박사</P>
<P>2002 ~ 2009 녹십자 항체공학팀 선임연구원</P>
<P>2009 ~ 2011 녹십자 정제공정개발팀 책임연구원</P>
<P>2012 ~ 2019 녹십자 정제팀 팀장; CMC팀장, Project Leader</P>
<P>2019 ~ 현재 ㈜고바이오랩 CMC본부장</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>3) 연구개발비용</P>
<P>당사는 보고서 작성기준일 현재 연구 및 임상개발 등에 소요되는 모든 비용을 아래와같이 당분기 비용으로 회계처리하고 있습니다.</P>

<TABLE BORDER="0" WIDTH="577" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="568"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="577" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"><연구개발비용 현황(연결재무제표 기준)></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="577" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="579" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구 분</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">

<P>2024년 1분기
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2023년</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2022년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(제11기 1분기)</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(제10기)</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(제9기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">
<P>자산처리</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>원재료비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>인건비</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>감가상각비</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위탁용역비</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타 경비</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>비용처리</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제조원가</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판관비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,682,284,973</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,261,999,430</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,197,515,487</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>합 계</P>
<P>(매출액 대비 비율)</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,682,284,973</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,261,999,430</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,197,515,487</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.28%</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43.04%</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">122.33%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE BORDER="0" WIDTH="577" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="568"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="577" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"><연구개발비용 현황(별도재무제표 기준)></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="577" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="578" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구 분</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">

<P>2024년 1분기
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2023년</P>
</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>2022년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(제11기 1분기)</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(제10기)</P>
</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(제9기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">
<P>자산처리</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>원재료비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>인건비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>감가상각비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위탁용역비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타 경비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소 계</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>비용처리</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제조원가</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판관비</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,438,851,307</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,085,072,899</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,585,401,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>합 계</P>
<P>(매출액 대비 비율)</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,438,851,307</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,085,072,899</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,585,401,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">307.94%</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">413.05%</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101.46%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>4) 연구개발실적</P>
<P>가) 연구개발 진행 현황 및 향후 계획보고서 작성기준일 현재 당사가 연구개발 진행 중인 현황은 다음과 같습니다.</P>

<TABLE BORDER="0" WIDTH="770" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="761"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="770" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[연구개발 진행 총괄표]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="786" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">품 목</TD>
<TD ROWSPAN="2" WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">적응증</TD>
<TD COLSPAN="2" WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">현재 진행단계</TD>
<TD ROWSPAN="2" WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">개시년도</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행단계(국가)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">마이크로바이옴 치료제</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>KBLP-001</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>건선</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2016년</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상2상(미국, 호주)</P>
</TD>

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>혁신신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>KBLP-002</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>천식, 아토피피부염</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2015년</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상1상 완료(호주)</P>
</TD>

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>혁신신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>KBLP-004</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비만</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2016년</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>개발후보도출</P>
</TD>

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>혁신신약, 신규 타깃</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">KBLP-006</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">염증성장질환</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017년</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전임상시험</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혁신신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>KBLP-010</P>
</TD>

<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자폐 스펙트럼 장애</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017년</P>
</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전임상시험</TD>

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>혁신신약</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(1) KBLP-001:</P>

<TABLE BORDER="1" WIDTH="663" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="505"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">① 구분</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>마이크로바이옴 신약(Live biotherapeutic product)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">② 적응증</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>건선</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="122" USERMARK=" BC0XD7D7D7">③ 작용기전</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="122">
<P>- 장-피부축(Gut-Skin Axis) 개념을 적용- 장내 면역세포에 작용하여 염증성 사이토카인(pro-inflammatory cytokine)인 IL-4, IL-5, IL-6, IL-13, IL-17 및 TNF-α 분비를 저해하고 항염증성 사이토카인(anti-inflammatory cytokine)인 IL-10 분비를 유도하여 염증 반응을 억제함 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">④ 제품의 특성</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="76">인체 공생 미생물 기반의 치료제로, 전신순환 없이 장 점막에 존재하는 면역세포의 조절을 통한 효능을 보여 기존 의약품 대비 안전성이 매우 우수하고 기존 치료제와의 병용 및 장기적인 사용이 가능함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="145" USERMARK=" BC0XD7D7D7">⑤ 진행경과</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="145">
<P>- 다양한 면역염증성 질환 동물모델을 통한 전임상시험에서 염증성 사이토카인 분비 저해 및 항염증성 사이토카인 분비 유도 등 확인</P>
<P>- 건강한 성인 대상의 임상 1상 시험에서 위약대비 우수한 안전성, 용량 의존적 장내 동태 및 배출 확인</P>
<P>- 중등도 건선환자 대상의 임상 2상 시험에 대한 환자 투약 완료 후, Topline Data 수취</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">⑥ 향후계획</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="76">

<P>-
<SPAN> 임상 2상 시험에 대한 후속 바이오마커 분석을 진행할 계획임 </SPAN>
</P>

<P>- 
<SPAN>분석 결과를 바탕으로 공동개발 및 라이선스 아웃, 후속 임상 등을 후속 개발 과정을 타진할 예정임</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="122" USERMARK=" BC0XD7D7D7">⑦ 경쟁제품</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="122">
<P>- 건선 치료제로 개발 중인 마이크로바이옴 기반 신약은 SFA Therapeutics사의 SFA002가 있음</P>
<P>- 마이크로바이옴 신약 외에 중등도 건선 및 중등도 아토피피부염 환자를 타깃으로 출시된 Amgen사의 PDE4 저해제 Otezla(Apremilast)가 향후 시장내 주요 경쟁품이 될 것으로 예상됨 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">⑧ 관련논문 등</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="76">Si, J. et al., 
<SPAN USERMARK=" I">Prevotella </SPAN>as a hub for vaginal microbiota under the influence of host genetics and their association with obesity(출처: Cell Host & Microbe, 2017)
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="99" USERMARK=" BC0XD7D7D7">⑨ 시장규모</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="99">
<P>- 건선 치료제 시장은 선진 7개국 시장(미국, 일본, 영국, 프랑스, 독일, 이탈리아, 스페인) 기준 2017년 약 163억 달러 수준이며, 2027년 약 242억 달러 수준으로 성장할 것으로 예상(출처: GlobalData, Plaque psoriasis: global drug forecast and market analysis to 2027)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="42" USERMARK=" BC0XD7D7D7">⑩ 기타사항</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="42">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) KBLP-002:</P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="503"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">① 구분 </TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>마이크로바이옴 신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">② 적응증</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>천식, 아토피피부염</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="145" USERMARK=" BC0XD7D7D7">③ 작용기전</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="145">
<P>- 장-피부축(Gut-Skin Axis) 개념을 적용- 장내 면역세포에 작용하여 염증성 사이토카인인 IL-4, IL-5, IL-6, IL-13, IL-17 및 TNF-α 분비를 저해하고 항염증성 사이토카인 IL-10 분비 유도를 촉진해 염증 반응을 억제함</P>
<P>- 염증반응 시 히스타민을 분비하는 비만세포(mast cell) 및 호염구(basophil)세포의 탈과립(degranulation)을 저해하여 히스타민 분비를 억제함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">④ 제품의 특성</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="76">인체 공생 미생물 기반의 치료제로, 전신순환 없이 장 점막에 존재하는 면역세포의 조절을 통한 효능을 보여 기존 의약품 대비 안전성이 매우 우수하고 기존 치료제와의 병용 및 장기적인 사용이 가능함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="99" USERMARK=" BC0XD7D7D7">⑤ 진행경과</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="99">
<P>- 다양한 면역염증성 질환 동물모델을 통한 전임상시험에서 염증성 사이토카인 분비 저해 및 항염증성 사이토카인 분비 유도 등 확인</P>
<P>- 건강한 성인 대상의 임상 1상 시험에서 위약대비 우수한 안전성, 용량 의존적 장내 동태 및 배출 확인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">⑥ 향후계획</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="76">
<P>- 진행 중인 호주 임상 1상 종료 후, 국내 예비 유효성 임상(아토피, 천식)결과를 바탕으로 향후 적용증을 확정하여 미국 FDA 임상 2상 등을 포함한 다각적인 계획을 수립할 계획임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">⑦ 경쟁제품</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="53">
<P>- 아토피 치료제로 개발 중인 마이크로바이옴 신약으로, MatriSys Bioscience사의 MSB-0221 및 ImmunoBiome사의 IMB-001 등이 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">⑧ 관련논문 등</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="76">

<P>Si, J. et al., 
<SPAN USERMARK=" I">Prevotella </SPAN>as a hub for vaginal microbiota under the influence of host genetics and their association with obesity(출처: Cell Host & Microbe, 2017)
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="145" USERMARK=" BC0XD7D7D7">⑨ 시장규모</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="145">
<P>- 천식 시장은 전 세계 시장 기준 2019년 181억 달러에서 2027년 260억 달러로 성장할 것으로 예상(출처: Fortune Business Insight, Asthma treatment market forecast, 2020-2027)- 아토피피부염 치료제 시장은 전 세계 시장 기준 2017년 약 64억 달러에서 2027년 약 183억 달러로 성장할 것으로 예상(출처: GlobalData, Atopic dermatitis: global drug forecast and market analysis to 2027)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">⑩ 기타사항</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>(3) KBLP-004: 
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="503"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">① 구분 </TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>마이크로바이옴 유래물질 기반 신약 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">② 적응증</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>비만</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">③ 작용기전</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="53">
<P>- 장에 분포하는 장내분비 세포(enteroendocrine cell)에 작용하여 GLP-1의 분비 유도</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="99" USERMARK=" BC0XD7D7D7">④ 제품의 특성</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="99">
<P>- 투여 후 흡수 및 전신 순환 없이 장관내 상피세포(epithelial cell)에 작용하여 효력을 보이므로 전신 순환에 따른 부작용 우려 낮음</P>
<P>- GLP-1 분비 유도 효과를 나타내는 신규 타깃으로 연관 질환으로의 적응증 확장 가능성 높음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="168" USERMARK=" BC0XD7D7D7">⑤ 진행경과</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="168">

<P>- GLP-1 분비 유도 기반 비만 및 당뇨 치료제 후보 균주 KBL983 발굴- 장 점막 강화, 단쇄지방산(SCFA) 생산, 산화스트레스에서의 간 보호 효과 및 장내 미생물 불균형 회복 등의 효능을 갖춘 KBL982 발굴- 장내 미생물 및 대사체 불균형(dysbiosis) 및
<SPAN USERMARK=" I"> Akkermansia </SPAN>균주 회복, 장 누수(leaky gut) 회복 등의 효능을 갖춘 치료제 후보 균주 KBL981 발굴 
</P>
<P>- 3종 복합 균주를  활용하여, 체중 및 체지방 감소, 인슐린 저항성 감소, 장내 GLP-1 분비 등 다중 타깃 기전을 갖춘 항비만 소재 개발 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="122" USERMARK=" BC0XD7D7D7">⑥ 향후계획</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="122">
<P>- 3종 복합 균주의 최적 비율을 도출, 비만용 신규 의약품 소재 개발을 진행할 계획임</P>
<P>- 개발 후보 도출 후 전임상 시험을 거쳐 임상 개발 진입 예상- 전임상 및 임상 시험 결과를 바탕으로 글로벌 제약사들과의 라이선스 아웃을 적극 추진</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="191" USERMARK=" BC0XD7D7D7">⑦ 경쟁제품</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="191">
<P>- 현재 GLP-1 유도능을 보이는 마이크로바이옴 유래물질 신약 및 개발 과제는 없음 </P>
<P>- GLP-1 유도체 기반의 당뇨 비만 치료제는 시장에 출시 중으로, Novo Nordisk사의 리라글루타이드(Liraglutide) 및 세마글루타이드(Semaglutide), Eli Lilly사의 엑세나타이드(Exenatide) 및 둘라글루타이드(Dulaglutide), Sanofi사의 릭시세나타이드(Lixisenatide) 등이 있음- 현존하는 치료제들의 경우 주사제 투여에 따른 편의성 문제와 위장관계 부작용 등 미충족 의료수요가 존재함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="237" USERMARK=" BC0XD7D7D7">⑧ 관련논문 등</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="237">

<P>Lim, M. Y. et al., The effect of heritability and host genetics on the gut microbiota and metabolic syndrome(출처: Gut, 2017).Seo, B. et al., 
<SPAN USERMARK=" I">Roseburia s</SPAN>pp. abundance associates with alcohol vonsumption in humans and its administration ameliorates alcoholic fatty liver in mice(출처: Cell Host & Microbe, 2022).Yoon, H. S. et al., 
<SPAN USERMARK=" I">Akkermansia muciniphila </SPAN>secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice(출처: Nature Microbiology, 2021).You, H.Y. et al., 
<SPAN USERMARK=" I">Bacteroides vulgatus </SPAN>SNUG 40005 restores Akkermansia depletion by metabolite modulation(출처: Gastroenterology, 2023).
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="122" USERMARK=" BC0XD7D7D7">⑨ 시장규모</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="122">
<P>- 비만 시장은 2019년 약 13억 달러 수준에서 2024년 약 29억 달러 수준으로 성장할 것으로 예상됨(출처: Evaluate Pharma)- 2형 당뇨 시장은 2016년 기준 약 286억 달러 규모에서 2026년 약 640억 달러 규모로 성장이 예상됨(출처: GlobalData, Type 2 diabetes; Global drug forecast and market analysis to 2026)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">⑩ 기타사항</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(4) KBLP-006: </P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="503"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="30">① 구분 </TD>

<TD WIDTH="512" HEIGHT="30">
<P>마이크로바이옴 신약(Live biotherapeutic product)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="30">② 적응증</TD>
<TD WIDTH="512" HEIGHT="30">염증성장질환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="76">③ 작용기전</TD>

<TD WIDTH="512" HEIGHT="76">
<P>- 인체 마이크로바이옴 유래 기능성 균주 활용- 우수한 숙주 항염증 및 면역조절 기능을 갖추었으며 장관벽 밀착연접의 강화 효과를 보임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="99">④ 제품의 특성</TD>

<TD WIDTH="512" HEIGHT="99">
<P>- 인체 공생 미생물을 황용하여 안전성이 매우 우수하고, 경구 투여 방식을 채택하여 복용편의성 역시 고려함</P>
<P>- 부작용이 없어 인플릭시맙(infliximab) 등타 염증성장질환 치료제와의 병용투여 역시 적합함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="99">⑤ 진행경과</TD>

<TD WIDTH="512" HEIGHT="99">
<P>- 염증성 장질환 및 아토피 피부염 등 다양한 면역 질환 모델에서의 효능을 확인함- 염증성 장질환 동물 모델에서 균주 및 기존 치료법(단클론항체) 병용투여로 인한 시너지 효과 확인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="53">⑥ 향후계획</TD>

<TD WIDTH="512" HEIGHT="53">
<P>- 기능성 향상을 위한 균주 복합체 구성 등을 추가 검토한 뒤, 임상 개발 및 추가 파트너십 구축 등을 통하여 본격적인 사업화 진행 계획</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="102">⑦ 경쟁제품</TD>

<TD WIDTH="512" HEIGHT="102">
<P>- 현재 생균치료제 측면에서의 염증성 장질환 치료제는 제시된 바  없으며, Vedanta Bioscience사의 VE202 등이 임상 2상에 진입함- 현재 제시되어 있는 5-ASA 및 인플릭시맙 등과는 별도의 기전을 보이는 바, 충분히 새로운 시장을 창출할 수 있을 것으로 판단됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="214">⑧ 관련논문 등</TD>

<TD WIDTH="512" HEIGHT="214">Kim, W. K. et al.,
<SPAN USERMARK=" I"> Lactobacillus paracasei </SPAN>KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota(출처: Gut Microbes, 2020).Han, D. H. et al., 
<SPAN USERMARK=" I">Lactobacillus paracasei </SPAN>treatment modulates mRNA expression in macrophages (출처: Biochemistry and Biophysics Reports, 2020).Kim, W. K. et al Administration of 
<SPAN USERMARK=" I">Lactobacillus paracasei </SPAN>strains improves immunomodulation and changes the composition of gut microbiota leading to improvement of colitis in mice (출처: Journal of functional foods, 2020).
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="168">⑨ 시장규모</TD>

<TD WIDTH="512" HEIGHT="168">
<P>- 염증성 장질환의 일종인 궤양 대장염의 경우, 만성 재발성 대장염, 만성 지속성 대장염 및 급성 전격성 대장염 등 세가지 양상을 보이며, 특히 95%를 차지하는 만성 재발성 대장염은 완치가 어려운 양상을 보임- 궤양성 대장염 유병률은 선진 7개국 시장 기준으로 2016년 약 174만명에서 연평균 0.7% 증가하여 2026년에는 약  187만명에 달할 것으로 예상됨.- 신규 진단 환자는 2016년 약 9만 4,300명에서 연평균 1.4% 증가하여 2026년에는 약 10만 8,400명으로 예상됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" USERMARK=" BC0XD7D7D7" HEIGHT="30">⑩ 기타사항</TD>
<TD WIDTH="512" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(5) KBLP-010:</P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="503"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">① 구분 </TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>마이크로바이옴 신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">② 적응증</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>자폐 스펙트럼 장애</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="122" USERMARK=" BC0XD7D7D7">③ 작용기전</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="122">
<P>- 장-뇌축(Gut-Liver Axis) 개념 적용- 장에서 세로토닌 전구체인 TPH-1(tryptophan hydroxylase-1)의 생합성을 촉진시켜 뇌의 세로토닌 농도를 조절</P>
<P>- 장내 면역세포에 작용하여 항염증성 사이토카인 IL-10 분비 및 염증성 사이토카인인 IL-1β감소 유도 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">④ 제품의 특성</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="76">
<P>- 인체 공생 미생물 기반의 치료제로 전신순환 없이 장 점막에 존재하는 면역세포를 조절하고 신경전달 물질 생합성 유도 효능을 보여, 안전성이 매우 우수하고 장기적인 사용이 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="122" USERMARK=" BC0XD7D7D7">⑤ 진행경과</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="122">
<P>-시험관 시험을 통해 주요 신경전달 물질인 세로토닌 합성 유도능이 높고 항염증 사이토카인인 IL-10 유도능이 높은 KBL396 균주 도출</P>
<P>- 스트레스 유도 동물모델 시험을 통하여 우울, 불안 등의 정신 신경계 증상의 완화 효능 확인</P>
<P>- 현재 자폐 스펙트럼 장애 동물모델 시험 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">⑥ 향후계획</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="53">
<P>- 자폐 스펙트럼 장애 동물모델 시험 결과 확보 후, 후속 의약품 임상 1상 진입 계획</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">⑦ 경쟁제품</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="76">
<P>- 마이크로바이옴 기반 신약 자폐 스펙트럼 장애 치료제로 개발을 진행 중인 과제로, Axial Therapeutics사의 AB-2004(프리바이오틱스) 및 Scioto Biosciences사의 SB-121(균주) 등을 들 수 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">⑧ 관련논문 등</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="76">
<P>Lim, J. S. et al., Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia(출처: Molecular Brain, 2017).</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XD7D7D7">⑨ 시장규모</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="76">
<P>- 자폐 스펙트럼 장애 치료 시장은 2018년 기준 약 33억 달러에서 2026년 46억 달러 규모로 성장할 것으로 예상됨(출처: Fortune Business Insight 및 BCC report)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">⑩ 기타사항</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="53">
<P>- 향후 자폐 동물모델 시험결과를 바탕으로 의약품 개발 또는 건강기능식품 개발 중 선택하여 추가 개발할 예정임</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>나) 계획 중인 후속 프로젝트당사는 현재 면역항암 파이프라인 KBLP-005를 구축하여, 전임상 수준에서 후보균주 및 유효물질을 탐색하고 있습니다. 향후 면역항암제 및 병용투여형 항암보조제 등으로 자체 개발 파이프라인을 확장하여 빠른 비임상 및 임상시험에 돌입할 수 있도록 준비 중입니다. 또한 (주)셀트리온과 마이크로바이옴 기반 과민성대장증후군 및 아토피피부염 치료 후보 물질을 공동으로 발굴하는 연구를 진행하고 있습니다.</P>
<P></P>
<P>5) 정부과제 수행실적  </P>
<P></P>

<TABLE BORDER="1" WIDTH="908" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="34"></COL>
<COL WIDTH="248"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>연번</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>과제명</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>주관기관</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>세부과제</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>기간</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>진행여부</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">1</TD>
<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">마이크로바이옴 및 천연물 복합체에 기반한 대사증후군 개선 차세대 식품 신소재 개발</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">농림식품기술기획평가원</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">농생명마이크로바이옴혁신기술기반구축사업</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">24.04. ~ 28.12.</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">진행 중주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2</TD>
<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">세로토닌과 T도움 17세포 이중 조절 휴먼마이크로바이옴을 통한 자폐스펙트럼 장애 중증도 개선</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">산업통상자원부/한국산업기술평가관리원</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">바이오산업기술개발사업</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">23.04. ~ 25.12.</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">3</TD>
<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">삼제 병용 마이크로바이옴 균주 복합체를 이용한 경구용 비만 치료제 개발</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">국가신약개발사업단</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">국가신약개발사업</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">23.04. ~ 25.03.</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">4</TD>
<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">마이크로바이옴 유래 대사성질환 제어 신소재 발굴 및 생산 플랫폼 구축</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">과학기술정보통신부/한국연구재단</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">바이오의료기술개발사업</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">23.04. ~ 27.12.</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">5</TD>
<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">장내미생물 기반 질환 맞춤형 스마트바이오 전달체 개발</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">과학기술정보통신부/한국연구재단</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">바이오의료기술개발사업</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">22.04. ~ 26.12.</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>6</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>염증성 장질환 제어 가능 장내 미생물 발굴 및 기전 연구</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>과학기술정보통신부/ 한국연구재단</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>포스트게놈다부처유전체사업</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>19.09. ~ 21.12.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>완료(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>7</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>장내 미생물 불균형 개선 및 요독 물질 감소를 통한 만성신장질환 개선을 위한 한국인 유래 균주 프로바이오틱스 제품의 개발 </P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>산업통상자원부/한국산업기술평가관리원</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>산업핵심기술개발사업</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>17.07. ~ 21.06.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>완료(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>8</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>정신건강 치유 목적의 사이코바이오틱스 개발 및 상용화</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>산업통상자원부</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사업화연계기술개발사업</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>18.04. ~ 19.12.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>완료</P>
<P>(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>9</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>질내 미생물 소재를 이용한 아토피 피부염 치료 효능 프로바이오틱스 제품 개발</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>중소벤처기업부(전 중소기업청)</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>혁신형기업기술개발사업 (글로벌스타벤처)</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>17.06. ~ 19.06.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>완료</P>
<P>(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>10</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>장내 미생물총 개선 소재 및 제품에 대한 면역기능 개선 효능 평가</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>농림수산식품기술기획평가원</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>고부가가치식품기술개발사업</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>16.10. ~ 18.10.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>완료</P>
<P>(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>11</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>류마티스 관절염 인체 미생물 바이오마커 후보군 발굴을 위한 메타게놈 분석</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>과학기술정보통신부(전 미래창조과학부) / 한국과학기술연구원</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>바이오의료기술개발사업</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>16.07. ~ 18.12.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>완료</P>
<P>(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>12</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">

<P>인간유래 마이크로비옴을 이용한 
<SPAN USERMARK=" I">Clostridium difficile</SPAN> 감염 예방 및 치료법 개발
</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>과학기술정보통신부(전 미래창조과학부) / 한국산업기술진흥협회</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>투자연계형 기업성장R&D사업</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>16.09. ~ 17.08.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>완료</P>
<P>(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>13</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>대사성 질환 개선을 위한 맞춤형 마이크로비옴 치료법 사업화</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>중소벤처기업부(전 중소기업청)</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>투자연계멘토링과제</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>15.08. ~ 16.08.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>완료</P>
<P>(성공)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="43" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>14</P>
</TD>

<TD WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>마이크로비옴 기반 염증성 장질환 제어기술</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>중소벤처기업부(전 중소기업청)</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>선도벤처연계창업지원사업</P>
</TD>

<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>15.08. ~ 16.06.</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>완료</P>
<P>(성공)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주) 본 과제는, 분기보고서 제출일(2024년 05월 03일) 현재 협약이 완료되었습니다. </SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-7-L1" ATOCID="49">7. 기타 참고사항</TITLE>
<P></P>
<P>【용어설명표】</P>
<P>당사가 영위하는 사업의 내용을 이해하기 위하여 개념정리가 필요한 용어에 대한 참고 해설은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="971" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="652"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>용어</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>해설</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>개념 증명</P>
<P>(Proof of concept, PoC)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>기존 시장에서 사용되지 않은 신기술을 도입하기에 앞서 신기술의 유효성을 검증하기 위한 목적으로 진행하는 다양한 실험 및 임상 시험들을 지칭합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>건선</P>
<P>(Psoriasis) </P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>건선은 피부에 경계가 뚜렷하며 다양한 크기의 은백색 비늘로 덮여 있는 홍반성 구진 및 판이 형성되는 질환을 의미하며, 특히 악화와 호전이 반복되는 만성 염증성 피부 질환입니다. 상피의 과다 증식이 건선의 주된 조직학적 특징입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>공생균</P>
<P>(Commensal bacteria)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>공생균은 숙주(host)와 함께 공존하여 좋은 영향을 주는 세균을 지칭합니다. 특히 인체 내 다양한 공생균들은 대사 및 면역 과정 등에 크게 기여하는 것으로 알려져 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>군집 분석</P>
<P>(Taxonomic analysis)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>특정 환경에 존재하는 미생물의 종류 및 분포를 파악하는 방법이며, 특히 미생물군의 분포 및 다양성, 상관성 등을 총체적으로 분석하여 질환-마이크로바이옴 간 연관성을 밝혀낼 수 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>균주</P>
<P>(Strain)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>최초 한 미생물 세포에서 유래한 동일한 미생물 개체들의 집합을 의미하며, 이들은 유전적으로 동일한 특성이 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>글루카곤 유사 펩타이드-1</P>
<P>(Glucagon like peptide-1, GLP-1)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>글루카곤 유사 펩타이드-1은 광범위한 효과를 가지는 것으로 알려져 있는 호르몬입니다. 글루카곤 유사 펩타이드-1은 장의 L세포에서 장관 내 영양분 및 혈당 농도에 자극을 받아 분비되며, 정상적인 포도당 향상성 및 음식 섭취 억제, 나트륨 배출, 배뇨 증가, 신경 및 인지 기능 조절 등의 다양한 대사과정 및 신경/인지 기능 조절 등에 주요한 역할을 수행하는 것으로 알려져 있습니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>난배양성 미생물</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>미생물은 각기 선호하는 생육 조건이 있으며, 특히 인체 장관계 등에서 유래한 균주들은 산소가 없는 혐기(anaerobic condition) 조건을 선호하거나 특정 영양 물질만을 사용하는 등 까다로운 조건을 맞추어 주어야만 합니다. 이렇듯 배양 조건이 까다로운 미생물을 난배양성 미생물로 지칭합니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>다중오믹스 분석</P>
<P>(Multi-Omics analysis) </P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="122">
<P>다중오믹스 분석은 유전체(genome), 전사체(transcriptome), 단백체(proteome), 대사체(metabolome), 후성유전체(epigenome), 지질체(lipodome) 등 분자 수준에서 생성된 다양한 데이터들의 총체적이고 통합적인 분석을 의미합니다. 특히 다중오믹스 분석은 단일 -체(-omics) 분석에 비해 매우 복합적이고 통합적인 정보를 제공하여, 생물학적 메커니즘들을 더욱 확고하게 규명하는 것이 가능합니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>대사물질</P>
<P>(Metabolite)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>다양한 대사과정에서 파생하는 물질들을 일컬으며, 특히 미생물의 대사과정에서 생성되는 짧은단쇄지방산(short-chain fatty acid) 등은 인간 등 숙주에게 이로운 건강 효과를 보이는 것으로 알려져 있습니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">대사성 지방간질환[Metabolic (dysfunction)-associated fatty liver disease (MAFLD)] </TD>
<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">대사성 지방간질환이란 알코올 섭취 및 지방간을 초래하는 약물의 복용 등 다른 원인에 의한 간질환의 존재 여부와 관계 없이, 대사 이상의 존재를 기초로 하여 영상의학 검사나 조직 검사에서 간내 지방 침작 소견을 보이는 질환을 말합니다. 대사성 지방간질환의 주요 병인은 인슐린 저항성으로 인한 간내 지방 침착, 과도한 영향 섭취, 유전적 원인 등으로 알려져 있습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>마이크로바이옴</P>
<P>(Microbiome)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>특정 환경에 존재하는 세균, 바이러스 및 곰팡이 등 모든 미생물의 유전체를 통칭하는 단어로, 미생물 군집(microbiota) 및 유전체의 합성어입니다. 최근에는 특정 환경에서의 모든 미생물군의 집합체로 의미가 확장되어 활용되고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>마이크로바이옴 치료제</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="122">
<P>마이크로바이옴 치료제는 인체 유래 균주에서 기반하여 전통적인 신약 대비 충분한 안전성을 보증할 수 있으며, 제조 공정 역시 용이한 편으로 생산 관련 비용 및 기간 역시 크게 낮은 편입니다. 특히 신약 임상시험이 안전성 부분이 큰 난점으로 작용하는 가운데, 마이크로바이옴 치료제는 안전성을 보장하면서도 치료 효과를 보일 수 있기에 신약 회사 및 바이오벤처 등의 관심이 높습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>면역 피부질환</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>면역 피부질환은 단순한 피부 감염병 등이 아닌 만성적인 전신 면역질환을 통칭하는 개념으로, 대표적으로 아토피 피부염(atopic dermatitis) 및 건선(psoriasis) 등이 있습니다. 현재 표준치료법으로 제시하고 있는 스테로이드나 항히스타민제와 같은 약물 치료 요법은 내성 및 부작용등이 보고된 바, 아직까지 근본적인 치료 방법이 부족합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">면역항암제</TD>
<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">체내 면역기능의 활성 또는 면역체계 간 신호 경로에 영향을 주는 등을 주요한 기전으로 하여 암세포의 증식을 막는 치료제들을 일컫습니다. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>미국 식품의약국</P>
<P>(US Food and Drug Administration, US FDA)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>미국 식품의약국은 전 세계적으로 가장 엄격한 기준을 가진 의약품 및 기타 식품/화장품 등의 허가당국으로, 그 공신력을 세계적으로 인정받고 있습니다. 동일한 역할을 하는 국내 부처는 식품의약품안전처(MFDS)입니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비교유전체 분석</P>
<P>(Comparative gemone analysis)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>다양한 대상 종/개체의 유전체를 서로 비교분석하는 방법입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">비만(Obesity)</TD>
<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">신체적, 행동적, 환경적 요인들의 상호 작용이 에너지 대사에 있어 만성적 잉여 에너지를 야기시켜, 결과적으로 비정상적 또는 과도하게 지방이 체내에 축적되고 체중이 증가하여 건강을 해치는 상태를 의미합니다. 비만은 당뇨병, 이상지질혈증, 암, 근골격계 질환 등 다양한 질환들의 발생 위험성을 크게 증가시키는 것으로 알려져 있습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>생균의약품</P>
<P>(Live biotherapeutics product, LBP)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>살아있는 미생물을 이용한 질병 치료 의약품을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>생물정보기술</P>
<P>(Bioinformatics) </P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>정보기술(information technology)을 적용하여 유전 정보 등 생명체에서 발생하는 방대한 생명 정보들을 분석하고 유용한 정보를 확보하는 것을 목적으로 하는 기술입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>세균</P>
<P>(Bacteria)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>세균은 생물의 주요 분류군 중 하나로, 독립적인 단세포 생명체이며 핵막이 없는 원핵생물(prokaryote)입니다. 크기가 매우 작아 현미경을 통하여 관찰할 수 있으며, 토양 및 해양, 인체 등 다양한 환경에서 적응이 가능하며 물질의 순환과 인체의 건강-질환 현상 등에 있어 매우 중요한 역할을 하는 것으로 알려져 있습니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>세로토닌</P>
<P>(Serotonin)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>세로토닌은 중추신경계와 소화기관에 있는 신경전달물질로, 소화기관에서는 소화를 조절하고 중추신경계에는 기분, 수면, 식욕, 기억 및 학습 등 광범위한 부분에 관여하는 것으로 알려져 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>신약허가신청</P>
<P>(New drug application, NDA)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품의 신약허가를 신청하는 것을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>안전성</P>
<P>(Safety)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>특정 용량 및 투여 방식을 적용할 때, 해당 의약품이 인체에 유해하지 않다는 것을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>알레르겐</P>
<P>(Allergen)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>다양한 알레르기 반응을 유발할 수 있는 모든 물질을 말하며, 특히 현재는 면역글로불린 E(immunoglobulin E, IgE) 항체에 의한 즉시형 알레르기의 발상에 관여하는 항원을 부르는 경우가 많습니다. 알레르겐의 종류는 꽃가루, 털, 진드기, 식품 등 다양하며 그 본태는 단백질이나 저분자 화학물질 등이 대부분입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>약물동태</P>
<P>(Pharmacokinetics)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>약물의 흡수(absorption), 분포(distribution), 대사(metabolism), 배설(excretion) 과정을 동역학적 관점에서 해석하고 예측하는 것으로, 특히 약물의 생체 내 이행 및 변화 과정을 살핍니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>역중개 연구(Reverse translational research)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>일반적인 신약개발은 실험실에서 기초 연구를 통해 세포나 동물에서 드러난 원리를 인간에게 적용하는 중개 연구(translational research)로 진행됩니다. 역중개 연구는 이와 반대로, 인체에서 나타나는 현상의 기초 원리를 다시 실험실 연구를 통해 밝히는 새로운 접근법으로, 질병의 기전 규명 및 치료제 개발 성공 가능성을 보다 높일 수 있는 연구 방법입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>염증성 장질환(Inflammatory bowel disease, IBD) </P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="122">
<P>염증성 장질환이란 호전과 재발을 반복하면서 장내 만성적인 염증과 궤양을 일으키는 질환으로, 특히 환경적 요인 및 유전적 요인과 더불어 장내 존재하는 세균 구성에 대한 체내 과도한 면역반응 등이 주요한 발병 요인으로 여겨집니다. 주요한 염증성 장질환으로 크론병(Crohn's disease) 및 궤양성 대장염(ulcerative colitis) 등이 있으며, 현존하는 치료법으로는 완치가 어려운 난치성 질병입니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>오가노이드(Organoid)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>오가노이드는 줄기세포 및 장기 기원세포로부터 분리한 세포를 3D 배양법 등으로 재응집/조합하여 만든 장기 특이적 세포집합체로, 실제 장기가 지닌 특정 기능을 생체외(in vitro)에서 재현할 수 있다는 장점이 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>완제의약품(Drug product)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>모든 제조 공정을 완료하여, 소비자에게 투여할 수 있도록 일정한 제형으로 제조된 의약품을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>우수 실험실 관리 기준(Good laboratory practice, GLP)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>의약품 및 기타 화장품, 건강기능 식품 등 안전성 평가를 받아야 하는 모든 제품들에 대한 독성시험의 신뢰성을 보증하는 기준으로, 식품의약품안전처 등 허가당국의 승인 하에 자격이 부여됩니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>우수 제조관리 기준(Good manufacturing practice, GMP)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>의약품 및 기타 화장품, 건강기능 식품 등의 제조 및 관리 기준으로 국가별로 GMP 규정을 구축하여 운영하며, 식품의약품안전처 등 허가당국의 승인 하에 자격이 부여되고 이후 지속적인 실사를 받습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>유전체(Genome)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>특정한 개체가 가지고 있는 유전 정보의 총합으로, DNA(deoxyribonucleic acid) 및 RNA(ribonucleic acid) 등으로 구성되어 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>유효성(Efficacy)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>특정 용량 및 투여 방식을 적용할 때, 해당 의약품이 원하는 수준의 약효를 나타낼 수 있음을 의미합니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>원료의약품(Drug substance)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품의 핵심 활성성분 또는 활성성분들의 혼합물을 의미하며, 약효를 나타내는 주성분을 지칭합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁제조기관(Contract manufacturing organization, CMO)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>대량 생산 시설을 갖추고, 사용자의 주문에 따라서 제조를 위탁해주는 기관들을 지칭합니다. 특히 생산 시설을 구축하기 힘든 바이오벤처 등에게 매우 유용한 기관 중 하나입니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁임상시험기관</P>
<P>(Contract research organization, CRO)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>사용자의 수요에 의거하여 임상시험의 설계 및 모니터링, 데이터 수취 및 관리, 허가대행 등의 업무를 일괄 대행해주는 기관들을 지칭합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>임상시험(Clinical trial)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="145">
<P>의약품의 안전성 및 유효성 등을 증명하기 위해 사람을 대상으로 실시하는 모든 시험을 총칭합니다. 임상 1상 시험은 건강한 사람들을 대상으로 안전한 약물의 용량 및 인체의 약물 흡수를 파악하는 것이며, 임상 2상 시험은 환자군을 대상으로 약물의 유효성 및 부작용 등을 평가하고자 진행합니다. 이후 대규모의 검증 시험인 임상 3상을 실시한 후 해당 자료를 허가당국에 제출하여 허가를 받는 수순으로 구성되어 있습니다. 필요시 허가 이후에 시판 후의 안전성 및 유효성을 조사하려는 목적으로 임상 4상을 진행하기도 합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상시험계획 승인 신청(Investigational new drug application, IND)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>임상시험을 수행하려고 하는 자가 식품의약품안전처 등 허가당국의 승인을 신청하는 과정으로, 특히 신약개발에 있어서 필수 과정입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">자폐 스펙트럼 장애(Autism spectrum disorder)</TD>
<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">자폐 스팩트럼 장애는 사회적 상호작용의 장애, 언어성 및 비언어성 의사소통의 장애, 상동적인 행동 등을 특징으로 하는 장애로, 대개 3세 이전에 발달상의 차이점을 확인할 수 있으나 일부 아이들은 학령기에 들어 진단을 받기도 합니다. 개별적인 환자들의 문제 행동들이 광범위한 스펙트럼을 보인다고 하는 의미에서 스펙트럼 장애라고 지칭합니다. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>작용기전(Mode of action, MOA)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>인체 내에서 치료제의 효능이 나타나는 원리(기전)을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>장-간 축(Gut-liver axis)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="122">
<P>장과 간 사이의 밀접한 연관성에 대한 새로운 이론으로, 특히 간으로 공급되는 혈액의 70% 이상이 장의 문정맥(portal vein)에서 유래한다는 점이 주요 요인으로 고려되고 있습니다. 현재 다양한 연구들이 장내 균총과 대사 이상으로 인한 다양한 간질환 사이의 밀접한 연관성을 규명한 바 있으며, 특히 장내 마이크로바이옴의 균형이 붕괴되면서 다양한 간질환이 유발될 수 있다는 점을 제시하고 있습니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>장-뇌 축</P>
<P>(Gut-brain axis)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>뇌와 장 사이의 밀접한 연관성에 대한 새로운 이론으로, 특히 자폐 스펙트럼 장애 및 치매 등의 각종 뇌 질환들과 소화기관 내 마이크로바이옴이 깊은 연관성을 보이는 최신 연구들을 통해 보다 구체화되고 있습니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>전임상시험(Pre-clinical study)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>임상시험 전, 쥐 등 다양한 동물군들을 대상으로 새로운 신약 후보 물질의 안전성 및 유효성을 평가하는 것을 말합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>전장유전체(Whole genome)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>한 생물의 전체 유전체 정보를 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>종(Species)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>미생물은 이분법(binary fission) 등 통상의 타 종들과는 번식방법이 다르기에, 형태 및 유전, 생리학적 조건이 동일하거나 통계적으로 유사한 무리를 종으로 지칭하여 구분합니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>차세대 염기서열분석(Next-generation sequencing, NGS)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>대규모 염기서열을 저비용, 고효율로 동시에 분석할 수 있는 방법으로, 현대 유전체 분석에 있어 필수적인 기법입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>천식(Asthma)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>천식은 알레르기 염증에 의해 기관지가 반복적으로 좁아지는 만성 호흡기 질환으로, 특히 기관지가 좁아져서 숨이 차고 기침이 나며, 가슴에서 색색거리는 소리가 들리고 답답해지는 증상 등이 반복적으로 되풀이되는 경향을 보입니다. 우리나라 성인 인구의 5% 정도가 천식을 앓고 있는 것으로 알려져 있으며, 최근 전 세계적으로도 환자 수가 증가하는 경향을 보이고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>컬처로믹스(Culturomics)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>컬쳐로믹스는 대규모 균주을 대상으로 한 배양조건을 구축하여 다양한 난배양성 미생물을 순수 분리한 후, 유전자 염기서열로 각 미생물을 동정하는 수순으로 진행하는 기법을 의미합니다. 이러한 과정을 통해, 희귀 난배양성 균주를 발견할 가능성을 높이고, 새로운 종에 대한 특성 파악이 가능하며, 다양한 균주들 사이의 상호작용 역시 확인할 수 있다는 장점이 있습니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>코호트(Cohort)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>코호트는 공통적인 특성을 가진 구성원들을 모은 집단을 의미합니다. 코호트 연구는 현대 역학 연구에서 가장 중요한 조사 방법 중 하나로 특정 질병의 발병률 또는 특정 치료법의 효과 등의 규명에 있어서 핵심적인 연구방법론으로 활용되고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">

<P>클로스트리디움 디피실레 감염증(
<SPAN USERMARK=" I">C.difficile </SPAN>infection, CDI)
</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>기회감염균인 클로스트리디움 디피실레가 장내에 이상적으로 많이 증식된 경우를 의미하며, 특히 항생제를 투여받는 환자의 장관 내 정상세균총(normal flora) 조성이 변하면서 발생하는 경우가 많습니다. 클로스트리디움 디피실레 감염증은 대표적인 의료관련 감염병(health-care associated infection)으로도 알려져 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">항암제(Anti-cancer drug)</TD>
<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">암세포의 증식을 억제하는 치료제들로, 암세포의 사멸을 위한 화학제재 및 표적항암제, 면역항암제 등이 제시되어 있습니다..</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>항생제 내성(Antimicrobial resistance)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>세균은 각기 다양한 항생제들에 대해 내성을 가지고 있으며, 이에 특정 항생제에 대한 내성 여부가 마이크로바이옴 기능성 소재의 안전성 판단의 주요한 기준이 됩니다. 현재 주로 사용하는 유익균들에 대해 유럽 식품안전청(European Food Safety Authority, EFSA) 공신력을 갖춘 기준을 제시하고 있습니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>혁신(First-in-class) 신약</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="53">
<P>적절한 치료제가 없거나, 또는 기존 약물 대비 월등한 치료효과를 보이는 신규 치료제를 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>혈액뇌장벽(Blood-brain barrier)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="99">
<P>색소, 약물, 독물 등 각종 이물질의 유입을 방지하여 뇌를 보호하는 뇌조직상 장벽(관문)을 의미합니다. 혈액뇌장벽은 대부분 인지질로 이루어져 있으며, 뇌세포를 둘러싼 뇌혈관에 전체적으로 분포합니다. 뇌모세혈관 내피세포가 혈액뇌장벽에 밀착 결합하고 있으며 주변을 아교세포가 빈틈없이 에워싸는 구조를 통해 약물이나 대사산물의 유입을 방지합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>16S ribosomal RNA(16S rRNA)</P>
</TD>

<TD WIDTH="661" VALIGN="MIDDLE" HEIGHT="76">
<P>미생물 리보솜의 30S 소단위체를 구성하고 있는 rRNA로, 특히 잘 보존되어 있는 유전자 부위이나 일부 구간에서 미생물 별로 다양성이 크게 발생하기 때문에, 주요한 미생물 동정 방법의 대상으로 활용됩니다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">가. 지적재산권 현황</P>

<TABLE BORDER="0" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 개)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="61"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">한국</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">미국</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">유럽</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">중국</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">일본</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타국가</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">PCT</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특허</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">174</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서비스</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">디자인</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">상표</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-1|ADX-1">※상세 현황은 '상세표-4. 지적재산권 상세' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">나. 주요 치료제 파이프라인 목표 시장 및 경쟁 우위</SPAN>1) 건선건선은 경계가 분명한 은백색의 인설로 덮여 있는 홍반성 피부 병변 및 표피의 두꺼워짐을 특징으로 하는 만성 염증성 피부질환입니다. 건선의 주된 원인은 면역 이상이며, 각막기질 세포의 과증식 및 염증성 사이토카인의 과발현을 일으키는 T 림프구의 피부 침윤 등이 주요 특징입니다. 특히 피부 외에 건선관절염, 대사증후군 및 심혈관계 합병증을 동반하는 경우가 많아 꾸준한 치료 및 관리가 필요합니다. 건선 유병률은 전 인구의 1.5~5% 수준으로, 특히 80~90%가 판상형 건선으로 알려져 있으며 이중 20% 가량이 중증 건선 환자입니다. 2018년 기준 주요 7개국(미국, 일본, 5개 EU국)에서 판상형 건선으로 진단받은 환자수는 약 1,490만 명 수준이며, 이중 판상형 건선으로 진단받은 환자 수는 약 1,490만 명 수준에 달합니다. 2027년 기준 환자 수는 약 1,690만 명, 치료 환자 수는 약 1,200만 명 수준으로 증가할 예정입니다.
</P>
<P>고바이오랩의 스마티옴 기술 기반 건선 치료제는 건강한 성인 상주균 유래 마이크로바이옴 치료제로 안전성이 매우 우수할 것으로 기대됩니다. 경구용 치료제로 환자 편의성이 높고 약가 측면에서도 단클론항체 대비 환자 접근성이 매우 용이할 것으로 보입니다. 특히 현재 미충족 의료 수요가 높은 중등도 건선 환자에서 장기간 사용이 가능한 안전한 1차 치료 옵션으로 자리매김할 것으로 기대되며, 중증 건선 환자 중 단클론항체 치료약의 적용이 어려운 환자에게 대안적인 치료 방법으로 사용될 수 있을 것입니다.</P>
<P></P>
<P>2) 아토피 피부염아토피 피부염은 주로 소아청소년에게 발병하는 염증성 피부질환으로 만성 재발성 피부질환이며 복잡한 발병 원인으로 인해 아직까지 미충족 의료 수요가 많은 질환입니다. 아토피 피부염 환자 수는 2022년 1억 3,100만 명까지 증가할 것으로 예측됩니다. 전 세계 아토피 피부염 치료제 시장은 2017년 약 64억 달러 수준에서 2027년에는 약 183억 달러로 성장할 것으로 전망됩니다. 2017년 기준 국가별 시장은 미국이 80%로 압도적인 시장 점유율을 기록하였습니다.</P>
<P></P>
<P>당사의 스마티옴 기술 기반 아토피 치료제는 건강한 성인 유래 마이크로바이옴 치료제로 안전성 측면에서 매우 우수할 것으로 기대되며, 경구 제제로 환자의 편의성이 높습니다. 이에 치료제 대안이 부족한 경/중증도 아토피 피부염 환자들에게 안전한 1차 치료제로 활용이 가능하며, 중증 아토피 피부염 환자에서 기존 약제와의 병용 요법용 치료제로도 충분히 활용할 수 있을 것입니다.</P>
<P>3) 천식천식은 기도의 만성염증과 만성기도폐쇄를 일으키는 만성질환으로, 국내 유병률이 5% 수준에 달합니다. 만성 폐쇄성기도질환은 최근 WHO 지정 4대 특별한 관리가 필요한 비감염성 질환군(심혈관질환, 암에 이어 사망률 3위의 질환)이며, 전 세계적으로 유병률과 사망률이 가장 빠르게 증가하는 질환입니다. 천식은 인종, 성별, 나이, 지역에 따라 유병률뿐 아니라 질환의 중증도와 예후가 다양한 질환으로 알려져 있습니다. 2019년 기준 주요 8개국(미국, 5EU, 일본, 중국)에서 천식으로 진단받은 환자 수는 약 1억 400만 명 수준으로 파악되고, 2023년 기준 환자 수는 약 1억 1,000만 명 수준으로 증가할 것으로 추정됩니다. 미국은 연평균 2.4% 수준으로 증가가 예상되는 등, 8개국 중 가장 빠른 증가세를 보이고 있습니다.</P>
<P>스마티옴 기반의 천식 치료제는 경구 제형의 치료제로 기존의 흡입 제형 치료제 및 주사 제형의 바이오의약품에 비하여 복용하기 쉽습니다. 주요 치료제인 ICS는 스테로이드 기반의 치료제로 장기 투입 시 부작용이 일어날 수 있다는 우려가 있는 반면, 스마티옴 기반의 천식 치료제는 안전성 측면에서 우려가 없을 것으로 기대됩니다. 아울러, 바이오의약품 대비 낮은 약가를 유지할 수 있으므로, 주 약제인 ICS/LABA와의 병용요법으로 환자의 약가 부담을 현저히 낮출 수 있을 것입니다.</P>
<P> </P>
<P>4) 염증성 장질환염증성 장질환이란 호전과 재발을 반복하면서 장내 만성적인 염증과 궤양을 일으키는 질환으로, 발병에 있어 유전, 식이, 환경, 면역 및 장내세균 등 여러가지 요인이 복합적으로 작용하는 것으로 알려져 있습니다. 주요한 염증성 장질환으로 크론병(Crohn's disease) 및 궤양성 대장염(ulcerative colitis) 등이 있으며, 현존하는 치료법으로는 완치가 어렵습니다. 또한 염증성 장질환의 일종인 궤양성 대장염 유병률은 선진 7개국 시장 기준으로 2016년 약 174만명에서 연평균 0.7% 증가하여 2026년에는 약 187만명에 달할 것으로 예상됩니다. 스마티옴 기술 기반 염증성 장질환 치료제는 건강한 성인 상주균 유래 마이크로바이옴 치료제로 안전성이 매우 우수하고, 경구용 치료제로 환자 편의성이 높고 약가 측면에서도 단클론항체 대비 환자 접근성이 매우 용이할 것으로 기대됩니다. 특히 중등도 궤양성 대장염 환자에서 장기간 사용이 가능한 안전한 1차 치료 옵션으로 자리 매김할 수 있을 것으로 보이고, 단클론항체 치료약제와의 병용 투여를 통해 환자 부담을 크게 낮추는 치료 옵션이 될 수 있을 것으로 예상됩니다.</P>
<P></P>
<P>5) 대사성 지방간질환</P>
<P>대사성 지방간질환이란 알코올 섭취 및 지방간을 초래하는 약물의 복용 등 다른 원인에 의한 간질환의 존재 여부와 관계 없이, 대사 이상의 존재를 기초로 하여 영상의학 검사나 조직 검사에서 간내 지방 침작 소견을 보이는 질환을 말합니다.  전체 대사성 지방간 환자의 10~20%는 대사성 지방간염으로 진행되고, 다시 이 환자들의 10~20%가 간경변증으로 진행합니다. 특히 지방간이 간경변증으로 진행하면 간기능 부전이나 간세포암 등으로 발전하여 사망에 이를 수 있습니다. 선진 7개국(미국, 5EU, 일본) 대사성 지방간질환 환자 유병률은 2016년 기준 약 6,129만 명 수준이고, 연평균 0.64% 증가하여 2026년에는 약 6,520만 명 수준이 될 것으로 예상됩니다.</P>
<P></P>
<P>스마티옴 기반의 대사성 지방간질환 치료제는 균주 자체 또는 균주 유래 물질로 부작용이 매우 작을 것으로 사료됩니다. 또한 경구 제형으로 복용 편의성을 확보할 수 있고, 적정한 약가로 출시 가능하여 환자 접근성 측면에서도 장점이 있으리라 기대됩니다. 특히 개발 중인 스마티옴 기반 파이프라인 특성상 대사성 지방간질환을 유발하는 여러 경로에서 효과를 발휘할 것으로 기대되는 만큼 치료 효능 측면에서도 타 제품 대비 개발 성공률이 높을 것입니다.6) 비만</P>
<P>비만은 신체적, 행동적, 환경적 요인들의 상호 작용이 에너지 대사에 있어 만성적 잉여 에너지를 야기시켜 결과적으로 비정상적 또는 과도하게 지방이 체내에 축적되고 체정이 증가하여 건강을 해치는 상태를 의미합니다. 한국에서는 체질량지수(body mass index, BMI) 25 이상을 비만으로 규정하나 국제적으로는 BMI 30을 초과할 때 비만으로 분류하고 있으며, 또한 한국에서는 허리둘레가 남성 90 cm, 여성은 85 cm 이상일 때 복부비만으로 정의하고 있습니다.  WHO의 2018년 발표에 의하면 전 세계적으로 약 650만 명의 인구가 BMI 30 이상의 비만 인구라고 평가받고 있습니다. 미국의 20세 이상 성인의 비만 유병률은 약 42.4%에 달하며, 2019년 기준 유럽 인규의 평균 과체중 비율은 약 53%에 달합니다. 국내 비만 환자 수는 2018-2021년 동안 가파르게 증가하였으며, 특히 2021년 환자 수는 2015년 대비 약 2배 이상으로 증가하는 양상을 보이는 등, 전 세계적으로 비만 환자수가 비약적으로 증가하는 경향을 보이고 있습니다.</P>
<P>스마티옴 기반의 비만 치료제는 인체 유래 균주로 구성되어 부작용이 매우 작을 것으로 사료됩니다. 또한 경구 제형으로 복용 편의성을 확보할 수 있고, 적정한 약가로 출시 가능하여 환자 접근성 측면에서도 장점이 있으리라 기대됩니다. 특히 주요한 비만 개선 효능을 지닌 균주들을 복합적으로 적용함으로써, 체중 및 체지방, 인슐린 저항성, 염증성 사이토카인 감소와 더불어 GLP-1 분비 및 thermogenesis 증가 등 다중 타깃 기전을 갖춘 비만 치료제를 개발하는 것이 가능합니다. 이에 향후 요요 효과(yo-yo effect)등, 기존 치료제들의 주요한 부작용을 극복할 수 있는 효과적인 비만 치료제로 시장에 자리매김할 것이라 기대하고 있습니다.</P>
<P>7) 자폐 스펙트럼 장애자폐 스펙트럼 장애는 사회적 상호 작용 장애, 언어 발달 장애, 반복되는 행동, 제한된 관심이나 활동 등을 특징으로 하는 질환입니다. 자폐 스펙트럼 장애는 자폐증 대비 상대적으로 증상은 약하지만 사회성에 문제가 있어 치료가 필요한 모든 경우를 포괄합니다. 자폐 장애(autistic disorder), 아스퍼거 증후군(Asperger syndrome) 및 전반적 발달 장애(pervasive development disorder)가 주요 3대 자폐 스펙트럼 장애의 형태입니다. 자폐 스펙트럼 장애의 전 세계 유병률은 약 1% 수준으로 알려져 있습니다. 행동 및 언어 치료, 의약품 치료제를 포함하는 글로벌 자폐 스펙트럼 장애 치료 시장은 2018년 기준 약 33억 달러 수준에 달하며, 연평균 4.3% 수준으로 증가하여 2026년에는 약 46억 달러 규모로 성장할 것으로 예측됩니다. 이 중 2018년 기준 미국 시장이 약 19억 달러 수준으로, 글로벌 시장의 약 58%를 차지했습니다.</P>
<P> </P>
<P> 장내 마이크로바이옴과 자폐 스펙트럼 장애와의 연관성은 많은 논문 등을 통해 밝혀져 있어, 마이크로바이옴을 이용한 치료제의 개발은 상당한 성공 가능성이 있습니다. 현재 적합한 치료제가 부재한 질환인 만큼, 치료제가 개발되면 시장에서 빠르게 매출을 늘려나갈 수 있으리라 기대됩니다. 스마티옴 기반의 자폐 스펙트럼 장애 치료제는 단일균주로 이루어진 경구 치료제로, 안전성 및 합리적인 약가, 품질 측면에서 잘 관리되는 마이크로바이옴 치료제로서 환자에게 좋은 치료제 옵션이 될 것입니다. </P>
<P></P>
<P>8) 암'종양(tumor)'이란, 신체 조직의 자율적인 과잉 성장에 의해 비정상적으로 자라난 덩어리를 의미하며, 이중 악성종양(malignant tumor)은 주위 조직에 침윤하면서 빠르게 성장하고 신체 각 부위에 확산되거나 전이되는 등의 양상을 보여 생명을 위협합니다. 이에 일반적으로 악성종양을 암과 동일하게 정의합니다. 암은 세포의 조절기능에 문제가 생겨, 정상적으로는 사멸해야 할 세포들이 비정상적으로 과다 증식하여 종괴를 형성하고 기존 구조를 변형/파괴시키는 과정을 거치며, 인체 내 대부분의 장기에 발생할 수 있습니다. 특히 인간의 수명이 길어짐에 따라, 전 세계적으로 암 유병률 및 사망률 등이 급격하게 증가하는 경향을 보입니다.  기존 화학항암제 및 표적항암제의 한계를 인식하여 최근 3세대 항암제인 면역항암제가 제시되고 있으나, 높은 생산 단가 및 염증성 사이토카인 폭풍 등의 부작용, 평균 70%에 달하는 비반응군 등의 한계점을 보이고 있습니다.</P>
<P>마이크로바이옴 연구가 보다 고도화됨에 따라, 흑색종 등 주요한 암종에 특정 미생물이 유의미한 치료효과를 보인다는 연구가 제시되고 있습니다. 현재 적합한 치료 방안이 제시된 바 없는 만큼, 향후 마이크로바이옴 치료제 개발 시 상당한 매출 효과를 기대할 있을 것으로 사료됩니다. 특히 마이크로바이옴 치료제는 비교적 낮은 독성으로 인하여 기존 치료제와의 병행투여 등 다양한 활용방안을 제시할 수 있으며 보다 범용적인 항암 기전을 제시할 수 있기에, 다양한 암 환자에게 있어 적합한 치료제 옵션이 될 수 있습니다. </P>
<P></P>

<P>
<SPAN USERMARK=" B">다. 경기 변동/계절적 요인의 영향</SPAN>
</P>
<P>신약은 인류의 생존과 직결되는 분야로, 특히 전 세계적인 인구 고령화 및 건강 관리에 대한 관심 증대 등으로 전체적인 시장이 빠르게 성장함에 따라 경기 변동 및 계절적인 요인에 대한 수요 영향이 크지 않습니다.프로바이오틱스 시장은 매년 빠르게 성장하여 기존 국내 최고의 건강기능식품으로 손꼽히는 홍삼의 아성을 위협하는 분야로 성장하였으며, 특히 개별인정을 받은 프로바이오틱스 소재들이 현재까지 시장에 많지 않기에 향후 당사의 개별인정형 제품들은 확고한 시장 경쟁력을 갖출 것으로 판단됩니다. 특히 건강기능식품은 인구 고령화 및 맞춤형 헬스케어 등이 강조되는 현대 사회에서 가장 빠르게 성장할 것으로 판단되는 분야로, 경기 및 계절의 영향을 충분히 최소화할 수 있습니다. 이에 당사가 지닌 사업모델들은 모두 경기 및 계절적 요인의 영향이 작다고 볼 수 있습니다.</P>

<P>
<SPAN USERMARK=" B">라. 라이프사이클</SPAN>
</P>
<P>마이크로바이옴 기술은 바이오 분야 중에서도 첨단에 있는 분야로, 현재까지 단 두 건의 치료제만 허가를 득하었으며 대부분의 파이프라인이 2상~3상에 머물러 있는 등 도입/성장기 수준으로 볼 수 있습니다. 특히 마이크로바이옴 기술을 적용할 수 있는 질병이 매우 다양하다는 점을 고려하였을 때, 향후 상용화될 시 그 수요는 매우 크게 증가할 것으로 판단됩니다.건강기능식품 분야는 현재 신바이오틱스, 포스트바이오틱스 등 프로바이오틱스를 넘어선 다양한 개념들이 제시되고 있고 신규 기능성을 입증받은 새로운 균주들이 개발되고 있어 수년 내 보다 크게 성장할 것으로 예측되기에. 성장기에 돌입한 것으로 판단됩니다.</P>

<P>
<SPAN USERMARK=" B">마. 관련 법령 또는 정부의 규제 등</SPAN>미국과 유럽 등 글로벌 과학기술 강국들은 인체 마이크로바이옴의 중요성을 선제적으로 인지하여, 막대한 자금 및 인력으로 구성된 대규모 프로젝트를 진행하고 있습니다. 마이크로바이옴 규제 측면에서 미생물기반의약품 및 분변이식에 대한 정식 기준을 갖춘 기관인 미국 FDA는 임상시험 품질관리 지침을 제공하고 지속적인 개정안을 제공하고 있습니다. 유럽연합(EMA)은 산학연 연합체로 구성된 Pharmabiotics Research Institute(PRI) 컨소시엄에서 치료제 관련 논의를 본격적으로 진행하고 있으며 유럽약전 상에 미생물기반의약품 품질관리 및 시험법 등을 등록한 바 있습니다. 국내 식품의약품안전처 역시 이러한 추세에 발맞추어 '마이크로바이옴 치료제 제품화 지원팀'을 구성하였으며, 생균치료제의 임상시험시 품질 가이드라인(마이크로바이옴 기반 의약품)을 발표하는 등 자체 허가기준을 제시하였습니다. 인체 유래 미생물기반의약품은, 인체 공생 미생물을 활용하고 약물의 전신 순환 과정을 배제할 수 있어 항체 및 세포치료제 등 기존 바이오 의약품보다 우수한 안전성을 가진다는 특징이 있으며, 규제 기관과의 논의를 바탕으로 독성 시험 최소화를 기대할 수 있습니다. 인체 마이크로바이옴 치료제는 바이오 업계에서도 매우 새로운 분야로써, 적절한 산업표준은 없으며 각국의 식품의약품 관련 규제 기관(예: 미국 FDA 및 한국 식품의약품안전처 등)가 제시하는 규정에 의거하여 임상 시험 및 의약품 허가를 받게 됩니다.  정부의 '건강기능식품 시장 규제 완화 정책' 시행에 따라 기존 건강기능식품 업체 외 일반 식품 업체들 역시 건강기능식품 시장에 참여하고 있으며, 보다 다양한 제품들이 출시되는 등 전 연령층에 걸쳐 건강기능식품에 대한 관심도가 높아지고 있습니다. 기능성 프로바이오틱스는 고시형 원료와 개별인정형 원료로 구분할 수 있습니다. 고시형 원료의 경우 '건강기능식품 공전'에 등재되어 있는 원료로 제조기준, 기능성 등 요건에 적합할 경우 누구나 사용이 가능합니다. 반면 개별인정형 원료는, '건강기능식품 공전' 에 등재되어 있지 않은 원료로 안정성, 기능성 및 기준 규격 등의 자료를 제출하여 식약처장으로부터 인정을 받은 업체만이 사용 가능합니다. 개별인정형 원료는 인정받은 일로부터 6년이 경과하고 품목제조신고가 50건 이상이면 고시형 원료로 전환될 수 있습니다.  건강기능식품의 경우 '건강기능식품에 관한 법률' 및 '건강기능식품 기능성 원료 및 기준·규격 인정에 관한 규정' 을 준수하고 있으며, 이외 주요한 부분들에 대해 한국식품의약품안전처 및 한국건강기능식품협회의 지침을 따르고 있습니다.
<SPAN USERMARK=" B">바. 주요 제품 등 관련 소비자 불만사항 등</SPAN>보고서 기준일 현재까지 당사 및 판매사를 통해 접수된 주요 제품 등 관련 소비자 불만사항 등의 발생 및 처리 내역은 없습니다.
<SPAN USERMARK=" B">사. 그 밖에 투자자의사결정에 필요한 사항</SPAN>당사는 보고서 작성기준일 현재까지 해당사항 없습니다.
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</LIBRARY>

</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0" ATOCID="10">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0" ATOCID="11">1. 요약재무정보</TITLE>
<P USERMARK=" 0X1814FF"></P>
<P USERMARK=" B">가. 요약연결재무정보</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="808">

<COLGROUP>
<COL WIDTH="799"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="808" HEIGHT="30">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="811">

<COLGROUP>
<COL WIDTH="318"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="327" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">   구   분</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제11기 1분기</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제10기</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제9기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(2024년 3월말)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(2023년 12월말)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(2022년 12월말)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">79,692,618,530</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,728,641,624</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,478,146,573</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ현금및현금성자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">23,591,770,365</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,046,639,594</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,432,871,701</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ단기금융상품</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">43,612,896,095</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,112,896,095</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">82,423,283,172</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ매출채권</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,116,583,688</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,857,806,384</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">701,914,026</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타유동금융자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,457,900,946</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,101,094,787</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,379,927,802</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타유동자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,617,953,271</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,663,233,415</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,408,128,051</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ당기법인세자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">682,026,784</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">433,768,144</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">184,413,466</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ재고자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,566,980,353</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,466,696,177</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">977,469,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ유동파생상품자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">970,138,761</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">39,453,569,074</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,894,266,983</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,451,787,164</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ유형자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">34,613,219,803</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,287,382,751</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,116,999,522</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ사용권자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">519,755,892</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">570,773,876</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">368,046,604</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ무형자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">621,404,958</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">637,665,461</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">279,600,682</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타비유동금융자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,181,133,301</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타비유동금자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">34,231,695</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">914,621,470</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">687,140,356</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타포괄손익-공정가치 측정 금융자산</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,483,823,425</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,483,823,425</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">자산총계</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">119,146,187,604</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">114,622,908,607</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,929,933,737</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">24,735,995,787</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,150,704,128</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,943,561,013</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">34,654,150,626</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,653,216,654</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,531,482,052</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">부채총계</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">59,390,146,413</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,803,920,782</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,475,043,065</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[자본금]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">9,715,074,000</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,950,617,802</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,452,857,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[주식발행초과금]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">214,421,546,294</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,685,074,000</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">214,356,598,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[기타자본항목]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(16,379,040,785)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">214,162,881,700</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,920,041,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[기타포괄손익누계액]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">269,669,830</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,282,304,959)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(431,870,971)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[결손금]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(165,013,693,893)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">212,245,018</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(148,974,520,307)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">[비지배주주지분]</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">16,742,485,745</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(162,827,277,957)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,131,785,393</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">자본총계</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">59,756,041,191</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,868,370,023</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">95,454,890,672</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년 1월~3월</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1월~12월</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 1월~12월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">매출액</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">14,909,719,393</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,138,037,063</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,605,576,680</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">영업이익(손실)</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,296,544,328)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(18,458,047,336)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(20,291,548,073)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">법인세차감전순이익(순손실)</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,312,300,214)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,682,704,469)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(23,030,373,296)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">당기순이익(순손실)</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,312,300,214)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(15,157,847,947)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(23,385,891,159)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">당기총포괄이익(손실)</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,254,875,402)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,472,057,031)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(23,551,178,546)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">기본주당순이익(손실)(원)</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(116)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(748)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,305)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">희석주당순이익(손실)(원)</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(116)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(748)</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,305)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" VALIGN="MIDDLE" HEIGHT="30">연결에 포함된 회사수</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>※ 상기 요약 연결재무정보 작성에 포함된 종속회사는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="107"></COL>
<COL WIDTH="247"></COL>
<COL WIDTH="247"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">사업연도</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당기에 연결에 포함된 회사</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기대비 연결에서 제외된 회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제11기 1분기</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">KoBioLabs Australia Pty Ltd주식회사 위바이옴</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제10기</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">KoBioLabs Australia Pty Ltd주식회사 위바이옴</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제9기</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">KoBioLabs Australia Pty Ltd주식회사 위바이옴</TD>
<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">나. 요약재무정보</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="634">

<COLGROUP>
<COL WIDTH="625"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="634" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="635">

<COLGROUP>
<COL WIDTH="210"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">   구   분</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제11기 1분기</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제10기</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제9기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(2024년 3월말)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(2023년 12월말)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">(2022년 12월말)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">58,854,827,209</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,266,125,617</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,555,338,537</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ현금및현금성자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">17,804,088,887</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,280,964,453</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,356,674,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ단기금융상품</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">39,012,896,095</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,512,896,095</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,423,283,172</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ매출채권</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">433,423,279</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">309,989,137</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">199,825,426</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타유동금융자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">492,407,447</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,543,434,658</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">902,236,347</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타유동자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">523,188,499</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">270,806,292</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">540,991,619</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ당기법인세자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">542,315,974</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">301,527,954</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">166,739,006</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ유동파생상품자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">965,588,606</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">35,494,883,517</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,627,605,012</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,187,514,337</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ종속기업투자</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">22,096,793,249</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,096,793,249</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,049,167,073</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ유형자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,037,270,714</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,146,524,410</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,654,553,059</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ사용권자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">85,673,753</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,027,118</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">111,903,254</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ무형자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">614,566,162</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">630,832,665</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">271,621,236</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타비유동금융자산</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">660,579,639</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">656,427,570</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,100,269,715</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">자산총계</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">94,349,710,726</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,893,730,629</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,742,852,874</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">17,000,854,922</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,941,539,596</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,587,202,037</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">7,944,071,124</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,950,679,536</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,215,925,897</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">부채총계</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">24,944,926,046</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,892,219,132</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,803,127,934</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[자본금]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">9,715,074,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,685,074,000</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,452,857,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[주식발행초과금]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">214,421,546,294</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">214,162,881,700</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">214,356,598,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[기타자본항목]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">5,252,052,222</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,348,788,048</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,408,077,903</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">[결손금]</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(159,983,887,836)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(157,195,232,251)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(145,277,808,264)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">자본총계</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">69,404,784,680</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,001,511,497</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,939,724,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">종속ㆍ관계ㆍ공동기업 투자주식의 평가방법</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원가법</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원가법</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원가법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년 1월~3월</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1월~12월</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 1월~12월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">매출액</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">467,251,645</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,715,314,389</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,476,416,092</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">영업이익(손실)</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,255,384,858)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,539,477,872)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,862,676,396)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">법인세차감전순이익(순손실)</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,788,655,585)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,419,808,155)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,399,436,429)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">당기순이익(순손실)</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,788,655,585)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,917,423,987)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,754,954,292)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">당기총포괄이익(손실)</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(2,788,655,585)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,917,423,987)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,754,954,292)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">기본주당순이익(손실)(원)</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(148)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(643)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(878)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" VALIGN="MIDDLE" HEIGHT="30">희석주당순이익(손실)(원)</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(148)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(643)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(878)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2><LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0" ATOCID="51">2. 연결재무제표</TITLE>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}BS_C">
<TITLE ATOC="Y" ATOCID="71">2-1. 연결 재무상태표</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">연결 재무상태표</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기말 2024.03.31 현재</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기말          2023.12.31 현재</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="586" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="295"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="304">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="141">
<P>제 11 기 1분기말</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="141">
<P>제 10 기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">자산</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　유동자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">79,692,618,530</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">75,728,641,624</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　현금및현금성자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">23,591,770,365</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">10,046,639,594</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　단기금융상품</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">43,612,896,095</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">56,112,896,095</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　매출채권</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,116,583,688</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,857,806,384</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동금융자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,457,900,946</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,101,094,787</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,617,953,271</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,663,233,415</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　당분기법인세자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">682,026,784</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">433,768,144</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　재고자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,566,980,353</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,466,696,177</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동파생상품자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">46,507,028</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">46,507,028</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　비유동자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">39,453,569,074</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">38,894,266,983</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유형자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">34,613,219,803</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">34,287,382,751</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　사용권자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">519,755,892</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">570,773,876</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　무형자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">621,404,958</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">637,665,461</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타비유동금융자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,181,133,301</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">914,621,470</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타비유동자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">34,231,695</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타포괄손익-공정가치 측정 금융자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,483,823,425</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,483,823,425</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　자산총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">119,146,187,604</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">114,622,908,607</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">부채</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　유동부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">24,735,995,787</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">21,150,704,128</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　매입채무</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">37,403,630</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동전환사채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">8,988,178,444</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">8,633,328,862</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동파생상품부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,648,076,654</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,648,076,654</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동금융부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,855,739,396</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,370,853,660</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동리스부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">235,658,770</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">234,205,400</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,111,399,445</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,205,876,071</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　단기차입금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,762,784,228</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동성장기차입금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">96,755,220</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">58,363,481</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　비유동부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">34,654,150,626</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">31,653,216,654</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　비유동리스부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">137,125,411</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">195,961,140</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타비유동금융부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">22,112,066,928</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">22,112,066,928</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타비유동부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">62,214,461</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">88,693,033</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　장기차입금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">12,258,254,712</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,172,006,439</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　종업원급여부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">84,489,114</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">84,489,114</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　부채총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">59,390,146,413</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">52,803,920,782</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">자본</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　지배기업의 소유주에게 귀속되는 자본</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">43,013,555,446</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">44,950,617,802</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　자본금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,715,074,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,685,074,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　주식발행초과금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,421,546,294</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,162,881,700</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타자본항목</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(16,379,040,785)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(16,282,304,959)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타포괄손익누계액</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">269,669,830</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">212,245,018</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　결손금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(165,013,693,893)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(162,827,277,957)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　비지배지분</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">16,742,485,745</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">16,868,370,023</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　자본총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">59,756,041,191</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">61,818,987,825</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="304" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">부채와 자본총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">119,146,187,604</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">114,622,908,607</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}IS_C1">
<TITLE ATOC="Y" ATOCID="72">2-2. 연결 포괄손익계산서</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">연결 포괄손익계산서</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기 2024.01.01 부터 2024.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기 1분기 2023.01.01 부터 2023.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="862" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="353"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="362" ROWSPAN="2">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="250" COLSPAN="2">
<P>제 11 기 1분기</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="250" COLSPAN="2">
<P>제 10 기 1분기</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>3개월</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>누적</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>3개월</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>누적</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">매출액</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">14,909,719,393</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">14,909,719,393</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">7,697,213,394</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">7,697,213,394</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">매출원가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,324,064,511</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,324,064,511</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,069,620,021</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,069,620,021</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">매출총이익</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,585,654,882</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,585,654,882</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,627,593,373</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,627,593,373</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">판매비와관리비</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">11,882,199,210</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">11,882,199,210</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,791,691,893</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,791,691,893</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">영업손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,296,544,328)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,296,544,328)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(4,164,098,520)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(4,164,098,520)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타수익</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">40,742,073</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">40,742,073</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">460,749,489</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">460,749,489</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타비용</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">206,870,260</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">206,870,260</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">17,838,291</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">17,838,291</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">금융수익</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">606,768,081</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">606,768,081</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">877,597,134</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">877,597,134</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">금융비용</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">456,395,780</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">456,395,780</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">565,786,585</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">565,786,585</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">법인세비용차감전순손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,312,300,214)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,312,300,214)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,409,376,773)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,409,376,773)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">법인세비용(수익)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기순손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,312,300,214)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,312,300,214)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,409,376,773)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,409,376,773)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기순손실의 귀속</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　지배기업의 소유주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,186,415,936)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,186,415,936)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,461,633,210)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,461,633,210)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　비지배지분</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(125,884,278)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(125,884,278)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">52,256,437</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">52,256,437</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타포괄손익</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　후속적으로 당기손익으로 재분류될 수 있는 항목:</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　해외사업장환산외환차이</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기총포괄손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,254,875,402)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,254,875,402)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,600,349,897)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,600,349,897)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기총포괄손실의 귀속</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　지배기업의 소유주</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,128,991,124)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,128,991,124)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,652,606,334)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,652,606,334)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　비지배지분</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(125,884,278)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(125,884,278)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">52,256,437</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">52,256,437</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">지배기업 지분에 대한 주당순손실</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　기본주당순손실 (단위 : 원)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(116)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(116)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(197)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(197)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="362" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　희석주당순손실 (단위 : 원)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(116)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(116)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(197)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(197)</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF_C">
<TITLE ATOC="Y" ATOCID="73">2-3. 연결 자본변동표</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1350" BORDER="0">

<COLGROUP>
<COL WIDTH="1341"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1350" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">연결 자본변동표</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1350" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기 2024.01.01 부터 2024.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1350" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기 1분기 2023.01.01 부터 2023.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1350" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1392" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="160"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="299"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="90" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="169" ROWSPAN="3">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="1223" COLSPAN="8">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="977" COLSPAN="6">
<P>지배기업의 소유주에게 귀속되는 지분</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="121" ROWSPAN="2">
<P>비지배지분</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125" ROWSPAN="2">
<P>자본 합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="113">
<P>자본금</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>주식발행초과금</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>기타자본항목</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="153">
<P>기타포괄손익누계액</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="141">
<P>결손금</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="308">
<P>지배기업의 소유주에게 귀속되는 지분 합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2023.01.01 (기초자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,452,857,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,356,598,301</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,920,041,256</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(431,870,971)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(148,974,520,307)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">77,323,105,279</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">18,131,785,393</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">95,454,890,672</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기순손실</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,461,633,210)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,461,633,210)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">52,256,437</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,409,376,773)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타포괄손익</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">해외사업환산손익</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(190,973,124)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식보상비용</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">288,160,977</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">288,160,977</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">288,160,977</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식매수선택권 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">11,000,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">304,972,087</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(242,265,247)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">73,706,840</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">73,706,840</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">전환우선주 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">61,728,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">503,842,604</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(729,601,847)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(164,031,243)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(164,031,243)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2023.03.31 (기말자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,525,585,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">215,165,412,992</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,236,335,139</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(622,844,095)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(152,436,153,517)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">73,868,335,519</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">18,184,041,830</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">92,052,377,349</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2024.01.01 (기초자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,685,074,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,162,881,700</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(16,282,304,959)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">212,245,018</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(162,827,277,957)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">44,950,617,802</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">16,868,370,023</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">61,818,987,825</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기순손실</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,186,415,936)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,186,415,936)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(125,884,278)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,312,300,214)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타포괄손익</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">해외사업환산손익</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">57,424,812</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식보상비용</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">40,608,768</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">40,608,768</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">40,608,768</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식매수선택권 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">30,000,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">258,664,594</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(137,344,594)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">151,320,000</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">151,320,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">전환우선주 행사</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="169" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2024.03.31 (기말자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,715,074,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,421,546,294</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(16,379,040,785)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="153" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">269,669,830</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(165,013,693,893)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="308" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">43,013,555,446</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">16,742,485,745</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">59,756,041,191</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}CF_C">
<TITLE ATOC="Y" ATOCID="74">2-4. 연결 현금흐름표</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">연결 현금흐름표</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기 2024.01.01 부터 2024.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기 1분기 2023.01.01 부터 2023.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="514" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="248">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 11 기 1분기</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 10 기 1분기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">영업활동으로 인한 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(4,202,829,237)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,367,324,728)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　영업으로부터 창출된 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(5,465,466,025)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,143,236,642)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　이자의 수취</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,612,664,708</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,004,828,252</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　이자의 지급</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(101,769,280)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(74,506,038)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　법인세 부담액</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(248,258,640)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(154,410,300)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">투자활동으로 인한 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">10,673,033,138</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,250,446,545</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　단기금융상품의 감소</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">38,999,868,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">45,965,241,327</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　단기금융상품의 증가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(26,499,868,000)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(41,999,868,000)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　단기대여금의 회수</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">10,000,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　유형자산의 취득</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(1,526,990,862)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,409,363,292)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　무형자산의 취득</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(347,585,490)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　보증금의 증가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(315,900,000)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　보증금의 감소</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">15,924,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">32,022,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">재무활동으로 인한 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">7,094,959,339</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(97,333,213)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　주식매수선택권의 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">151,320,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">73,706,840</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　단기차입금의 증가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,800,000,000</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　장기차입금의 증가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,200,000,000</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　리스부채의 상환</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(56,360,661)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(111,040,053)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　전환사채의 상환</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(60,000,000)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">현금및현금성자산의 증감</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">13,565,163,240</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(1,214,211,396)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기초 현금및현금성자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">10,046,639,594</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">10,432,871,701</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">현금및현금성자산의 환율변동효과</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(20,032,469)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">228,093,639</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기말 현금및현금성자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">23,591,770,365</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,446,753,944</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0" ATOCID="56">3. 연결재무제표 주석</TITLE>
<P USERMARK="F-16 0XFF0000 B"></P>
<P USERMARK="F-16 0XFF0000 B">주석</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 11 기 1분기  2024년 1월 1일부터 2024년 3월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 10 기 1분기  2023년 1월 1일부터 2023년 3월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">주식회사 고바이오랩과 그 종속기업</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">1. 연결회사의 개요</SPAN>주식회사 고바이오랩(이하 '지배기업', 주식회사 고바이오랩과 그 종속기업을 일괄하여 "연결회사")은 2014년 8월에 설립되었고, 2020년 11월 18일 코스닥 시장에 상장하였습니다. 연결회사는 인체 마이크로바이옴과 임상 메타데이터 분석을 통한 면역, 대사, 뇌 질환의 신약 개발과 기능성 프로바이오틱스 및 건강기능식품 제조와 판매를 주요 사업으로 영위하고 있습니다. 지배기업은 서울특별시 관악구 관악로 1 서울대학교 종합연구동에 본사를 두고 있습니다.2024년 3월 31일로 종료하는 보고기간에 대한 연결재무제표는 지배기업과 지배기업의 종속기업 KoBioLabs Australia Pty Ltd 및 주식회사 위바이옴(이하 주식회사 고바이오랩과 그 종속기업을 일괄하여 "연결회사")을 연결대상으로 하여 작성된 연결재무제표입니다.
</P>
<P></P>
<P>당분기말 현재 주요 주주현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="768">

<COLGROUP>
<COL WIDTH="353"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="362" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">주 주 명</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">보통주</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전환우선주</TH>
<TH COLSPAN="2" WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">합계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주식수</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주식수</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주식수</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" VALIGN="MIDDLE" HEIGHT="30">고광표</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">5,062,237</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">5,062,237</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">26.05%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" VALIGN="MIDDLE" HEIGHT="30">특수관계자(*)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">761,702</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">761,702</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3.92%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" VALIGN="MIDDLE" HEIGHT="30">(주)이마트</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">544,960</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">544,960</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2.80%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" VALIGN="MIDDLE" HEIGHT="30">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">213,442</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">64,138</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">277,580</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1.43%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,349,867</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">433,802</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,783,669</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">65.80%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">18,932,208</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">497,940</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">19,430,148</TD>
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">100.00%</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 특수관계자는 등기임원을 포함합니다.</P>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" B">1.1 종속기업 현황</SPAN>당분기말과 전기말 현재 연결회사의 연결대상 종속기업 현황은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1102">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">회사명</TD>
<TD ROWSPAN="2" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">자본금(원)</TD>
<TD ROWSPAN="2" WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">투자주식수</TD>
<TD COLSPAN="2" WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">지분율(%)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7" ROWSPAN="2">결산월</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7" ROWSPAN="2">업종</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7" ROWSPAN="2">소재지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기말</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,781</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">100%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">100%</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6월</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">호주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30">주식회사 위바이옴</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,863,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,751,013</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">51%</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">51%</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">건강기능식품 판매업</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당분기말과 전기말 현재 종속기업의 요약 재무현황은 다음과 같습니다(단위: 원).① 당분기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1096">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">회사명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자산</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">부채</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자본</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">매출</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">분기순손실</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기총포괄손실</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="201" HEIGHT="30">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,297,400,581</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,024,020,483</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,726,619,902)</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,533,865)</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,890,947</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="201" HEIGHT="30">주식회사 위바이옴</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,935,457,350</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,653,822,710</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,281,634,640</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,849,972,084</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(256,906,688)</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(256,906,688)</TD>
</TR>
</TBODY>
</TABLE>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1104">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="172"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">회사명</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자산</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">부채</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자본</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">매출</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기순이익(손실)</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기총포괄이익(손실)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="201" HEIGHT="30">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,235,254,705</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,008,765,554</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,773,510,849)</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,620,203,430)</TD>
<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,811,176,554)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="201" HEIGHT="30">주식회사 위바이옴</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,023,382,461</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,484,841,133</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,538,541,328</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,449,040,583</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106,645,790</TD>
<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106,645,790</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">1.2 연결대상범위의 변동</SPAN>당분기 중 연결재무제표 종속기업의 변동내역은 없습니다.
</P>
<P></P>

<P>
<SPAN USERMARK=" B">2. 중요한 회계정책</SPAN>다음은 연결재무제표 작성에 적용된 중요한 회계정책입니다. 이러한 정책은 별도의 언급이 없다면, 표시된 회계기간에 계속적으로 적용됩니다.
</P>
<P USERMARK=" B">2.1 연결재무제표 작성기준</P>

<P>연결회사의 2024년 3월 31일로 종료하는 3개월 보고기간에 대한 분기연결재무제표는 기업회계기준서 제1034호 '중간재무보고'에 따라 작성되었습니다. 이 분기연결재무제표는 보고기간말인 2024년 3월 31일 현재 유효하거나 조기 도입한 한국채택국제회계기준에 따라 작성되었습니다.2024년 1월 1일부터 시행되는 회계기준이 있으나, 그 기준들은 회사의 분기연결재무제표에 중요한 영향을 미치지 않으며, 이를 제외하고는 중간재무제표의 작성에 적용된 유의적 회계정책은 2023년 12월 31일로 종료하는 회계연도에 대한 연차재무제표 작성시채택한 회계정책과 동일합니다.
<SPAN USERMARK=" B">2.2 회계정책</SPAN>
<SPAN>분기연결재무제표의 작성에 적용된 유의적 회계정책과 계산방법은 아래 문단에서 설명하는 사항을 제외하고는 전기 재무제표 작성에 적용된 회계정책이나 계산방법과 동일합니다.</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">2.2.1 법인세비용</SPAN>중간기간의 법인세비용은 전체 회계연도에 대해서 예상되는 최선의 가중평균연간법인세율, 즉 추정평균연간유효법인세율을 중간기간의 세전이익에 적용하여 계산합니다.
</P>
<P USERMARK=" B">3. 중요한 판단과 추정불확실성의 주요원천</P>
<P>중간재무제표를 작성함에 있어, 경영진은 회계정책 적용과 자산ㆍ부채 및 수익ㆍ비용에 영향을 미치는 판단, 추정 및 가정을 해야 합니다. 실제 결과는 이러한 추정치와다를 수 있습니다.</P>
<P>중간재무제표 작성을 위해 연결회사의 회계정책의 적용과 추정 불확실성의 주요원천에 대해 경영진이 내린 중요한 판단은 2023년 12월 31일로 종료하는 회계연도에 대한 연차재무제표와 동일합니다.</P>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">4. 공정가치</SPAN>
</P>
<P></P>
<P>(1) 금융상품 종류별 공정가치금융상품의 종류별 장부금액 및 공정가치는 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="774" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="284"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="293" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" ROWSPAN="2">구분</TH>

<TH COLSPAN="2" WIDTH="241" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기말</P>
</TH>
<TH COLSPAN="2" WIDTH="240" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="121" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>장부금액</P>
</TH>

<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>공정가치</P>
</TH>

<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>장부금액</P>
</TH>

<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>공정가치</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="774" HEIGHT="30">
<P>금융자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  현금및현금성자산</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">23,591,770,365</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10,046,639,594</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  단기금융상품</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">43,612,896,095</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">56,112,896,095</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  매출채권</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,116,583,688</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,857,806,384</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  기타유동금융자산</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,457,900,946</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,101,094,787</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  기타비유동금융자산</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,181,133,301</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">914,621,470</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  기타포괄손익-공정가치 측정 금융자산</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,483,823,425</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,483,823,425</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  유동파생상품자산</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">77,490,614,848</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">74,563,388,783</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="774" HEIGHT="30" VALIGN="MIDDLE">
<P>금융부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  기타유동금융부채</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,855,739,396</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,370,853,660</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  기타비유동금융부채</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">22,112,066,928</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">22,112,066,928</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  유동전환사채</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">8,988,178,444</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">8,633,328,862</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  유동파생상품부채</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,648,076,654</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,648,076,654</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,648,076,654</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,648,076,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  유동성장기차입금</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">96,755,220</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">58,363,481</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30">  단기차입금</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,762,784,228</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30" VALIGN="MIDDLE">  장기차입금</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">12,258,254,712</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">9,172,006,439</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">55,721,855,582</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT"></TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">48,994,696,024</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT"></TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 장부금액이 공정가치의 합리적인 근사치이므로 공정가치 공시에서 제외하였습니다.(*2) 리스부채는 기준서 제1107호에 따라 공정가치 공시에서 제외하였습니다.(2) 공정가치 서열체계</P>
<P>공정가치로 측정되는 금융상품은 공정가치 서열체계에 따라 구분되며 정의된 수준들은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="17"></COL>
<COL WIDTH="565"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="55" USERMARK="F-BT12">-</TD>
<TD WIDTH="574" HEIGHT="55" USERMARK="F-BT12">측정일에 동일한 자산이나 부채에 대해 접근할 수 있는 활성시장의 (조정하지 않은) 공시가격 (수준 1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="55" USERMARK="F-BT12">-</TD>
<TD WIDTH="574" HEIGHT="55" USERMARK="F-BT12">수준 1의 공시가격 외에 자산이나 부채에 대해 직접적으로나 간접적으로 관측할 수 있는 투입변수 (수준 2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="574" HEIGHT="31" USERMARK="F-BT12">자산이나 부채에 대한 관측할 수 없는 투입변수 (수준 3)</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>공정가치로 측정되는 금융상품의 공정가치 서열체계 구분은 다음과 같습니다(단위: 원).</P>
<P>① 당분기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="718">

<COLGROUP>
<COL WIDTH="208"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수준 1</P>
</TH>

<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수준 2</P>
</TH>

<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수준 3</P>
</TH>

<TH WIDTH="126" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="718" HEIGHT="30" COLSPAN="5">금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30"> 유동파생상품자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="718" HEIGHT="30" COLSPAN="5">금융부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30"> 유동파생상품부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="718">

<COLGROUP>
<COL WIDTH="208"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수준 1</P>
</TH>

<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수준 2</P>
</TH>

<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수준 3</P>
</TH>

<TH WIDTH="126" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="718" HEIGHT="30" COLSPAN="5">금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30"> 유동파생상품자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="718" HEIGHT="30" COLSPAN="5">금융부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30"> 유동파생상품부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 반복적인 공정가치 측정치의 서열체계 수준 간 이동</P>
<P>연결회사는 공정가치 서열체계의 수준 간 이동을 이동을 발생시킨 사건이나 상황의 변동이 일어난 날짜에 인식합니다.</P>
<P>각 공정가치 서열체계의 수준 간 이동 내역은 다음과 같습니다.① 반복적인 측정치의 수준 1과 수준 2간의 이동 내역당분기 중 수준 1과 수준 2간의 대체는 없습니다.</P>
<P></P>
<P>② 반복적인 측정치의 수준 3의 변동 내역(단위: 원)</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="959">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기초</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전환</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">평가손익</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">상환</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">유동성대체</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" VALIGN="MIDDLE" HEIGHT="30">유동파생상품자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" VALIGN="MIDDLE" HEIGHT="30">유동파생상품부채</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,648,076,654</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,648,076,654</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">5. 현금및현금성자산 및 단기금융상품</SPAN>
</P>
<P>(1) 당분기말과 전기말 현재 현금및현금성자산의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="512">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="248" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기말</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="248" HEIGHT="30">보통예금</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,795,462,264</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,273,800,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="248" HEIGHT="30">정기예금 등</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,796,308,101</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,772,838,994</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="248" HEIGHT="30">합계</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,591,770,365</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,046,639,594</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기말과 전기말 현재 단기금융상품의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="512">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="248" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="132" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="132" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30" VALIGN="MIDDLE">중금채</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">38,012,896,345</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">43,612,896,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30" VALIGN="MIDDLE">정기예금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,599,999,750</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,499,999,750</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">43,612,896,095</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">56,112,896,095</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">6. 기타포괄손익-공정가치 측정 금융자산</SPAN>(1) 당분기말과 전기말 현재 기타포괄손익-공정가치 측정 금융자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="512">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="248" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="512" HEIGHT="30" COLSPAN="3">비유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="248" HEIGHT="30">  국고채권</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,483,823,425</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,483,823,425</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>(2) 기타포괄손익-공정가치 측정 금융자산 중 국고채는 연결회사의 차입금과 관련하여 담보로 제공되어 있습니다(주석 31 참조).</SPAN>
<SPAN USERMARK=" B">7. 매출채권</SPAN>
</P>
<P> </P>
<P>(1) 당분기말과 전기말 현재 매출채권의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="597" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="189"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기말</TH>
<TH WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30">매출채권</TD>
<TD WIDTH="200" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">1,857,806,384</TD>
<TD WIDTH="199" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">701,914,026</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30">손실충당금 </TD>
<TD WIDTH="200" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="199" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="BOTTOM" HEIGHT="30">매출채권(순액)</TD>
<TD WIDTH="200" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">1,857,806,384</TD>
<TD WIDTH="199" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">701,914,026</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>매출채권은 정상적인 영업 과정에서 판매된 재화나 용역에 대하여 고객이 지불해야 할 금액입니다. 일반적으로 30일 이내에 정산해야 하므로 모두 유동자산으로 분류됩니다. 최초 인식시점에 매출채권이 유의적인 금융요소를 포함하지 않는 경우에는 거래가격을 공정가치로 측정합니다. </P>
<P></P>

<P>
<SPAN USERMARK=" B">8. 기타금융자산</SPAN>당분기말과 전기말 현재 기타금융자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="227" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="185" VALIGN="BOTTOM" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="186" VALIGN="BOTTOM" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">기타유동금융자산</TD>
<TD WIDTH="185" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="186" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  미수금</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,895,322,113</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,524,022,812</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  미수수익</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">481,828,833</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,496,321,975</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  기타보증금</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">750,000</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">750,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  임차보증금</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,000,000</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,457,900,946</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,101,094,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">기타비유동금융자산</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  기타보증금</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,502,968</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">79,602,968</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  현재가치할인차금</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,657,022)</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(15,980,241)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  임차보증금</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,172,665,000</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">873,589,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">  현재가치할인차금</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,377,645)</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,590,257)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,181,133,301</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">914,621,470</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">9. 기타자산</SPAN>당분기말과 전기말 현재 기타자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P> 구분</P>
</TH>
<TH WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기말</TH>
<TH WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">기타유동자산</TD>
<TD WIDTH="199" VALIGN="BOTTOM" HEIGHT="30">　</TD>
<TD WIDTH="199" VALIGN="BOTTOM" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  부가세대급금</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">139,248,287</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">558,857,245</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  선급금</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,368,446,500</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">897,963,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  선급비용</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,110,258,484</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,206,413,170</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,617,953,271</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,663,233,415</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">기타비유동자산</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">  장기선급비용</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">34,231,695</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,652,184,966</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,663,233,415</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>

<P>
<SPAN USERMARK=" B">10. 재고자산</SPAN>당분기말과 전기말 현재 재고자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="201" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P> 구분</P>
</TH>
<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기말</TH>
<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">제품</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,351,903,999</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,489,085,993</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">제품평가충당금</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(14,606,475)</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(59,722,519)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">66,805,754</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">23,279,336</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">부재료</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">10,309,511</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">9,793,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">반품자산</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">8,794,707</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,259,612</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">반제품</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">213,224,962</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">반제품평가충당금</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(69,452,105)</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,566,980,353</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,466,696,177</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>
<P>비용으로 인식되어 '매출원가'에 포함된 재고자산의 원가는 4,905백만원(전기: 1,866백만원) 입니다.</P>

<P>
<SPAN USERMARK=" B">11. 파생상품자산</SPAN>(1) 당분기말 현재 파생상품자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="476">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기말</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" VALIGN="MIDDLE" HEIGHT="30">유동파생상품자산(*)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 연결회사는 전기 이전에 전환우선주 및 전환사채를 발행하였으며, 연결회사가 보유한 매도청구권(콜옵션)을 파생상품자산으로 계상하였습니다. 동 파생상품자산은 이항옵션모형으로 평가하였습니다.(2) 당분기 및 전분기 중 파생상품자산의 변동내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="540">

<COLGROUP>
<COL WIDTH="207"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기초잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">970,138,761</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  증가</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  평가손익</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,467,297</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  전환</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(164,031,243)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  상환</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,017,452)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기말잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">801,557,363</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">12. 유형자산</SPAN>(1) 당분기말과 전기말 현재 유형자산의 내역은 다음과 같습니다(단위: 원).① 당분기말
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="706">

<COLGROUP>
<COL WIDTH="157"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">취득원가</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">상각누계액</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">정부보조금</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,476,606,361</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,476,606,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,260,441,030</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(319,664,113)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(54,797,048)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,885,979,869</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">구축물</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,213,949,418</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(359,903,398)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">854,046,020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,724,876,230</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,902,932,641)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,821,943,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">차량운반구</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,028,297</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,882,206)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,146,091</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,054,343,982</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(109,625,390)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,944,718,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,638,987,676</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(36,208,395)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,602,779,281</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,398,232,994</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,730,216,143)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(54,797,048)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,613,219,803</TD>
</TR>
</TBODY>
</TABLE>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="706">

<COLGROUP>
<COL WIDTH="157"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">취득원가</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">상각누계액</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">정부보조금</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,476,606,361</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,476,606,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,260,441,030</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(224,286,345)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(54,936,890)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,981,217,795</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">구축물</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,357,119,418</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(358,576,536)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">998,542,882</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,447,613,494</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,693,999,556)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,753,613,938</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">차량운반구</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,028,297</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,100,351)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,927,946</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92,793,279</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,542,204)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,251,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">250,500,000</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,087,499)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">248,412,501</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,765,810,253</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,765,810,253</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,679,912,132</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,337,592,491)</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(54,936,890)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,287,382,751</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당분기와 전분기 중 유형자산의 변동내역은 다음과 같습니다(단위: 원).① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1126">

<COLGROUP>
<COL WIDTH="157"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="166" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 순장부금액</TH>
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">본계정대체</TH>
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">국고보조금</TH>
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비(*)</TH>
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 순장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,476,606,361</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,476,606,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,981,217,795</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">139,842</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(95,377,768)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,885,979,869</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">구축물</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">998,542,882</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,000,000</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(121,238,500)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(49,258,362)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">854,046,020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,753,613,938</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">155,533,682</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">124,229,054</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,791,645)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(209,641,440)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,821,943,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,927,946</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(781,855)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,146,091</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,251,075</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,961,550,703</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(52,083,186)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,944,718,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">시설장치</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">248,412,501</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,388,487,676</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(34,120,896)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,602,779,281</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,765,810,253</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">734,457,180</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,500,267,433)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,287,382,751</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">889,990,862</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(123,030,145)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">139,842</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(441,263,507)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,613,219,803</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 감가상각비는 연결포괄손익계산서상 판매비와관리비(경상연구개발비 포함)에 포함되어 있습니다.</P>
<P>② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="736">

<COLGROUP>
<COL WIDTH="157"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="166" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 순장부금액</TH>
<TH WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비(*)</TH>
<TH WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 순장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,476,606,361</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,476,606,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,533,227,847</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(28,874,064)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,504,353,783</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">구축물</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,162,707,171</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(52,963,990)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,109,743,181</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">공구와기구</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,906,783</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,066,500)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,840,283</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,817,673</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(112,287)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,705,386</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,949,111,134</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">464,519,673</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(192,408,940)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,221,221,867</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,865,003</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,403,515)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">42,461,488</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,928,757,550</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,712,309,095</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,641,066,645</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,116,999,522</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,176,828,768</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(277,829,296)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,015,998,994</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 감가상각비는 연결포괄손익계산서상 판매비와관리비(경상연구개발비 포함)에 포함되어 있습니다.(3) 당분기 중 감가상각비의 계정과목별 배부내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="415">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="132" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="132" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30">매출원가</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">106,419,100</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,485,296</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="BOTTOM">판매비와관리비</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">71,387,456</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,544,396</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="BOTTOM">경상연구개발비</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">263,317,109</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">251,799,604</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="BOTTOM">합계</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">441,123,665</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">277,829,296</TD>
</TR>
</TBODY>
</TABLE>
<P>(4) 유형자산 중 토지와 건물은 연결회사의 차입금과 관련하여 담보로 제공되어 있습니다.(주석 31 참조)</P>

<P>
<SPAN USERMARK=" B">13. 리스</SPAN>연결회사가 리스이용자인 경우의 리스에 대한 정보는 다음과 같습니다.(1) 연결재무상태표에 인식된 금액
</P>
<P>리스와 관련해서 재무상태표에 인식된 금액은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="306"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="315" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="152" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기말</P>
</TH>

<TH WIDTH="152" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="619" HEIGHT="30">사용권자산(*)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">부동산</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">356,846,585</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">393,439,855</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30">차량운반구</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">162,909,307</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">177,334,021</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">519,755,892</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">570,773,876</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="619" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">리스부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" VALIGN="MIDDLE">유동</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">235,658,770</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">234,205,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" VALIGN="MIDDLE">비유동</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">137,125,411</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">195,961,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">372,784,181</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">430,166,540</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당분기 중 신규계약에 따른 사용권자산의 증가액은 88백만원(전분기: 114백만원)이며, 변경에 따른 사용권자산의 감소액은 74백만원(전분기: 49백만원)입니다.</P>
<P>(2) 연결포괄손익계산서에 인식된 금액</P>
<P>리스와 관련해서 연결포괄손익계산서에 인식된 금액은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="615">

<COLGROUP>
<COL WIDTH="316"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="325" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="145" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기</P>
</TH>

<TH WIDTH="145" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전분기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" HEIGHT="30">사용권자산의 감가상각비</TD>
<TD WIDTH="145" HEIGHT="30"></TD>
<TD WIDTH="145" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" HEIGHT="30">  부동산</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">64,332,952</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">28,837,634</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" HEIGHT="30">  차량운반구</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">14,424,714</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">13,067,674</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">78,757,666</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">41,905,308</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" HEIGHT="30">리스부채에 대한 이자비용(금융원가에 포함)(*)</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">10,841,190</TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">5,629,327</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" HEIGHT="30">단기리스료(매출원가 및 관리비에 포함)</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,088,792</TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">12,712,686</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" HEIGHT="30">리스자산변경이익</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">13,771,259</TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 리스부채 이자비용은 적격자산에 대한 자본화금액이 차감된 금액입니다.당분기 중 리스의 총 현금유출은 62백만원(전분기: 88백만원)입니다.</P>

<P>
<SPAN USERMARK=" B">14. 무형자산</SPAN>(1) 당분기말과 전기말 현재 무형자산의 내역은 다음과 같습니다(단위: 원).
</P>
<P>① 당분기말</P>

<TABLE BORDER="1" WIDTH="639" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>취득원가</P>
</TH>

<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>상각누계액</P>
</TH>

<TH WIDTH="159" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>장부금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">특허권</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">438,843,400</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(292,904,288)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">145,939,112</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">상표권</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600,000</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(599,000)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">소프트웨어</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">120,409,437</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(70,505,581)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,903,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">회원권</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">985,413,827</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(364,008,869)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">621,404,958</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="639">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="160" HEIGHT="30">
<P>구분</P>
</TH>

<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="160" HEIGHT="30">
<P>취득원가</P>
</TH>

<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="160" HEIGHT="30">
<P>상각누계액</P>
</TH>

<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="159" HEIGHT="30">
<P>장부금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">특허권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">438,843,400</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">(281,411,233)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">157,432,167</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">상표권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">600,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">(599,000)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">소프트웨어</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">120,409,437</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">(65,738,133)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">54,671,304</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">회원권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">425,560,990</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">425,560,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">합계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">985,413,827</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">(347,748,366)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">637,665,461</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 무형자산의 변동내역은 다음과 같습니다(단위: 원).</P>
<P>① 당분기</P>

<TABLE BORDER="1" WIDTH="768" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특허권</TH>
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상표권</TH>
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소프트웨어</TH>
<TH WIDTH="134" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="122" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30">기초</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,432,167</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,671,304</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">637,665,461</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30">상각(*)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,493,055)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,767,448)</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,260,503)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30">당분기말</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">145,939,112</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,903,856</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">621,404,958</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 무형자산상각비는 연결포괄손익계산서상 판매비와관리비에 포함되어 있습니다.② 전분기</P>

<TABLE BORDER="1" WIDTH="768" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특허권</TH>
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상표권</TH>
<TH WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소프트웨어</TH>
<TH WIDTH="134" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="122" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30">기초</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,835,039,053</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">74,806,630</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,909,846,683</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30">취득</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,924,000,000)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,822,990</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,579,177,010)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30">상각(*)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">281,817,623</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,145,583)</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">276,672,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30">전분기말</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">192,856,676</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,661,047</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,822,990</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">607,341,713</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 무형자산상각비는 연결포괄손익계산서상 판매비와관리비에 포함되어 있습니다.(3) 당분기와 전분기 중 연결회사가 비용으로 인식한 경상연구개발비는 각각 1,682백만원 및 3,612백만원입니다.</P>

<P>
<SPAN USERMARK=" B">15. 기타금융부채</SPAN>당분기말과 전기말 현재 기타금융부채의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="217"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="226" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="186" VALIGN="BOTTOM" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="186" VALIGN="BOTTOM" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" HEIGHT="30">기타유동금융부채</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" HEIGHT="30">  미지급금</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,803,124,149</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,243,706,110</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" HEIGHT="30">  미지급비용</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,052,615,247</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,127,147,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,855,739,396</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,370,853,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="BOTTOM" HEIGHT="30">기타비유동금융부채</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="BOTTOM" HEIGHT="30">  장기미지급금(*)</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,112,066,928</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,112,066,928</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,967,806,324</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,482,920,588</TD>
</TR>
</TBODY>
</TABLE>

<P>(*) 연결회사는 주석 31에 기재된 주주간계약으로 발생한 풋옵션으로 인해 종속회사 지분을 매입할 의무가 존재합니다. 동 풋옵션 매매대금의 현재가치를 금융부채로 인식하여 장기미지급금으로 계상하였습니다.
<SPAN USERMARK=" B">16. 기타부채</SPAN>당분기말과 전기말 현재 기타부채의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P> 구분</P>
</TH>
<TH WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기말</TH>
<TH WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">기타유동부채</TD>
<TD WIDTH="199" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="199" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  선수금</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">66,511,220</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">107,652,098</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  예수금</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">127,582,251</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">249,690,242</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  부가세예수금</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,503,700</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  반품충당부채</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">33,075,476</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">16,152,211</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  계약부채</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,984,066,413</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,057,296,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">  선수수익</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">887,660,385</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">775,084,625</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,111,399,445</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,205,876,071</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">기타비유동부채</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30">  복구충당부채</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">62,214,461</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">88,693,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,173,613,906</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,294,569,104</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">17. 전환사채</SPAN>(1) 당분기말 현재 전환사채의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1079">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="257"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="184" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">차입처</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">만기일</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">표면이자율(%)</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="158" VALIGN="MIDDLE" HEIGHT="152" ALIGN="CENTER">주식회사 고바이오랩</TD>
<TD WIDTH="184" VALIGN="MIDDLE" HEIGHT="99">제1회 무보증 사모 전환사채</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="99">뉴딜익스텐션신기술투자조합1호스마트코리아 컴퍼니케이 언택트펀드씨케이피-KIS2020 투자조합메리츠에셋원신기술금융조합 제1호</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="99" ALIGN="CENTER">2026.11.19</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="99" ALIGN="CENTER">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="118" HEIGHT="99">7,135,045,207</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="99">6,826,790,640</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="MIDDLE" HEIGHT="53">제2회 무보증 사모 전환사채</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="53" ALIGN="CENTER">2026.12.30</TD>
<TD VALIGN="MIDDLE" WIDTH="118" HEIGHT="53" ALIGN="CENTER">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="118" HEIGHT="53">1,853,133,237</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,806,538,222</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="844" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소계</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,988,178,444</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,633,328,862</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기말 현재 연결회사가 발행한 사모 전환사채의 주요내용은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="792" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="560"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="569" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제1회 무보증 사모 전환사채(*1)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">발행일</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">2021.11.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">액면가액</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">11,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">발행가액</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">11,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">이자지급방법</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">상환방법</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">만기일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">조기상환청구권</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">발행일로부터 30개월이 되는 날 및 이후 매 3개월에 해당되는 날</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">매도청구권</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">발행일로부터 12개월이 되는 날부터 본 사채 발행일로부터 30개월이 되는 날까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">전환비율(%)</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">전환가격(*2)</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">17,675</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">전환에 따라 발행할 주식수(*2)</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">622,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">전환청구기간</TD>
<TD WIDTH="569" VALIGN="MIDDLE" HEIGHT="30">2022.11.19~2026.10.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="605">전환가액 조정에 관한 사항(*1)</TD>

<TD WIDTH="569" HEIGHT="605">
<P>(1) 본 사채를 소유한 자가 전환청구권 행사를 하기 전에 발행회사가 시가를 하회하는 발행가액으로 유상증자, 무상증자, 주식배당 및 준비금의 자본전입 등을 함으로써 주식을 발행하거나 또는 시가를 하회하는 전환가격 또는 행사가격으로 전환사채 또는 신주인수권부사채를 발행하는 경우에는 아래와 같이 전환가격을 조정한다. </P>
<P>조정 후 전환가격 = 조정 전 전환가격 × [{기발행주식수+(신발행주식수×1주당 발행가격/시가)} / (기발행주식수+신발행주식수)]</P>
<P></P>
<P>(2) 합병, 자본의 감소, 주식분할 및 병합 등에 의하여 전환가격의 조정이 필요한 경우에는 당해 사유 발생 직전에 전환청구권이 행사되어 전액 주식으로 인수되었더라면 본 사채의 사채권자가 가질 수 있었던 동일한 효과가 날 수 있도록 조정한다.</P>
<P>(3) 감자 및 주식 병합 등 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합 등으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가격을 조정한다.</P>
<P>(4) 위 (1)호 내지 (3)호과는 별도로 2021년 11월 19일 및 이후 매 3개월이 되는 날을 전환가격 조정일로 하고, 각 전환가격 조정일 전일을 기산일로 하여 그 기산일로부터 소급한 1개월 가중산술평균주가, 1주일 가중산술평균주가 및 기산일 가중산술평균주가를 산술평균한 가액과 기산일 가중산술평균주가 중 높은 가격이 해당 조정일 직전일 현재의 전환가격보다 낮은 경우 동 낮은 가격을 새로운 전환가격으로 한다. 단, 전환가격의 최저 조정한도는 최초 전환가액의 100분의 70에 해당하는 가액으로 한다.</P>
<P>(5) 위 (1)호 내지 (4)호에 의하여 조정된 전환가격이 주식의 액면가 이하일 경우에는 액면가를 전환가격으로 하며, 각 전환사채에 부여된 전환청구권의 행사로 인하여 발행할 주식의 발행가액의 합계액은 각 전환사채의 발행가액을 초과할 수 없다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 행사가격 인하조건이 내재된 제1회 사모전환사채의 전환권에 대해서 금융감독원의 질의회신(회제이-00094)에 따라 발행시점에 자본으로 분류하고, 최초 인식시점이후의 공정가액변동은 회계처리 하지 아니하였습니다. 만일 동 질의회신의 내용에 대하여 한국채택국제회계기준 유권해석이 변경될 경우 전환사채와 관련된 회계처리가 변경될 수 있습니다.(*2) 전환가격은 최초 발행 이후 2회에 걸쳐 조정되었습니다.보고기간 후 제1회 무보증 사모 전환사채 액면가액 전액 상환청구 되었습니다.</P>

<TABLE BORDER="1" WIDTH="794" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="211"></COL>
<COL WIDTH="565"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="220" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="574" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제2회 무보증 사모 전환사채(*1)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">발행일</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">2021.12.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">액면가액</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">2,350,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">발행가액</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">2,350,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">이자지급방법</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">상환방법</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">만기일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">조기상환청구권</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">본 사채의 발행일로부터 30개월이 되는 날 및 이후 매 3개월에 해당되는 날</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">매도청구권</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">발행일로부터 12개월이 되는 날로부터 본 사채 발행일로부터 30개월이 되는 날까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">전환비율(%)</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">전환가격(*2)</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">17,675</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">전환에 따라 발행할 주식수(*2)</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">132,956</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="30">전환청구기간</TD>
<TD WIDTH="574" VALIGN="MIDDLE" HEIGHT="30">2022.12.30~2026.11.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" VALIGN="MIDDLE" HEIGHT="697">전환가액 조정에 관한 사항(*1)</TD>

<TD WIDTH="574" HEIGHT="697">
<P>(1) 본 사채를 소유한 자가 전환청구권 행사를 하기 전에 발행회사가 시가를 하회하는 발행가액으로 유상증자, 무상증자, 주식배당 및 준비금의 자본전입 등을 함으로써 주식을 발행하거나 또는 시가를 하회하는 전환가격 또는 행사가격으로 전환사채 또는 신주인수권부사채를 발행하는 경우에는 아래와 같이 전환가격을 조정한다. </P>
<P> </P>
<P>조정 후 전환가격 = 조정 전 전환가격 × [{기발행주식수+(신발행주식수×1주당 발행가격/시가)} / (기발행주식수+신발행주식수)]</P>
<P> </P>
<P>(2) 합병, 자본의 감소, 주식분할 및 병합 등에 의하여 전환가격의 조정이 필요한 경우에는 당해 사유 발생 직전에 전환청구권이 행사되어 전액 주식으로 전환되었더라면 본 사채의 사채권자가 가질 수 있었던 것과 동일한 효과가 날 수 있도록 조정한다.</P>
<P>(3) 감자 및 주식 병합 등 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합 등으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가격을 조정한다.</P>
<P>(4) 위 (1)호 내지 (3)호와는 별도로 2021년 12월 30일 및 이후 매 3개월이 되는 날을 전환가격 조정일로 하고, 각 전환가격 조정일 전일을 기산일로 하여 그 기산일로부터 소급한 1개월 가중산술평균주가, 1주일 가중산술평균주가 및 기산일 가중산술평균주가를 산술평균한 가액과 기산일 가중산술평균주가 중 높은 가격(이하 본 호 및 (5)호에서 “시가산정액”)이 해당 조정일 직전일 현재의 전환가격보다 낮은 경우 시가산정액을 새로운 전환가격으로 한다. 단, 전환가격의 최저 조정한도는 최초 전환가액의 100분의 70에 해당하는 가액으로 한다.</P>
<P>(5) 위 (4)호에 따라 전환가격을 하향조정한 이후에 위 (4)호에 따라 산정한 시가산정액이 해당 조정일 직전일 현재의 전환가격보다 높게 되는 경우 시가산정액을 새로운 전환가격으로 한다. 단, 전환가격의 최고 조정한도는 최초 전환가액으로 한다.</P>
<P>(6) 위 (1)호 내지 (4)호에 의하여 조정된 전환가격이 주식의 액면가 이하일 경우에는 액면가를 전환가격으로 하며, 각 전환사채에 부여된 전환청구권의 행사로 인하여 발행할 주식의 발행가액의 합계액은 각 전환사채의 발행가액을 초과할 수 없다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 제2회 사모전환사채의 전환권은 상향리픽싱 조항으로 인해 부채로 분류됐습니다.(*2) 전환가격은 최초 발행 이후 2회에 걸쳐 조정되었습니다. </P>

<P>
<SPAN USERMARK=" B">18. 파생상품부채</SPAN>(1) 당분기말과 전기말 현재 파생상품의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="223"></COL>
<COL WIDTH="222"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="232" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="231" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">유동파생상품부채</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>연결회사는 파생상품부채의 공정가치 변동에 대해 연결포괄손익계산서상 '금융수익 및 금융비용'으로 표시하고 있습니다.</P>
<P>(2) 당분기와 전분기 중 파생상품부채의 변동내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="540">

<COLGROUP>
<COL WIDTH="207"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기초잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,442,447,552</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  평가손익</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,338,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  상환</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(38,308,236)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기말잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,410,478,137</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">19. 차입금</SPAN>(1) 당분기말 현재 연결회사의 차입금 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1128">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">차입처</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">내역</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">차입일</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">만기일</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">이자율(%)</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">약정한도액</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기말</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="60" ALIGN="CENTER" ROWSPAN="2">주식회사 고바이오랩</TD>
<TD WIDTH="85" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">시설자금대출(*1)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.25</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2029.12.15</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">4.84</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">산업은행</TD>
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">시설자금대출(*1)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.24</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2025.01.24</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">4.18</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="330" ALIGN="CENTER" ROWSPAN="11">주식회사 위바이옴</TD>
<TD WIDTH="85" VALIGN="MIDDLE" HEIGHT="300" ALIGN="CENTER" ROWSPAN="10">기업은행</TD>
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">지방구조조정자금(*2)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2023.05.15</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2028.03.25</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">0.60</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">400,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">400,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">400,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="60" ALIGN="CENTER" ROWSPAN="2">지방구조조정시설자금(*3)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2023.06.12</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2031.03.25</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1.60</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">700,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">700,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">700,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2023.09.15</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2031.03.25</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1.60</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">600,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">600,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">600,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">지방구조조정자금(*3)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2023.09.20</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2026.06.25</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1.60</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">300,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">300,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">300,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="180" ALIGN="CENTER" ROWSPAN="6">중소기업자금대출(*4)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024.03.28</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2025.03.28</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2.98</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024.03.28</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2025.03.28</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.37</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">300,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">300,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024.03.28</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2025.03.28</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.15</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">500,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">500,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024.03.28</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2025.03.28</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.54</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024.03.28</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2025.03.27</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.50</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024.03.28</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2026.03.28</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.81</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,200,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,200,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">농협은행</TD>
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">금융농업중기자금대출(*5)</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2023.10.06</TD>
<TD WIDTH="102" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2028.09.25</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2.50</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="876" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="7">차입금 계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">17,000,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">10,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="876" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="7">현재가치할인차금</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(882,205,840)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(769,630,080)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="876" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="7">소계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">16,117,794,160</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">9,230,369,920</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="876" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="7">유동성장기부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(96,755,220)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(58,363,481)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="876" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="7">합계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">16,021,038,940</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">9,172,006,439</TD>
</TR>
</TBODY>
</TABLE>

<P>(*1) 상기 차입금과 관련하여 연결회사의 유형자산 중 토지와 건물을 담보로 제공하고 있습니다(주석31 참조).(*2) 연결회사는 해당 차입금과 관련하여 기술보증기금으로부터 380백만원의 대출보증을 제공받고 있습니다(주석31 참조).(*3) 연결회사는 해당 차입금과 관련하여 연결회사의 단기금융상품 중 중금채를 담보로 제공하고 있습니다(주석31 참조).(*4) 연결회사는 해당 차입금과 관련하여 연결회사의 건물을 담보로 제공하고 있습니다(주석31 참조).(*5) 연결회사는 해당 차입금과 관련하여 연결회사의 기타포괄손익-공정가치 측정 금융자산 중 국고채를 담보로 제공하고 있습니다(주석31 참조).
<SPAN USERMARK=" B">20. 법인세비용</SPAN>
</P>
<P>연결회사는 법인세비용을 전체 회계연도에 대해서 예상되는 최선의 가중평균 연간법인세율의 추정에 기초하여 인식하고 있으며, 당분기와 전분기 중 법인세비용차감전순손실이 발생하여 인식한 법인세비용은 없습니다.</P>

<P>
<SPAN USERMARK=" B">21. 자본금과 주식발행초과금</SPAN>
</P>
<P>(1) 당분기말과 전기말 현재 자본금 및 주식발행초과금의 내역은 다음과 같습니다(단위: 원). </P>

<TABLE BORDER="1" WIDTH="797" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="154"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="145" VALIGN="MIDDLE" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH COLSPAN="2" WIDTH="326" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH COLSPAN="2" WIDTH="326" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주</TH>
<TH WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">우선주</TH>
<TH WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주</TH>
<TH WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">수권주식수</TD>
<TD COLSPAN="2" WIDTH="326" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">50,000,000주</TD>
<TD COLSPAN="2" WIDTH="326" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">50,000,000주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">주당 액면금액</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">발행주식수</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,932,208주</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,940주</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,872,208주</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,940주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">자본금</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,466,104,000</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">248,970,000</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,436,104,000</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">248,970,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">주식발행초과금</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">203,893,635,218</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,527,911,076</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">203,634,970,624</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,527,911,076</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당분기와 전분기 중 자본금과 주식발행초과금의 변동 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="161"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="170" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="144" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수</TH>
<TH WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본금</TH>
<TH WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식발행초과금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">전기초</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,022,274</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,011,137,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">201,332,398,720</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">  유상증자</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,905,714</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,452,857,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">214,356,598,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">  전환우선주의 행사</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,456</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">61,728,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">808,814,691</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">  주식선택권 행사</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,000,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30">전분기말</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,051,170</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,525,585,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">215,165,412,992</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30">당분기초</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,370,148</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,685,074,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">214,162,881,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30">  주식선택권 행사</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">30,000,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">258,664,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30">당분기말</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,430,148</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,715,074,000</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">214,421,546,294</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 전환우선주당분기말 현재 연결회사가 발행한 전환우선주의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="815" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="579"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="227" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="588" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제2회 전환우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">발행가액(원)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">33,449,803,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="53">전환조건(*2)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="53">- 전환가격 : 발행가와 동일- 전환비율 : 1 대 1.4262295082</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환청구기간</TD>
<TD WIDTH="588" HEIGHT="30">2022년 11월 19일 ~ 2026년 11월 18일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환으로 발행할 주식의 종류</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">기명식 보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환으로 발행할 주식수(*2)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">618,695</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">의결권에 관한 사항</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">우선주 1주당 1의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">이익배당에 관한 사항</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">누적적(액면가 기준 1%), 참가적 우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="99">기타 약정사항(주주간 약정 및 재무약정 사항 등)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="99">본 주식의 발행일로부터 12개월이 되는 날로부터 본 주식 발행일로부터 30개월이 되는날까지 매 영업일에 본 주식 보유자에게 보유하고 있는 본 주식의 일부를 매수인에게 매도하여 줄 것을 청구할 수 있으며, 본 주식 보유자는 이 청구에 따라 보유하고 있는 본 주식을 매수인에게 매도하여야 한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="927">전환조건의 조정(*1)</TD>

<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="927">
<P>가. 인수회사의 본 주식의 1주당 취득가격은 제1조의 납입총액을 본 주식 총수로 나눈 가액으로 한다.</P>
<P>나. 발행회사가 당시 전환가액을 하회하는 가격으로 발행가격 등을 정하여 신주, 상환우선주, 전환우선주, 상환전환우선주, 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우 본 주식의 전환조건 및 1주당 전환되는 보통주식의 수를 정하는 전환비율을 다음과 같이 조정한다.</P>
<P>조정 후 전환가액 = [(조정 전 전환가액 × 기발행주식수)+(신발행주식수 × 1주당 발행가액)] / (기발행주식수+신발행주식수)</P>
<P> </P>
<P>조정후 전환비율= 본 주식 1주당 취득가액/ 조정 후 전환가액</P>
<P> </P>
<P>다. 발행회사가 시가를 하회하는 발행가액으로 신주, 상환우선주, 전환우선주, 상환전환우선주, 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우에는 다음과 같이 전환가격을 조정한다.</P>
<P>조정 후 전환가액 = 조정 전 전환가액 × {[기발행주식수+(신주발행주식수 × 1주당발행가액/시가)]/(기발행주식수+신발행주식수)}</P>
<P> </P>
<P>조정후 전환비율= 본 주식 1주당 취득가액/ 조정 후 전환가액</P>
<P> </P>
<P>라. 발행회사의 주식을 분할 또는 합병하는 경우 전환조건은 그 분할 및 병합의 비율에 따라 조정된다.</P>
<P> </P>
<P>마. 발행회사의 분할 또는 합병 등이 이루어지는 경우 그 사유가 발생하기 전에 본 주식이 보통주로 전환되었다면 받을 수 있었던 대가가 우선주로서 받을 수 있는 대가보다 큰 경우에는 보통주로 전환되었다면 받을 수 있었던 대가가 보장되도록 본 주식의 전환조건이 조정된다.</P>
<P> </P>
<P>바. 감자 및 주식 병합 등 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가액을 조정한다.</P>
<P> </P>
<P>사. 위의 전환조건 조정과는 별도로 2021년 11월 19일 이후 매 3개월마다 전환가액을 조정하며, 각 조정일의 전일을 기준일로 산정한 보통주의 산술평균가액{(1개월 거래량가중평균주가 + 1주일 거래량 가중평균주가 + 최근일 종가)/3}과 최근일 종가 중 높은 가격으로 조정하되, 조정후 전환가격이 조정전 전환가격보다 높은 경우에는 그 중 낮은 금액으로 전환가격을 조정함. 단, 최초 전환가액(조정일 전에 전환가액을 이미 조정한 경우에는 이를 감안하여 산정한 가액)의 100분의 70에 해당하는 가액 미만으로 조정되지 아니한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 행사가격 인하조건이 내재된 제2회 전환우선주에 대해서 금융감독원의 질의회신(회제이-00094)에 따라 발행시점에 자본으로 분류하였습니다.(*2) 전환가격은 최초 발행 이후 3회에 걸쳐 조정되었습니다.보고기간 후 전환우선주 28,965주가 보통주로 전환청구 되었습니다.</P>

<TABLE BORDER="1" WIDTH="815" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="579"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="227" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="588" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제3회 전환우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">발행가액(원)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">4,649,997,750</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="53">전환조건(*2)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="53">- 전환가격 : 발행가와 동일- 전환비율 : 1 대 1.4262295082</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환청구기간</TD>
<TD WIDTH="588" HEIGHT="30">2022년 12월 30일 ~ 2026년 12월 29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환으로 발행할 주식의 종류</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">기명식 보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환으로 발행할 주식수(*2)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">91,475</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">의결권에 관한 사항</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">우선주 1주당 1의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">이익배당에 관한 사항</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">누적적(액면가 기준 1%), 참가적 우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="99">기타 약정사항(주주간 약정 및 재무약정 사항 등)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="99">본 주식의 발행일로부터 12개월이 되는 날로부터 본 주식 발행일로부터 30개월이 되는날까지 매 영업일에 본 주식 보유자에게 보유하고 있는 본 주식의 일부를 매수인에게 매도하여 줄 것을 청구할 수 있으며, 본 주식 보유자는 이 청구에 따라 보유하고 있는 본 주식을 매수인에게 매도하여야 한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="927">전환조건의 조정(*1)</TD>

<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="927">
<P>가. 인수회사의 본 주식의 최초 전환가액은 납입총액을 본 주식 총수로 나눈 가액으로 한다. </P>
<P> </P>
<P>나. 발행회사가 당시 전환가액을 하회하는 가격으로 발행가격 등을 정하여 신주(상환우선주, 전환우선주, 상환전환우선주 포함), 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우 본 주식의 전환가액 및 1주당 전환되는 보통주식의 수를 정하는 전환비율을 다음과 같이 조정한다.</P>
<P> </P>
<P>조정 후 전환가액 = [(조정 전 전환가액 × 기발행주식수)+(신발행주식수 × 1주당 발행가액)] / (기발행주식수+신발행주식수) </P>
<P> </P>
<P>조정후 전환비율= 최초 전환가액/ 조정 후 전환가액</P>
<P> </P>
<P>다. 발행회사가 시가를 하회하는 발행가액으로 신주(상환우선주, 전환우선주, 상환전환우선주 포함), 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우에는 다음과 같이 전환가격 및 전환비율을 조정한다. </P>
<P> </P>
<P>조정 후 전환가액 = 조정 전 전환가액 × {[기발행주식수+(신주발행주식수 × 1주당발행가액/시가)]/(기발행주식수+신발행주식수)}</P>
<P> </P>
<P>조정후 전환비율= 최초 전환가액/ 조정 후 전환가액</P>
<P> </P>
<P>라. 발행회사의 주식을 분할 또는 합병하는 경우 전환조건은 그 분할 및 병합의 비율에 따라 조정된다.</P>
<P> </P>
<P>마. 발행회사의 분할 또는 합병 등이 이루어지는 경우 그 사유가 발생하기 전에 본 주식이 보통주로 전환되었다면 받을 수 있었던 대가가 우선주로서 받을 수 있는 대가보다 큰 경우에는 보통주로 전환되었다면 받을 수 있었던 대가가 보장되도록 본 주식의 전환조건이 조정된다.</P>
<P> </P>
<P>바. 보통주식에 한하여 이루어지는 감자 및 주식 병합 등 본 주식의 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가액을 조정한다.</P>
<P> </P>
<P>사. 위의 전환조건 조정과는 별도로 2021년 12월 30일 이후 매 3개월마다 전환가액을 조정하며, 각 조정일의 전일을 기준일로 산정한 보통주의 산술평균가액{(1개월 거래량가중평균주가 + 1주일 거래량 가중평균주가 + 최근일 종가)/3}과 최근일 종가 중 높은 가격으로 조정하되, 조정후 전환가격이 조정전 전환가격보다 높은 경우에는 조정하지 아니함(단, 최초 전환가액(조정일 전에 전환가액을 이미 조정한 경우에는 이를 감안하여 산정한 가액)의 100분의 70에 해당하는 가액 미만으로 조정되지 아니한다). </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 행사가격 인하조건이 내재된 제3회 전환우선주에 대해서 금융감독원의 질의회신(회제이-00094)에 따라 발행시점에 자본으로 분류하였습니다.(*2) 전환가격은 최초 발행 이후 2회에 걸쳐 조정되었습니다.</P>

<P>
<SPAN USERMARK=" B">22. 주식기준보상</SPAN>
</P>
<P>(1) 연결회사는 임직원 등에게 주식결제형 주식선택권을 부여하였으며, 그 주요 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1023">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="171"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="171" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차 부여분</TH>
<TH WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">4차 부여분</TH>
<TH WIDTH="171" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5차 부여분</TH>
<TH WIDTH="170" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6차 부여분</TH>
<TH WIDTH="180" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">7차 부여분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여일</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.04.02</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.07.01</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.08.29</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.06.13</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.04.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여수량(주)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">564,065</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">270,034</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,004</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">222,000</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사가격(원)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,522</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,553</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,553</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,119</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,196</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53" VALIGN="MIDDLE">행사가능기간</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2021.04.01~2026.03.31</TD>
<TD WIDTH="173" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.06.30~2027.06.29</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.08.28~2027.08.27</TD>
<TD WIDTH="170" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2023.06.12~2028.06.11</TD>
<TD WIDTH="180" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2023.10.20~2028.10.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="76">가득조건</TD>
<TD WIDTH="171" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년, IPO조건</TD>
<TD WIDTH="173" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년 , 부여 즉시 가득</TD>
<TD WIDTH="171" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년, 부여 즉시 가득</TD>
<TD WIDTH="170" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년, 부여 즉시 가득</TD>
<TD WIDTH="180" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 2년6개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여방법</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사한 주식수(주)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">471,026</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">201,026</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,004</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31,500</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">소멸된 주식수(주)(*1)</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">48,000</TD>
<TD WIDTH="173" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">60,007</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="170" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">24,000</TD>
<TD WIDTH="180" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">14,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">변경된 주식수(주)(*2)</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="173" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="170" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="180" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,635</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미행사 주식수(주)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,039</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,001</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">166,500</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">48,635</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="854">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="166"></COL>
<COL WIDTH="167"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="176" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">8차 부여분</TH>
<TH WIDTH="169" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10-1차 부여분</TH>
<TH WIDTH="175" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10-2차 부여분</TH>
<TH WIDTH="176" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">11-1차 부여분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">부여일</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2021.07.21</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.05.18</TD>
<TD WIDTH="175" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.05.18</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.08.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여수량(주)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">110,000</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,000</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,000</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사가격(원)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31,516</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,600</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,600</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="99" VALIGN="MIDDLE">행사가능기간</TD>
<TD WIDTH="176" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2024.01.21~2029.01.20</TD>
<TD WIDTH="169" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2024.05.18~2029.05.17</TD>
<TD WIDTH="175" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2025.05.18~2030.05.17</TD>
<TD WIDTH="176" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2024.08.31~2029.08.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="122">가득조건</TD>
<TD WIDTH="176" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 2년6개월</TD>
<TD WIDTH="169" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건:  부여일로부터 2년</TD>
<TD WIDTH="175" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건:  부여일로부터 3년</TD>
<TD WIDTH="176" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건:  부여일로부터 2년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">부여방법</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="175" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사한 주식수(주)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">소멸된 주식수(주)(*1)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,000</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,000</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,000</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">변경된 주식수(주)(*2)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,049</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미행사 주식수(주)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">56,049</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="859">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="158" HEIGHT="30">구분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="169" HEIGHT="30">11-2차 부여분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="174" HEIGHT="30">12-1차 부여분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="185" HEIGHT="30">12-2차 부여분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="173" HEIGHT="30">12-3차 부여분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">2022.08.31</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">2023.05.16</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">2023.05.16</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">2023.05.16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여수량(주)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">30,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">56,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사가격(원)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">14,100</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">15,040</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">15,040</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">15,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="53">행사가능기간</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="53">2025.08.31~2030.08.30</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="53">2025.05.16~2030.05.15</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="53">2026.05.16~2031.05.15</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="53">2027.05.16~2032.05.15</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="76">가득조건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="76">용역제공조건:  부여일로부터 3년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="76">용역제공조건:  부여일로부터 2년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="76">용역제공조건:  부여일로부터 3년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="76">용역제공조건:  부여일로부터 4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여방법</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">신주발행교부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">신주발행교부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">신주발행교부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">신주발행교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사한 주식수(주)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">소멸된 주식수(주)(*1)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">변경된 주식수(주)(*2)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미행사 주식수(주)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">30,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">56,000</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 직원의 퇴사 등으로 인하여 부여되었던 주식선택권이 소멸되었습니다.(*2) 행사조건 변경 주식수입니다.</P>
<P>(2) 주식선택권의 수량과 가중평균행사가격의 변동은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="676" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="135" VALIGN="MIDDLE" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH COLSPAN="2" WIDTH="271" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주식매수선택권 수량(단위: 주)</P>
</TH>

<TH COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>가중평균행사가격(단위: 원)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="136" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당분기</P>
</TH>

<TH WIDTH="135" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>전분기</P>
</TH>

<TH WIDTH="135" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당분기</P>
</TH>

<TH WIDTH="135" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>전분기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" HEIGHT="30">
<P>기초</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">609,224</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">614,040</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,975</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,814</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" VALIGN="MIDDLE" HEIGHT="30">행사</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(60,000)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,000)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,522</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,553)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" HEIGHT="30">
<P>소멸</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(18,000)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,600)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" HEIGHT="30">
<P>기말</P>
</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">531,224</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">592,040</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,463</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,814</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>보고기간말 현재 유효한 주식선택권의 가중평균잔여만기는 2.37년입니다.</P>
<P>(3) 전기중 부여된 주식선택권의 보상원가를 이항모형을 이용한 공정가치접근법을 적용하여 산정했으며, 보상원가를 산정하기 위한 제반 가정 및 변수는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="557" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" WIDTH="171" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12-1차(*1)</TH>
<TH VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12-2차(*1)</TH>
<TH VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12-3차(*1)</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">부여일 공정가치(원)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3,248</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">4,336</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">5,178</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">부여일의 주가(원)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">11,770</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">11,770</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">11,770</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">주가변동성</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">60.60%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">60.60%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">60.60%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">배당수익률</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">0.00%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">0.00%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">기대만기(년)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">2.0</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3.0</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">4.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">무위험수익률</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3.37%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3.28%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">3.28%</TD>
</TR>
</TBODY>
</TABLE>

<P>(*1) 주가변동성은 부여일 기준 자사 개별종목의 과거 180일 변동성을 반영하였습니다.(4) 당분기와 전분기 중 비용으로 인식한 주식기준보상비용은 각각 41백만원과 288백만원이며, 전액 주식결제형 주식기준보상과 관련된 비용입니다. 
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">23. 고객과의 계약에서 생기는 수익 및 관련 계약자산과 계약부채</SPAN>
</P>
<P>(1) 고객과의 계약에서 생기는 수익① 당분기와 전분기 중 연결회사는 수익과 관련해 연결포괄손익계산서에 다음 금액을 인식하였습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="510">

<COLGROUP>
<COL WIDTH="237"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">구 분</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전분기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" VALIGN="MIDDLE" HEIGHT="30">고객과의 계약에서 생기는 수익</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,909,719,393</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,697,213,394</TD>
</TR>
</TBODY>
</TABLE>
<P>② 고객과의 계약에서 생기는 수익의 구분연결회사는 다음의 주요부문과 지역에서 재화나 용역을 기간에 걸쳐 이전하거나 한 시점에 이전함으로써 수익을 창출합니다(단위: 원).</P>

<TABLE WIDTH="514" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="240"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="249" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">기술이전(*)</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">73,230,482</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">255,224,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30">용역의 제공</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,000,000</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">재화판매</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,766,488,911</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,441,988,765</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,909,719,393</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,697,213,394</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">지리적 시장</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">  국내</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,902,555,225</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,539,908,862</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">  해외</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,164,168</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,304,532</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,909,719,393</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,697,213,394</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">수익인식 시점</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">  한 시점에 인식</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,836,488,911</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,441,988,765</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" HEIGHT="30">  기간에 걸쳐 인식</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">73,230,482</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">255,224,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,909,719,393</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,697,213,394</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 기술이전 계약의 주요 내용은 주석 31 참조</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">(2) 고객과의 계약과 관련된 자산과 부채  당분기말과 전기말 현재 연결회사가 인식하고 있는 계약부채는 다음과 같습니다(단위: 원).</SPAN>
</P>

<TABLE BORDER="1" WIDTH="517" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="247"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="256" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="131" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기말</P>
</TH>

<TH WIDTH="130" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" HEIGHT="30">계약부채 - 기술이전계약</TD>
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,984,066,413</TD>
<TD WIDTH="130" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,057,296,895</TD>
</TR>
</TBODY>
</TABLE>
<P>연결회사는 기업회계기준서 제1115호에 따라 기업이 고객에게서 이미 받은 대가(또는 지급기일이 된 대가)에 상응하여 고객에게 재화나 용역을 이전하여야 하는 기업의의무에 해당하는 금액을 계약부채로 계상하였습니다.(3) 당분기 중 원가기준 투입법을 적용하여 진행기준수익을 인식한 계약으로서 계약금액이 전기 매출액의 5% 이상인 주요 계약의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="794">

<COLGROUP>
<COL WIDTH="260"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="269" HEIGHT="60" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<P>구분</P>
</TH>
<TH WIDTH="132" HEIGHT="60" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">계약일</TH>
<TH WIDTH="131" HEIGHT="60" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">계약기한</TH>
<TH WIDTH="262" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">진행률</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제 1</TH>
<TH WIDTH="131" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제 2</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" HEIGHT="30">LICENSE AGREEMENT(SPH SINE)(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2021.10.28</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">상업화 후 20년</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4.43%</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">80.06%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" HEIGHT="30">주식회사 셀트리온(*2)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2022.03.23</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2년(*3)</TD>
<TD WIDTH="262" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" COLSPAN="2">42.95%</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 계약기간 동안 계약지역 내 건선 등의 계약적응증 개발 및 상업화에 필요한 지적재산권에 대한 독점적 라이선스 및 업데이트된 지적재산권의 지속적 제공의무가 포함되어 있습니다. 계약금액은 과제 1에 대한 대가와 과제 2에 대한 대가로 구분됩니다. 연결회사는 기업회계기준서 제1115호에 따라 계약금액을 각 수행의무의 개별 판매가격으로 배분하였으며, 각 수행의무 별 진행률을 측정하였습니다 (주석 31 참조).(*2) 연결회사는 2022년 3월 23일에 주식회사 셀트리온과 마이크로바이옴 신약 후보물질 발굴을 위한 공동연구계약을 체결하였습니다(주석 31 참조).(*3) 상기 계약기간은 공동연구기간이며 그 진행 현황에 따라 변동가능합니다.</P>

<P>
<SPAN USERMARK=" B">24. 판매비와 관리비</SPAN>당분기와 전분기 중 판매비와 관리비의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="216"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="225" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구 분</TH>
<TH WIDTH="198" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기</TH>
<TH WIDTH="198" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">급여</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">560,293,632</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">479,984,156</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">85,019,114</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">38,487,380</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">복리후생비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">56,584,711</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">37,330,789</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">여비교통비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">39,522,775</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">65,763,908</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">세금과공과</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">20,475,590</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">14,586,430</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">감가상각비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">71,387,456</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">13,544,396</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">16,260,503</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">16,795,295</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">사용권자산상각비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">74,912,607</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">37,594,281</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">임차료</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,833,390</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">10,900,344</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">보험료</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">23,706,112</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">19,715,979</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">차량유지비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,850,950</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">5,240,258</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,682,284,973</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,611,555,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">소모품비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,418,491</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">13,805,474</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">지급수수료</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6,071,022,680</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,715,752,367</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">57,219,665</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">163,961,885</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">광고선전비</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,843,441,376</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,371,562,720</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">264,965,185</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">175,111,097</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,882,199,210</TD>
<TD WIDTH="198" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,791,691,893</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">25. 비용의 성격별 분류</SPAN>당분기와 전분기 중 비용의 성격별 분류는 다음과 같습니다(단위: 원).
</P>

<TABLE WIDTH="618" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="263"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="272" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="173" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기</P>
</TH>

<TH WIDTH="173" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전분기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">재고자산의 변동</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">163,306,755</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(512,871,110)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">연구관련 재료비 및 소모품비</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131,459,109</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,154,145</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">종업원 급여</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,694,893,151</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,482,859,639</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,608,768</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">288,160,977</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">용역비</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,869,198,626</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,134,135,564</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">감가상각비 및 무형자산상각비</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,877,675</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">319,733,576</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">지급수수료</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,071,022,680</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,715,752,367</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="BOTTOM" HEIGHT="30">광고선전비</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,843,441,376</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,371,562,720</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="MIDDLE" HEIGHT="30">기타 비용</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">966,455,581</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">904,824,036</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매출원가 및 판매비와 관리비 합계</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,206,263,721</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,861,311,914</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">26. 기타수익과 기타비용</SPAN>
</P>
<P>(1) 당분기와 전분기 중 기타수익의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE WIDTH="591" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="309" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" VALIGN="MIDDLE" HEIGHT="30">고용지원금</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,855,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,650,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" VALIGN="MIDDLE" HEIGHT="30">외환차익</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,580,624</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,146,863</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" VALIGN="MIDDLE" HEIGHT="30">외화환산이익</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">872,518</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">418,397,138</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" VALIGN="MIDDLE" HEIGHT="30">잡이익</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,662,672</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,847,091</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" VALIGN="MIDDLE" HEIGHT="30">리스자산변경이익</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,771,259</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,708,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,742,073</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">460,749,489</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 기타비용의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE WIDTH="590" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="257"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="162" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기</TH>
<TH WIDTH="162" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">외환차손</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,382,109</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,260,771</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">외화환산손실</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">77,574,275</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">잡손실</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">883,731</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">810,331</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">기부금</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000,000</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,767,189</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">유형자산처분손실</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,030,145</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">206,870,260</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,838,291</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">27. 금융수익과 금융비용</SPAN>
</P>
<P>(1) 당분기와 전분기 중 금융수익의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE WIDTH="583" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기</TH>
<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">이자수익</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">606,768,081</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">858,139,340</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">파생상품평가이익</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,467,297</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">사채상환이익</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,990,497</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">606,768,081</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">877,597,134</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 금융비용의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="583">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">이자비용</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">456,395,780</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">559,447,764</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">파생상품평가손실</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,338,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">456,395,780</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">565,786,585</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN USERMARK=" B">28. 주당순손실</SPAN>
</P>
<P>기본주당손실은 연결회사의 보통주당기순손실을 가중평균 유통보통주식수로 나누어 산정했습니다(단위: 원).</P>
<P>(1) 보통주당분기순손실</P>

<TABLE WIDTH="454" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="188" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">지배주주 당분기순손실</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,186,415,936)</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,461,633,210)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">가중평균 유통보통주식수</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,874,186</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,565,933</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">기본주당순손실</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(116)</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(197)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">희석주당순손실</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(116)</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(197)</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 가중평균 유통보통주식수당분기와 전분기 중 발행보통주식수를 유통기간으로 가중평균하여 산정한 유통보통주식수의 산출내역은 다음과 같습니다.</P>
<P>① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="811">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="219"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="175" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="190" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="122" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유통주식수</TH>
<TH WIDTH="96" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일수</TH>
<TH WIDTH="228" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균유통보통주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2024.01.01 ~ 2024.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,872,208</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,717,370,928</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권행사</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2024.03.29 ~ 2024.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,000</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">180,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,717,550,928</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">유통일수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">가중평균 유통보통주식수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,874,186</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="811">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="219"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="175" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="190" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="122" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유통주식수</TH>
<TH WIDTH="96" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일수</TH>
<TH WIDTH="228" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균유통보통주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.01.01 ~ 2023.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,443,645</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">90</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,569,928,050</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">제 2회 전환우선주 전환</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.01.26 ~ 2023.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">68,849</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">65</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,475,185</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권행사</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.02.01 ~ 2023.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,000</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">59</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,298,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">제 2회 전환우선주 전환</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.03.09 ~ 2023.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,179</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,431,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">제 2회 전환우선주 전환</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.03.22 ~ 2023.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,900</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">459,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">제 2회 전환우선주 전환</TD>
<TD WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.03.23 ~ 2023.03.31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,179</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,342,611</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,580,933,963</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">유통일수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">가중평균 유통보통주식수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,565,933</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 희석주당순이익</P>
<P>① 연결회사의 잠재적보통주는 희석화 효과가 없으므로 기본주당손익과 희석주당손익은 동일합니다.</P>
<P>② 희석효과가 없어 보통주희석주당손익을 계산할 때 가중평균 보통주식수에서 제외된 잠재적 보통주 내역은 다음과 같습니다(단위: 주).</P>

<TABLE BORDER="1" WIDTH="639" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">전환우선주</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">710,170</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">710,170</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">전환사채</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">755,301</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">755,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">주식선택권</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">549,224</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">609,224</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,014,695</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,074,695</TD>
</TR>
</TBODY>
</TABLE>

<P>(*) 상기 잠재적 보통주식수에는 시가하락에 의한 전환비율의 조정이 고려되었습니다.
<SPAN USERMARK=" B">29. 연결현금흐름표</SPAN>
</P>
<P>(1) 당분기와 전분기 중 영업활동으로 인한 현금흐름은 다음과 같습니다(단위: 원). </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="325"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="334" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기</TH>
<TH WIDTH="140" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">법인세비용차감전 순손실</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(2,312,300,214)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(3,409,376,773)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">조정</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  감가상각비</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">441,123,665</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">277,829,296</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  무형자산상각비</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">16,260,503</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">16,795,295</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  사용권자산상각비</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">78,757,666</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">41,905,308</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  이자비용</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">456,395,780</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">559,447,764</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  주식보상비용</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">40,608,768</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">288,160,977</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  파생상품평가손실</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">6,338,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  유형자산처분손실</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">123,030,145</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  파생상품평가이익</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(2,467,297)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  리스자산변경이익</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(13,771,259)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(1,708,397)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  외화환산손실</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">77,574,275</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  사채상환이익</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(16,990,497)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  이자수익</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(606,768,081)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(858,139,340)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  외화환산이익</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(375,293)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(418,397,138)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30" ALIGN="CENTER">소  계</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">612,836,169</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(107,225,208)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">영업 활동관련 자산부채의 변동</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  매출채권의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(2,415,211,446)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(1,034,218,670)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  미수금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(279,712,047)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">1,715,879,394</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  선급금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(1,470,483,500)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">133,402,640</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  선급비용의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">39,300,284</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">10,884,751</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  장기선급비용의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(17,377,293)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  부가세대급금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">417,820,258</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">19,450,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  재고자산의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(122,831,537)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(422,577,383)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  재고자산평가충당금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">24,336,061</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(88,756,463)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  외상매입금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">37,403,630</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  미지급금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">301,523,226</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">26,416,719</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  선수금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(41,140,878)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(1,984,175)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  선수수익의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(102,736,943)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  미지급비용의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(73,717,230)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">113,876,806</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  반품충당부채의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">16,923,265</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">2,000,059</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  부가세예수금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">12,503,700</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  계약부채의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(73,230,482)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(5,224,629)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">  예수금의 증감</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(122,107,991)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">6,952,641</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30" ALIGN="CENTER">소  계</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(3,766,001,980)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">373,365,339</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="334" HEIGHT="30">영업으로부터 창출된 현금</TD>
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30" ALIGN="RIGHT">(5,465,466,025)</TD>
<TD VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="RIGHT">(3,143,236,642)</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 현금의 유입ㆍ유출이 없는 거래 중 중요한 사항은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="629" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="325"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="334" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="148" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">사용권자산의 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88,077,369</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">113,801,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">리스부채의 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,873,258</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">109,176,170</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">계약변경에 따른 사용권자산/리스부채의 감소</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,705,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권의 종속기업투자주식 대체</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,027,942</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">전환우선주 행사로 인한 자본 증가</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,162,091,107</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">전환사채의 이자비용 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">354,849,582</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">294,575,338</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">건설중인자산 미지급금</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,239,212,726</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">유형자산 본계정대체</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,500,267,433</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">전환사채의 상환</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,007,949</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">단기차입금 현재가치할인차금 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,215,772</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="30" VALIGN="MIDDLE">장기차입금 현재가치할인차금 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,108,045</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 당분기와 전분기 중 재무활동에서 생기는 부채의 조정내용은 다음과 같습니다(단위: 원).</P>
<P>① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="705">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="196" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">현금흐름</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비현금거래</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">유동리스부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">234,205,400</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(56,360,661)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">57,814,031</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">235,658,770</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">비유동리스부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,961,140</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(58,835,729)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">137,125,411</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">전환사채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,633,328,862</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">354,849,582</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,988,178,444</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">장기차입금</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="705">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="196" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">현금흐름</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비현금거래</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">유동리스부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">136,507,335</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(114,225,370)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91,822,368</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">114,104,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">비유동리스부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">180,532,120</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(5,648,812)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">174,883,308</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">전환사채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,465,191,521</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(45,699,713)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">294,724,944</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,714,216,752</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">장기차입금</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">30. 영업부문 정보</SPAN>(1) 부문에 대한 정보당분기말 현재 연결회사의 영업부문은 단일 영업부문입니다. 당분기와 전분기 중 영업수익(매출액) 정보는 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="507" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="153" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">제품매출</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">14,766,488,911</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,441,988,765</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">기술이전</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">73,230,482</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">255,224,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">용역매출</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">70,000,000</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="143" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">14,909,719,393</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,697,213,394</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 지역에 대한 정보</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="421">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전분기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30">국내</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,902,555,225</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,539,762,278</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30">해외</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,164,168</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,451,116</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="157" HEIGHT="30">합계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">14,909,719,393</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">7,697,213,394</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 주요 고객에 대한 정보</P>
<P>당분기와 전분기 중 연결회사 매출액의 10% 이상을 차지하는 외부고객은 없습니다.</P>

<P>
<SPAN USERMARK=" B">31. 우발상황 및 약정사항</SPAN>
</P>
<P>(1) 당분기말과 전기말 현재 사용이 제한된 예금의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1127">

<COLGROUP>
<COL WIDTH="176"></COL>
<COL WIDTH="270"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="178"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="279" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예금분류</TH>
<TH WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예금종류</TH>
<TH WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
<TH WIDTH="187" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용제한내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">주식회사 위바이옴</TD>
<TD WIDTH="279" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">단기금융상품</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">정기예금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000,000</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000,000</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">질권설정등록계좌</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="279" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타포괄손익-공정가치 측정 금융자산</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">국고채권</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신한투자증권</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,483,823,425</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,483,823,425</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">질권설정등록계좌</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>(2) 연결회사는 전기 이전에 서울대학교 산학협력단과 상표사용허락 계약을 체결 하였습니다. 본 계약을 통해 연결회사는 계약상표에 대한 사용권리를 확보하였고, 경상상표사용료를 지급할 의무를 부담하고 있습니다.(3) 연결회사는 전기 이전에 서울대학교 산학협력단 및 서울대병원과 특허에 대한 기술이전계약(양도 등)을 체결하였습니다. 연결회사는 향후 동 기술에 대한 임상 진행경과에 따라 총 11,630백만원(경상기술료 별도)의 마일스톤 지급약정을 체결하고 있습니다. 전기 이전에 체결한 기술이전계약의 계약기술은 서울대학교 산학협력단으로부터양도받은 특허에 포함되어 있는 기술이며, 기술이전으로 수취한 기술료 중 일부(최대10%, 부가세 별도)에 대해 서울대학교 산학협력단과 합의된 비율에 따라 배분됩니다.(4) 연결회사는 2021년 11월 1일에 서울대학교 산학협력단과 '인체 마이크로바이옴 유래분 균주의 면역 항암 효과 검증'을 위한 위탁연구용역 계약을 체결하였습니다. 전기까지 총 연구비 6억원 전액을 납부하였습니다.(5) 기술이전계약① 연결회사가 체결한 주요 기술이전 계약의 내용은 다음과 같습니다.연결회사는 2021년 10월 28일에 SPH Sine Pharmaceutical Laboratories Co., Ltd. 와 마이크로바이옴 신약 후보물질에 대한 기술이전 계약을 체결하였습니다. 연결회사는 계약금(upfront payment) USD 2,500,000 중 USD 1,250,000은 2021년 12월 17일에 수령하였으며, 2022년 12월 20일 나머지 USD 1,250,000를 모두 수령하였습니다. 동 계약금은 수행의무 이행 기간 동안 진행기준에 따라 수익을 인식합니다. 계약에 따라 향후 임상단계, 허가, 상업화 등 단계별  마일스톤 지급 조건 충족 시 USD 104,750,000(경상기술료(royalty)별도) 규모의 마일스톤 금액(milestone payment)을추가로 수령할 수 있습니다. ② 기술이전계약과 관련된 불확실성 및 기타사항본 계약을 통한 수익 인식은 개발 및 임상시험과 품목허가 등의 성공 여부에 따라 달라질 수 있습니다. 계약 조건에 따라, 규제기관에 의한 연구-개발의 중단, 품목허가 실패 등 발생시 계약이 해지될 수 있으므로 발생가능성에 불확실성이 내포되어 있습니다.(6) 공동연구개발연결회사는 2022년 3월 23일에 주식회사 셀트리온과 마이크로바이옴 신약 후보물질발굴을 위한 공동연구계약을 체결하였습니다. 한편 공동연구계약은 라이선스 옵션 계약을 포함하고 있습니다. 연결회사는 연구의 결과로 얻어지는 지적재산권에 대하여 독점적 실시권을 취득할 수 있는 권리를 부여하였습니다. (7) 합작투자계약
<SPAN>연결회사는 2022년 1월 27일에 연결회사의 종속기업인 주식회사 위바이옴의 지분 49%를 보유한 주식회사 이마트와 주식회사 위바이옴의 소유와 지배구조 등에 대한 합작투자계약서를 체결하였습니다. 동 계약에 따라 각 당사자는 일정 기간 동안 주식처분이 제한되어 있으며, 주식처분제한 기간 이후 거래상대방의 지분 양도 시 회사는 이에 대한 우선매수권을 가집니다. 한편 거래상대방인 주식회사 이마트는 교착상태 또는 합작회사의 설립일로부터 10년이 경과된 경우, 이마트의 보유 지분에 대하여 회사에 매수청구권을 행사할 수 있습니다. 연결회사가 동 매수청구권의 행사를 거부하는 경우 주식회사 이마트의 주식매도청구권(Penalty Call Option)이 발동됩니다. </SPAN>
<SPAN>연결회사는 주주간계약에 따른 자기지분상품의 매입 의무에 대한 상환금액의 현재가치를 금융부채로 인식하여 장기미지급금으로 계상하였습니다.</SPAN>(8) 당분기말 현재 연결회사의 채무를 위하여 담보로 제공되어 있는 자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1124">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="174" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="147" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보권자</TH>
<TH WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보제공자산</TH>
<TH WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="130" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보설정액</TH>
<TH WIDTH="116" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관련 채무</TH>
<TH WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무금액</TH>
<TH WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정한도액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">주식회사 고바이오랩</TD>
<TD WIDTH="147" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">분양 토지(토지)</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,414,625,766</TD>
<TD WIDTH="130" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">3,600,000,000</TD>
<TD WIDTH="116" HEIGHT="210" ROWSPAN="7" ALIGN="CENTER" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="134" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,000,000</TD>
<TD WIDTH="134" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">판교 사옥(건물)</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,388,857,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">산업은행</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">분양 토지(토지)</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,414,625,766</TD>
<TD WIDTH="130" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">3,600,000,000</TD>
<TD WIDTH="134" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,000,000</TD>
<TD WIDTH="134" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">판교 사옥(건물)</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,388,857,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="90" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="3">주식회사 위바이옴</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">중금채</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000,000</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,760,000,000</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000,000</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">농협은행</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">국고채권</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,483,823,425</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,483,823,425</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000,000</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,640,590,991</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,000,000,000</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,000,000,000</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,000,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P>(9) 보고기간말 현재 연결회사는 이행보증 및 인허가보증 등과 관련하여 서울보증보험(주) 등으로부터 457백만원(전기말 : 457백만원)의 지급보증을 제공받고 있습니다.(10) 보고기간말 현재 연결회사는 기술보증기금으로부터 380백만원의 대출보증을 제공받고 있습니다.</P>
<P>(11) 보고기간말 현재 연결회사의 주요 보험가입 내용은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="714">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="218"></COL>
<COL WIDTH="148"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="187" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부보금액</TH>
<TH WIDTH="227" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보험사</TH>
<TH WIDTH="157" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보험금수익자</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE">생산물배상책임보험</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">에이스아메리칸화재해상보험</TD>
<TD WIDTH="157" HEIGHT="180" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="6">주식회사 위바이옴</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE">임상시험배상책임보험</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">200,000,000</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">에이스아메리칸화재해상보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE">재산종합보험</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,550,790,878</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">메리츠화재보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE">생산물배상책임보험</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">에이스아메리칸화재해상보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE">생산물배상책임보험</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500,000,000</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">에이스아메리칸화재해상보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE">생산물배상책임보험</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">USD 100,000</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">삼성화재보험</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 연결회사는 상기 보험이외에 자동차종합보험, 국민건강보험 및 고용보험 등에 가입하고 있습니다.</P>

<P>(13) 연결회사는 마이크로바이옴 치료제 개발 등에 대하여 창업진흥원 등과의 협약에 따라 정부보조금을 수령하였습니다. 진행중인 과제 포함한 전체 국책과제에 대한 총 수령 보조금은 5,274백만원이며, 기술료 납부 의무가 종료된 과제의 보조금은 3,315백만원입니다. 상환의무가 존재하는 정부보조금의 경우에는 상환의무가 확정되는 시점에 회계추정의 변경으로 처리하고 있습니다.
<SPAN USERMARK=" B">32. 특수관계자 거래</SPAN>
</P>
<P>(1) 당분기말과 전기말 현재 연결회사의 특수관계자 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="634">

<COLGROUP>
<COL WIDTH="226"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30" VALIGN="MIDDLE">유의적인 영향력을 행사하는 기업</TD>
<TD WIDTH="399" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="180" VALIGN="MIDDLE" ROWSPAN="6">기타 특수관계자</TD>
<TD WIDTH="399" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2">주식회사 이마트</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="399" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2">주식회사 지마켓</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="399" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2">주식회사 에스에스지닷컴</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="399" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2">주식회사 신세계야구단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="399" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2">(주)신세계아이앤씨</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="399" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">대표이사 및 주요 경영진</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 매출 및 매입 등 거래당분기와 전분기 중 특수관계자와의 매출 및 매입 등 거래내역은 다음과 같습니다(단위: 원).① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="494">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="151" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출 등</TH>
<TH WIDTH="150" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE">주식회사 이마트</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,681,120</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">88,035,380</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE">주식회사 지마켓</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,211,510</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE">(주)에스에스지닷컴</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,005,160</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,549,041</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE">(주)신세계아이앤씨</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,686,280</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">117,813,931</TD>
</TR>
</TBODY>
</TABLE>
<P>② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="494">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="151" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출 등</TH>
<TH WIDTH="150" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE">주식회사 이마트</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,920,320</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">78,680,624</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE">주식회사 지마켓</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,453,153</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE">(주)에스에스지닷컴</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,846,792</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,920,320</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">90,980,569</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 특수관계자에 대한 채권, 채무의 주요 잔액당분기말과 전기말 현재 특수관계자에 대한 채권ㆍ채무의 주요 내역은 다음과 같습니다(단위: 원).① 당분기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="859">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="203" HEIGHT="60" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<SPAN>특수관계 구분</SPAN>
</TH>
<TH WIDTH="328" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">채권</TH>
<TH WIDTH="328" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">채무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출채권</TH>
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채권</TH>
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입채무</TH>
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">주식회사 이마트</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,371,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">주식회사 지마켓</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,974,301</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">(주)에스에스지닷컴</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,498,670</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,472,971</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,371,309</TD>
</TR>
</TBODY>
</TABLE>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="859">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="203" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>특수관계 구분</SPAN>
</TH>
<TH WIDTH="328" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권</TH>
<TH WIDTH="328" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출채권</TH>
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채권</TH>
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입채무</TH>
<TH WIDTH="164" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">주식회사 이마트</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,432,771</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">주식회사 지마켓</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,352,341</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">(주)에스에스지닷컴</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,258,350</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,610,691</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,432,771</TD>
</TR>
</TBODY>
</TABLE>
<P>(4) 특수관계자와의 자금 거래당분기와 전분기 중 특수관계자와의 자금 거래내역은 없습니다.</P>
<P>(5) 전환상환우선주 및 전환사채의 발행내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="712">

<COLGROUP>
<COL WIDTH="703"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="712" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="717">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<SPAN>특수관계 구분</SPAN>
</TH>
<TH COLSPAN="2" WIDTH="317" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">발행금액</TH>
<TH ROWSPAN="2" WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">합계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제2회 전환사채</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제3회 전환우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="53">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,350,000,000</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,649,997,750</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">6,999,997,750</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(6) 연결회사는 2022년 1월 27일에 연결회사의 종속기업인 주식회사 위바이옴의 지분 49%를 보유한 주식회사 이마트와 주식회사 위바이옴의 소유와 지배구조 등에 대한 합작투자계약서를 체결하였습니다(주석31 참조).(7) 당분기말과 전기말 현재 연결회사는 차량리스 약정과 법인신용카드와 관련하여 대표이사로부터 연대보증을 제공받고 있습니다.(8) 연결회사는 전기 이전에 서울대학교 산학협력단(연구책임자 고광표 교수)과 마이크로바이옴 관련 위탁연구용역 계약을 체결하였고, 전기 중 연구용역이 완료되었습니다(주석 31 참조).(9) 주요 경영진에 대한 보상 주요 경영진은 등기 이사 및 감사를 포함하고 있습니다. 당분기와 전분기 중 주요 경영진에게 지급됐거나 지급될 보상금액은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="508" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="218" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>구분</P>
</TH>
<TH WIDTH="143" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기</TH>
<TH WIDTH="147" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="218" HEIGHT="30">
<P>급여 및 기타 단기종업원 급여</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">302,168,669</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">130,294,249</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="218" HEIGHT="30">
<P>퇴직급여 </P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">72,311,737</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">26,026,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="218" HEIGHT="30">
<P>주식기준보상 </P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">64,392,958</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">429,300,226</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="218" HEIGHT="30" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">438,873,364</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">585,620,577</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">33. 보고기간 후 사건</SPAN>보고기간 후 기업은행 중금채 16억의 질권설정을 해지하고 토지와 건물에 담보를 재설정하였습니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0" ATOCID="57">4. 재무제표</TITLE>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}BS_S">
<TITLE ATOC="Y" ATOCID="75">4-1. 재무상태표</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">재무상태표</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기말 2024.03.31 현재</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기말          2023.12.31 현재</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="463" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="181">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="141">
<P>제 11 기 1분기말</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="141">
<P>제 10 기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">자산</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　유동자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">58,854,827,209</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">61,266,125,617</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　현금및현금성자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">17,804,088,887</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,280,964,453</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　단기금융상품</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">39,012,896,095</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">53,512,896,095</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　매출채권</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">433,423,279</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">309,989,137</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동금융자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">492,407,447</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,543,434,658</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">523,188,499</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">270,806,292</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　당분기법인세자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">542,315,974</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">301,527,954</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동파생상품자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">46,507,028</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">46,507,028</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　비유동자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">35,494,883,517</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">35,627,605,012</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　종속기업투자</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">22,096,793,249</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">22,096,793,249</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유형자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">12,037,270,714</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">12,146,524,410</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　사용권자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">85,673,753</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">97,027,118</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　무형자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">614,566,162</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">630,832,665</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타비유동금융자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">660,579,639</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">656,427,570</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　자산총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">94,349,710,726</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">96,893,730,629</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">부채</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　유동부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">17,000,854,922</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">16,941,539,596</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동전환사채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">8,988,178,444</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">8,633,328,862</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동파생상품부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,648,076,654</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,648,076,654</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동금융부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,154,941,249</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,348,622,333</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　유동리스부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">34,453,702</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">34,453,702</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　기타유동부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,175,204,873</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,277,058,045</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　비유동부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">7,944,071,124</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">7,950,679,536</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　비유동파생상품부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,815,501,063</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,815,501,063</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　비유동리스부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">44,080,947</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">50,689,359</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　장기차입금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">6,000,000,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">6,000,000,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　　종업원급여부채</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">84,489,114</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">84,489,114</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　부채총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">24,944,926,046</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">24,892,219,132</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">자본</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　자본금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,715,074,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,685,074,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　주식발행초과금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,421,546,294</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,162,881,700</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　기타자본항목</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,252,052,222</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,348,788,048</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　결손금</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(159,983,887,836)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(157,195,232,251)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　자본총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">69,404,784,680</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">72,001,511,497</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="181" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">부채와 자본총계</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">94,349,710,726</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">96,893,730,629</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}IS_S1">
<TITLE ATOC="Y" ATOCID="76">4-2. 포괄손익계산서</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">포괄손익계산서</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기 2024.01.01 부터 2024.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기 1분기 2023.01.01 부터 2023.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="714" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="205"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="214" ROWSPAN="2">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="250" COLSPAN="2">
<P>제 11 기 1분기</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="250" COLSPAN="2">
<P>제 10 기 1분기</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>3개월</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>누적</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>3개월</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>누적</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">매출액</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">467,251,645</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">467,251,645</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">427,102,165</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">427,102,165</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">매출원가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">401,801,713</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">401,801,713</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">203,570,744</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">203,570,744</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">매출총이익</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">65,449,932</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">65,449,932</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">223,531,421</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">223,531,421</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">판매비와관리비</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,320,834,790</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,320,834,790</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,805,332,532</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2,805,332,532</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">영업손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,255,384,858)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,255,384,858)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,581,801,111)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,581,801,111)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타수익</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,627,966</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">4,627,966</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">460,684,903</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">460,684,903</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타비용</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">666,853,385</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">666,853,385</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,456,119,129</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,456,119,129</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">금융수익</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">553,834,080</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">553,834,080</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">629,079,189</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">629,079,189</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">금융비용</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">424,879,388</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">424,879,388</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">359,296,881</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">359,296,881</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">법인세비용차감전순손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">법인세비용(수익)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기순손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타포괄손익</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기총포괄손실</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주당순손실</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　기본주당순손실 (단위 : 원)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(148)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(148)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(188)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(188)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="214" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　희석주당순손실 (단위 : 원)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(148)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(148)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(188)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(188)</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF_S">
<TITLE ATOC="Y" ATOCID="77">4-3. 자본변동표</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="900" BORDER="0">

<COLGROUP>
<COL WIDTH="891"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">자본변동표</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기 2024.01.01 부터 2024.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기 1분기 2023.01.01 부터 2023.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="900" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="844" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="227" ROWSPAN="2">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="617" COLSPAN="5">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="113">
<P>자본금</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>주식발행초과금</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="113">
<P>기타자본항목</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="141">
<P>결손금</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="121">
<P>자본 합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2023.01.01 (기초자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,452,857,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,356,598,301</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">6,408,077,903</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(145,277,808,264)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">84,939,724,940</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기순손실</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,307,453,029)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타포괄손익</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식보상비용</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">271,133,035</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">271,133,035</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">전환우선주 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">61,728,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">503,842,604</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(729,601,847)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(164,031,243)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식매수선택권 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">11,000,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">304,972,087</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(242,265,247)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">73,706,840</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">종속기업에 대한 주식보상비용</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">17,027,942</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">17,027,942</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2023.03.31 (기말자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,525,585,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">215,165,412,992</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,724,371,786</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(148,585,261,293)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">81,830,108,485</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2024.01.01 (기초자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,685,074,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,162,881,700</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,348,788,048</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(157,195,232,251)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">72,001,511,497</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">당분기순손실</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,788,655,585)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기타포괄손익</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식보상비용</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">40,608,768</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">40,608,768</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">전환우선주 행사</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">주식매수선택권 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">30,000,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">258,664,594</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(137,344,594)</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">151,320,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">종속기업에 대한 주식보상비용</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">　</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="227" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">2024.03.31 (기말자본)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">9,715,074,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">214,421,546,294</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,252,052,222</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(159,983,887,836)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">69,404,784,680</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}CF_S">
<TITLE ATOC="Y" ATOCID="78">4-4. 현금흐름표</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="35" AUPDATECONT="N">
<P USERMARK="F-GL B">현금흐름표</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 11 기 1분기 2024.01.01 부터 2024.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">제 10 기 1분기 2023.01.01 부터 2023.03.31 까지</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(단위 : 원)</P>
</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="514" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="248">　</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 11 기 1분기</P>
</TH>

<TH VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 10 기 1분기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">영업활동으로 인한 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(1,304,368,972)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(1,210,025,868)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　영업으로부터 사용된 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(2,556,469,911)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(1,843,661,133)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　이자의 수취</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">1,563,733,838</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">826,085,576</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　이자의 지급</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(70,844,879)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(65,320,721)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　법인세 부담액</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(240,788,020)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(127,129,590)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">투자활동으로 인한 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">13,684,724,440</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(3,553,209,963)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　단기금융상품의 감소</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">37,999,868,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">35,965,241,327</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　단기금융상품의 증가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(23,499,868,000)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(37,999,868,000)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　단기대여금의 회수</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">10,000,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　유형자산의 취득</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(153,890,000)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(461,000,000)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　무형자산의 취득</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(344,822,990)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　장기대여금의 증가</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(661,385,560)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(754,782,300)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　보증금의 감소</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">　</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">32,022,000</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">재무활동으로 인한 현금흐름</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">144,711,588</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">69,027,129</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　주식매수선택권의 행사</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">151,320,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">73,706,840</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">　리스부채의 상환</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(6,608,412)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(4,679,711)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">현금및현금성자산의 증감</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">12,525,067,056</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(4,694,208,702)</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기초 현금및현금성자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">5,280,964,453</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">8,356,674,361</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">현금및현금성자산의 환율변동효과</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">(1,942,622)</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">41,974,927</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE VALIGN="MIDDLE" WIDTH="248" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">기말 현금및현금성자산</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">17,804,088,887</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="133" HEIGHT="34" AUPDATECONT="N">
<P USERMARK="F-GL11">3,704,440,586</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0" ATOCID="62">5. 재무제표 주석</TITLE>
<P></P>
<P USERMARK="F-16 0XFF0000 B">주석</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 11 기 1분기 2024년 1월 1일부터 2024년 3월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 10 기 1분기 2023년 1월 1일부터 2023년 3월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">주식회사 고바이오랩</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">1. 회사의 개요</SPAN>주식회사 고바이오랩(이하 '당사')은 2014년 8월에 설립되었고, 2020년 11월 18일 코스닥 시장에 상장하였습니다. 인체 마이크로바이옴과 임상 메타데이터 분석을 통한 면역, 대사, 뇌 질환의 신약 개발과 건강기능식품 개발을 주요 사업으로 영위하고 있습니다. 한편, 당사는 서울특별시 관악구 관악로 1 서울대학교 종합연구동에 본사를 두고 있습니다.당분기말 현재 주요 주주현황은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="726">

<COLGROUP>
<COL WIDTH="354"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ROWSPAN="2" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="363" HEIGHT="60">주 주 명</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="92" HEIGHT="30">보통주</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="93" HEIGHT="30">전환우선주</TH>
<TH VALIGN="MIDDLE" COLSPAN="2" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="178" HEIGHT="30">합계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="92" HEIGHT="30">주식수</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="93" HEIGHT="30">주식수</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="92" HEIGHT="30">주식수</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="86" HEIGHT="30">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="363" HEIGHT="30">고광표</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">5,062,237</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">5,062,237</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30">26.05%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="363" HEIGHT="30">특수관계자(*)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">761,702</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">761,702</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30">3.92%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="363" HEIGHT="30">(주)이마트</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">544,960</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">544,960</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30">2.80%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="363" HEIGHT="30">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">213,442</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">64,138</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">277,580</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30">1.43%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="363" HEIGHT="30">기타</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">12,349,867</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">433,802</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">12,783,669</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30">65.80%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="363" HEIGHT="30">합계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">18,932,208</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">497,940</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30">19,430,148</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="86" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 특수관계자는 등기임원을 포함합니다.</P>

<P>
<SPAN USERMARK=" B">2. 중요한 회계정책</SPAN>다음은 재무제표 작성에 적용된 중요한 회계정책입니다. 이러한 정책은 별도의 언급이 없다면, 표시된 회계기간에 계속적으로 적용됩니다.
</P>

<P>
<SPAN USERMARK=" B">2.1 재무제표 작성기준</SPAN>
</P>
<P USERMARK=" B"></P>

<P>회사의 재무제표는 기업회계기준서 제1027호 '별도재무제표'에 따른 별도재무제표입니다. 2024년 3월 31일로 종료하는 3개월 보고기간에 대한 분기재무제표는 기업회계기준서 제1034호 '중간재무보고'에 따라 작성되었습니다. 이 분기재무제표는 보고기간말인 2024년 3월 31일 현재 유효하거나 조기 도입한 한국채택국제회계기준에 따라 작성되었습니다.2024년 1월 1일부터 시행되는 회계기준이 있으나, 그 기준들은 회사의 분기재무제표에 중요한 영향을 미치지 않으며, 이를 제외하고는 중간재무제표의 작성에 적용된 유의적 회계정책은 2023년 12월 31일로 종료하는 회계연도에 대한 연차재무제표 작성시채택한 회계정책과 동일합니다.
<SPAN USERMARK=" B">2.2 회계정책</SPAN>분기재무제표의 작성에 적용된 유의적 회계정책과 계산방법은 아래 문단에서 설명하는 사항을 제외하고는 전기 재무제표 작성에 적용된 회계정책이나 계산방법과 동일합니다.
<SPAN USERMARK=" B">2.2.1 법인세비용</SPAN>중간기간의 법인세비용은 전체 회계연도에 대해서 예상되는 최선의 가중평균연간법인세율, 즉 추정평균연간유효법인세율을 중간기간의 세전이익에 적용하여 계산합니다.
</P>
<P USERMARK=" B">3. 중요한 판단과 추정불확실성의 주요원천</P>
<P>중간재무제표를 작성함에 있어, 경영진은 회계정책 적용과 자산ㆍ부채 및 수익ㆍ비용에 영향을 미치는 판단, 추정 및 가정을 해야 합니다. 실제 결과는 이러한 추정치와다를 수 있습니다.</P>
<P>중간재무제표 작성을 위해 당사의 회계정책의 적용과 추정 불확실성의 주요원천에 대해 경영진이 내린 중요한 판단은 2023년 12월 31일로 종료하는 회계연도에 대한 연차재무제표와 동일합니다.</P>
<P></P>

<P>
<SPAN USERMARK=" B">4. 공정가치</SPAN>
</P>
<P></P>
<P>(1) 금융상품 종류별 공정가치금융상품의 종류별 장부금액 및 공정가치는 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="783">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="245" VALIGN="MIDDLE" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH COLSPAN="2" WIDTH="274" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH COLSPAN="2" WIDTH="264" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">금융자산</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  현금및현금성자산</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,804,088,887</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,280,964,453</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  단기금융상품</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">39,012,896,095</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">53,512,896,095</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  매출채권</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,423,279</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">309,989,137</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  기타유동금융자산</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">492,407,447</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,543,434,658</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  기타비유동금융자산</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">660,579,639</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">656,427,570</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  유동파생상품자산</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">58,449,902,375</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,350,218,941</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">금융부채</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  기타유동금융부채</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,154,941,249</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,348,622,333</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  유동전환사채</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,988,178,444</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,633,328,862</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  유동파생상품부채</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  비유동파생상품부채</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,815,501,063</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,815,501,063</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,815,501,063</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,815,501,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  장기차입금</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,606,697,410</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,445,528,912</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 장부금액이 공정가치의 합리적인 근사치이므로 공정가치 공시에서 제외하였습니다.(*2) 리스부채는 기준서 제1107호에 따라 공정가치 공시에서 제외하였습니다.(2) 공정가치 서열체계</P>
<P>공정가치로 측정되는 금융상품은 공정가치 서열체계에 따라 구분되며 정의된 수준들은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="17"></COL>
<COL WIDTH="565"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="55" USERMARK="F-BT12">-</TD>
<TD WIDTH="574" HEIGHT="55" USERMARK="F-BT12">측정일에 동일한 자산이나 부채에 대해 접근할 수 있는 활성시장의 (조정하지 않은) 공시가격 (수준 1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="55" USERMARK="F-BT12">-</TD>
<TD WIDTH="574" HEIGHT="55" USERMARK="F-BT12">수준 1의 공시가격 외에 자산이나 부채에 대해 직접적으로나 간접적으로 관측할 수 있는 투입변수 (수준 2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="574" HEIGHT="31" USERMARK="F-BT12">자산이나 부채에 대한 관측할 수 없는 투입변수 (수준 3)</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>당분기말에 공정가치로 측정되는 금융상품의 공정가치 서열체계 구분은 다음과 같습니다(단위: 원).</P>
<P>① 당분기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="783">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 1</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 2</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 3</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="783" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="5">금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  유동파생상품자산</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="783" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="5">금융부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  유동파생상품부채</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,648,076,654</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,648,076,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  비유동파생상품부채</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,815,501,063</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,815,501,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">6,463,577,717</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">6,463,577,717</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="783">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 1</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 2</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 3</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="783" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="5">금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  유동파생상품자산</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="783" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="5">금융부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  유동파생상품부채</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,648,076,654</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,648,076,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  비유동파생상품부채</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,815,501,063</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,815,501,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">6,463,577,717</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">6,463,577,717</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 반복적인 공정가치 측정치의 서열체계 수준 간 이동</P>
<P>당사는 공정가치 서열체계의 수준 간 이동을 발생시킨 사건이나 상황의 변동이 일어난 날짜에 인식합니다.</P>
<P>각 공정가치 서열체계의 수준 간 이동 내역은 다음과 같습니다.① 반복적인 측정치의 수준 1과 수준 2간의 이동 내역당분기 중 수준 1과 수준 2간의 대체는 없습니다.</P>
<P></P>
<P>② 반복적인 측정치의 수준 3의 변동 내역(단위: 원)</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="835">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="181" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환</TH>
<TH WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손익</TH>
<TH WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
<TH WIDTH="130" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">유동파생상품자산</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">    -</TD>
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">46,507,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">유동파생상품부채</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,648,076,654</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,648,076,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">비유동파생상품부채</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,815,501,063</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,815,501,063</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">5. 현금및현금성자산 및 단기금융상품</SPAN>
</P>
<P>(1) 당분기말과 전기말 현재 현금및현금성자산의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="509">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="245" HEIGHT="30">보통예금</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">7,780,786</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">8,125,459</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="245" HEIGHT="30">정기예금 등</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">17,796,308,101</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">5,272,838,994</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="245" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">17,804,088,887</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">5,280,964,453</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기말과 전기말 현재 단기금융상품의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="509">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="245" HEIGHT="30">중금채</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">35,012,896,345</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">42,012,896,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="245" HEIGHT="30">정기예금</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">3,999,999,750</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">11,499,999,750</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="245" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">39,012,896,095</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">53,512,896,095</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">6. 매출채권</SPAN>
</P>
<P> </P>
<P>당분기말과 전기말 현재 매출채권의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="519" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="237"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="246" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>구분</P>
</TH>
<TH WIDTH="129" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기말</TH>

<TH WIDTH="144" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30">매출채권</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">433,423,279</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">309,989,137</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="246" HEIGHT="30">
<P>손실충당금 </P>
</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="246" VALIGN="BOTTOM" HEIGHT="30">
<P>매출채권(순액)</P>
</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">433,423,279</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">309,989,137</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>매출채권은 정상적인 영업 과정에서 판매된 재화나 용역에 대하여 고객이 지불해야 할 금액입니다. 일반적으로 30일 이내에 정산해야 하므로 모두 유동자산으로 분류됩니다. 최초 인식시점에 매출채권이 유의적인 금융요소를 포함하지 않는 경우에는 거래가격을 공정가치로 측정합니다. </P>

<P>
<SPAN USERMARK=" B">7. 기타금융자산</SPAN>당분기말과 전기말 현재 기타금융자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="519">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 구분</TH>
<TH WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">기타유동금융자산</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  미수금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">63,361,870</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">100,337,254</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  미수수익</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">428,295,577</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,442,347,404</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  기타보증금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">750,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">750,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">492,407,447</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,543,434,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">기타비유동금융자산</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  장기대여금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">24,950,265,412</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">24,364,394,511</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  대손충당금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(24,950,265,412)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(24,364,394,511)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  임차보증금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">600,000,000</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">600,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  현재가치할인차금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(1,966,307)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(4,795,157)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  기타보증금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">77,202,968</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">77,202,968</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">  현재가치할인차금</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(14,657,022)</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(15,980,241)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">660,579,639</TD>
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">656,427,570</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">8</SPAN>
<SPAN USERMARK=" B">. 기타자산</SPAN>당분기말과 전기말 현재 기타자산의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="525" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="244" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P> 구분</P>
</TH>
<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기말</TH>
<TH WIDTH="143" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="BOTTOM" HEIGHT="30">기타유동자산</TD>
<TD WIDTH="138" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="143" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="BOTTOM" HEIGHT="30">  부가세대급금</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">94,343,049</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">80,499,770</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="BOTTOM" HEIGHT="30">  선급금</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">151,320,000</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="BOTTOM" HEIGHT="30">  선급비용</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">277,525,450</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">190,306,522</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">523,188,499</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">270,806,292</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">9. 파생상품자산</SPAN>(1) 당분기말 현재 파생상품자산의 내역은 다음과 같습니다(단위: 원).
</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="521">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기말</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" VALIGN="MIDDLE" HEIGHT="30">유동파생상품자산(*)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,507,028</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당사가 보유한 전환우선주의 콜옵션, 전환사채의 콜옵션은 이항옵션모형에 따라 평가하였습니다.(2) 당분기와 전분기 중 파생상품의 변동내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="540">

<COLGROUP>
<COL WIDTH="207"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기초잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">965,588,606</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  증가</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  평가손익</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  전환</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(164,031,243)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기말잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,507,028</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">801,557,363</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">10. 종속기업투자</SPAN>
<SPAN>(1) 당분기말과 전기말 현재 종속기업투자의 내역은 다음과 같습니다(단위: 원).</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="914">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="245" VALIGN="MIDDLE" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재</TH>
<TH ROWSPAN="2" WIDTH="120" VALIGN="MIDDLE" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH COLSPAN="2" WIDTH="219" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH COLSPAN="2" WIDTH="242" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="104" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH WIDTH="115" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH WIDTH="129" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">호주</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">78,781</TD>
<TD WIDTH="104" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">100%</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">100%</TD>
<TD WIDTH="129" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30">주식회사 위바이옴</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">20,654,997,960</TD>
<TD WIDTH="104" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">51%</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">22,096,793,249</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">51%</TD>
<TD WIDTH="129" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">22,096,793,249</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="557" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">22,096,793,249</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">22,096,793,249</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 종속기업투자의 변동내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="536" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="169" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="168" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기초 장부금액</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">22,096,793,249</TD>
<TD WIDTH="168" ALIGN="RIGHT" HEIGHT="30">22,049,167,073</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  취득</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="168" ALIGN="RIGHT" HEIGHT="30">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  증감</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="168" ALIGN="RIGHT" HEIGHT="30">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  주식보상비용</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="168" ALIGN="RIGHT" HEIGHT="30">17,027,942</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기말 장부금액</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">22,096,793,249</TD>
<TD WIDTH="168" ALIGN="RIGHT" HEIGHT="30">22,066,195,015</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 당분기말과 전기말 현재 종속기업의 요약 재무현황은 다음과 같습니다(단위: 원).① 당분기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="997">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="156"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본</TH>
<TH WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1분기 매출</TH>
<TH WIDTH="135" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분기순이익(손실)</TH>
<TH WIDTH="165" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분기총포괄이익(손실)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,297,400,581</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,024,020,483</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,726,619,902)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(10,533,865)</TD>
<TD WIDTH="165" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,890,947</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">주식회사 위바이옴</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">48,935,457,350</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,653,822,710</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,281,634,640</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,849,972,084</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(256,906,688)</TD>
<TD WIDTH="165" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(256,906,688)</TD>
</TR>
</TBODY>
</TABLE>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="989">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="156"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="121" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본</TH>
<TH WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1분기 매출</TH>
<TH WIDTH="135" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분기순이익(손실)</TH>
<TH WIDTH="165" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분기총포괄이익(손실)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,235,254,705</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,008,765,554</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,773,510,849)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,620,203,430)</TD>
<TD WIDTH="165" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,811,176,554)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">주식회사 위바이옴</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">42,023,382,461</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,484,841,133</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,538,541,328</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,449,040,583</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">106,645,790</TD>
<TD WIDTH="165" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">106,645,790</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">11. 유형자산</SPAN>(1) 당분기말과 전기말 현재 유형자산의 내역은 다음과 같습니다(단위: 원).① 당분기말
</P>

<TABLE ACLASS="NORMAL" WIDTH="535" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득원가</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" USERMARK=" BC0XD7D7D7">상각누계액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" USERMARK=" BC0XD7D7D7">장부금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30">토지</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">4,414,625,766</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">4,414,625,766</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30">건물</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">4,619,850,039</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">(230,992,515)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">4,388,857,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30">구축물</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">1,132,813,054</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">(352,888,992)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">779,924,062</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30">비품</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">4,249,167,750</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">(1,795,304,388)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">2,453,863,362</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">14,461,180,246</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">(2,423,909,532)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">12,037,270,714</TD>
</TR>
</TBODY>
</TABLE>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="539">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">취득원가</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상각누계액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">장부금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="30">토지</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,414,625,766</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,414,625,766</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="30">건물</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,619,850,039</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(202,118,448)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,417,731,591</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="30">구축물</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,132,813,054</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(308,565,296)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">824,247,758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="30">비품</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,095,277,750</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,605,358,455)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,489,919,295</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,262,566,609</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,116,042,199)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,146,524,410</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 유형자산의 변동내역은 다음과 같습니다(단위: 원).① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="704">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 순장부금액</TH>
<TH WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비(*)</TH>
<TH WIDTH="151" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 순장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30">토지</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,414,625,766</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,414,625,766</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30">건물</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,417,731,591</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(28,874,067)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,388,857,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30">구축물</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">824,247,758</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(44,323,696)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">779,924,062</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="142" HEIGHT="30">비품</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,489,919,295</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">153,890,000</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(189,945,933)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,453,863,362</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,146,524,410</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">153,890,000</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(263,143,696)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,037,270,714</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 감가상각비는 포괄손익계산서상 판매비와관리비(경상연구개발비 포함)에 포함되어있습니다.② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="757">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="145"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="141" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 순장부금액</TH>
<TH WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비(*)</TH>
<TH WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 순장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">토지</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,414,625,766</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,414,625,766</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">건물</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,533,227,847</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(28,874,064)</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,504,353,783</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">구축물</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,001,542,443</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(44,323,672)</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">957,218,771</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">비품</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,705,157,003</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">461,000,000</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(178,817,420)</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,987,339,583</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,654,553,059</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">461,000,000</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(252,015,156)</TD>
<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">12,863,537,903</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 감가상각비는 포괄손익계산서상 판매비와관리비(경상연구개발비 포함)에 포함되어있습니다.(3) 유형자산 중 토지와 건물은 당사의 차입금과 관련하여 담보로 제공되어 있습니다(주석30 참조).</P>

<P>
<SPAN USERMARK=" B">12. 리스</SPAN>당사가 리스이용자인 경우의 리스에 대한 정보는 다음과 같습니다.(1) 재무상태표에 인식된 금액
</P>
<P>리스와 관련해서 재무상태표에 인식된 금액은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="644">

<COLGROUP>
<COL WIDTH="362"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="371" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="137" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기말</P>
</TH>

<TH WIDTH="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="644" HEIGHT="30">
<P>사용권자산(*)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="371" HEIGHT="30">
<P>  부동산</P>
</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,868,975</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,671,869</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="371" HEIGHT="30">
<P>  차량운반구</P>
</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">83,804,778</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">92,355,249</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="371" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P> 합계</P>
</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">85,673,753</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">97,027,118</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="644" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">리스부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" HEIGHT="30" VALIGN="MIDDLE">  유동</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">34,453,702</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">34,453,702</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="371" HEIGHT="30" VALIGN="MIDDLE">  비유동</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">44,080,947</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">50,689,359</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="371" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">78,534,649</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">85,143,061</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당분기 중 신규계약에 따른 사용권자산의 증가액(전분기: 32백만원)은 없으며, 변경에 따른 사용권자산의 감소액(전분기: 49백만원)도 없습니다.</P>
<P>(2) 포괄손익계산서에 인식된 금액</P>
<P>리스와 관련해서 포괄손익계산서에 인식된 금액은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="645">

<COLGROUP>
<COL WIDTH="360"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="369" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기</P>
</TH>

<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전분기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="369" HEIGHT="30">
<P>사용권자산의 감가상각비</P>
</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT"></TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="369" HEIGHT="30">
<P>  부동산</P>
</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,802,894</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,148,901</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="369" HEIGHT="30">
<P>  차량운반구</P>
</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,550,471</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,558,691</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="369" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,353,365</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,707,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="369" HEIGHT="30">
<P>리스부채에 대한 이자비용(금융원가에 포함)</P>
</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,619,234</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,444,010</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="369" HEIGHT="30">
<P>단기리스료(매출원가 및 관리비에 포함)</P>
</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,235,584</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,110,362</TD>
</TR>
</TBODY>
</TABLE>
<P>당분기 중 리스의 총 현금유출은 10백만원(전분기: 9백만원)입니다.</P>

<P>
<SPAN USERMARK=" B">13. 무형자산</SPAN>(1) 당분기말과 전기말 현재 무형자산의 내역은 다음과 같습니다(단위: 원).
</P>
<P>① 당분기말</P>

<TABLE BORDER="1" WIDTH="639" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>취득원가</P>
</TH>

<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>상각누계액</P>
</TH>

<TH WIDTH="159" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>장부금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">특허권</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">438,843,400</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(293,196,952)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">145,646,448</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">상표권</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600,000</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(599,000)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">소프트웨어</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">112,334,437</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(68,976,713)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,357,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">회원권</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">977,338,827</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(362,772,665)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">614,566,162</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="639">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득원가</P>
</TH>

<TH WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>상각누계액</P>
</TH>

<TH WIDTH="159" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>장부금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">특허권</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">438,843,400</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(281,411,233)</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">157,432,167</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">상표권</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">600,000</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(599,000)</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">소프트웨어</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,334,437</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(64,495,929)</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,838,508</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE">회원권</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">425,560,990</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">425,560,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>합계</P>
</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">977,338,827</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(346,506,162)</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">630,832,665</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당분기와 전분기 중 무형자산의 변동내역은 다음과 같습니다(단위: 원).</P>
<P>① 당분기</P>

<TABLE BORDER="1" WIDTH="812" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특허권</TH>
<TH WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상표권</TH>
<TH WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소프트웨어</TH>
<TH WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="139" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">기초</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,432,167</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,838,508</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">630,832,665</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">상각(*)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,785,719)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,480,784)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,266,503)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">145,646,448</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,357,724</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,560,990</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">614,566,162</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 감가상각비는 포괄손익계산서상 판매비와관리비에 포함되어있습니다.② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="812">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="139" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특허권</TH>
<TH WIDTH="139" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상표권</TH>
<TH WIDTH="139" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소프트웨어</TH>
<TH WIDTH="139" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="139" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">기초</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">204,793,052</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">66,827,184</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">271,621,236</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">취득</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">344,822,990</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">344,822,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">상각(*)</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(11,936,376)</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,858,919)</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(16,795,295)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">192,856,676</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,968,265</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">344,822,990</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">599,648,931</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 감가상각비는 포괄손익계산서상 판매비와관리비에 포함되어있습니다.(3) 당분기와 전분기 중 당사가 비용으로 인식한 경상연구개발비는 각각 1,439백만원 및 1,854만원입니다.</P>

<P>
<SPAN USERMARK=" B">14. 기타금융부채</SPAN>당분기말과 전기말 현재 기타금융부채의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="217"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="226" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="186" VALIGN="BOTTOM" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="186" VALIGN="BOTTOM" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" HEIGHT="30">기타유동금융부채</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" HEIGHT="30">  미지급금</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">494,754,016</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">519,445,734</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" HEIGHT="30">  미지급비용</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">660,187,233</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">829,176,599</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,154,941,249</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,348,622,333</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">15. 기타부채</SPAN>당분기말과 전기말 현재 기타부채의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P> 구분</P>
</TH>
<TH WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기말</TH>
<TH WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">기타유동부채</TD>
<TD WIDTH="199" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="199" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  예수금</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">78,638,460</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">107,261,150</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30">  계약부채</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,096,566,413</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,169,796,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,175,204,873</TD>
<TD WIDTH="199" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">2,277,058,045</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">16. 전환사채</SPAN>(1) 당분기말 현재 전환사채의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="933">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="274"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="245" VALIGN="MIDDLE" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="283" VALIGN="MIDDLE" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기일</TH>
<TH WIDTH="89" VALIGN="MIDDLE" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">표면이자율(%)</TH>
<TH WIDTH="109" VALIGN="MIDDLE" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="114" VALIGN="MIDDLE" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">제1회 무보증 사모 전환사채</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">뉴딜익스텐션신기술투자조합1호 스마트코리아 컴퍼니케이 언택트펀드 씨케이피-KIS2020 투자조합 메리츠에셋원신기술금융조합 제1호</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="99" ALIGN="CENTER">2026.11.19</TD>
<TD VALIGN="MIDDLE" WIDTH="89" HEIGHT="99" ALIGN="CENTER">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" HEIGHT="99" ALIGN="RIGHT">7,135,045,207</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="99" ALIGN="RIGHT">6,826,790,640</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">제2회 무보증 사모 전환사채</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ALIGN="CENTER">2026.12.30</TD>
<TD VALIGN="MIDDLE" WIDTH="89" HEIGHT="53" ALIGN="CENTER">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" HEIGHT="53" ALIGN="RIGHT">1,853,133,237</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53" ALIGN="RIGHT">1,806,538,222</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="710" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="109" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">8,988,178,444</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">8,633,328,862</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기말 현재 당사가 발행한 사모 전환사채의 주요내용은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="792">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="560"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="569" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제1회 무보증 사모 전환사채(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">발행일</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">2021.11.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">액면가액</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">11,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">발행가액</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">11,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">이자지급방법</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">상환방법</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">만기일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">조기상환청구권</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">발행일로부터 30개월이 되는 날 및 이후 매 3개월에 해당되는 날</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">매도청구권</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">발행일로부터 12개월이 되는 날부터 본 사채 발행일로부터 30개월이 되는 날까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">전환비율(%)</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">전환가격(*2)</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">17,675</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">전환에 따라 발행할 주식수(*2)</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">622,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">전환청구기간</TD>
<TD WIDTH="569" HEIGHT="30" VALIGN="MIDDLE">2022.11.19~2026.10.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="651" VALIGN="MIDDLE">전환가액 조정에 관한 사항(*1)</TD>

<TD WIDTH="569" HEIGHT="651">
<P>(1) 본 사채를 소유한 자가 전환청구권 행사를 하기 전에 발행회사가 시가를 하회하는 발행가액으로 유상증자, 무상증자, 주식배당 및 준비금의 자본전입 등을 함으로써 주식을 발행하거나 또는 시가를 하회하는 전환가격 또는 행사가격으로 전환사채 또는 신주인수권부사채를 발행하는 경우에는 아래와 같이 전환가격을 조정한다. </P>
<P>조정 후 전환가격 = 조정 전 전환가격 × [{기발행주식수+(신발행주식수×1주당 발행가격/시가)} / (기발행주식수+신발행주식수)]</P>
<P></P>
<P>(2) 합병, 자본의 감소, 주식분할 및 병합 등에 의하여 전환가격의 조정이 필요한 경우에는 당해 사유 발생 직전에 전환청구권이 행사되어 전액 주식으로 인수되었더라면 본 사채의 사채권자가 가질 수 있었던 동일한 효과가 날 수 있도록 조정한다. </P>
<P>(3) 감자 및 주식 병합 등 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합 등으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가격을 조정한다. </P>
<P>(4) 위 (1)호 내지 (3)호과는 별도로 2021년 11월 19일 및 이후 매 3개월이 되는 날을 전환가격 조정일로 하고, 각 전환가격 조정일 전일을 기산일로 하여 그 기산일로부터 소급한 1개월 가중산술평균주가, 1주일 가중산술평균주가 및 기산일 가중산술평균주가를 산술평균한 가액과 기산일 가중산술평균주가 중 높은 가격이 해당 조정일 직전일 현재의 전환가격보다 낮은 경우 동 낮은 가격을 새로운 전환가격으로 한다. 단, 전환가격의 최저 조정한도는 최초 전환가액의 100분의 70에 해당하는 가액으로 한다.</P>
<P>(5) 위 (1)호 내지 (4)호에 의하여 조정된 전환가격이 주식의 액면가 이하일 경우에는 액면가를 전환가격으로 하며, 각 전환사채에 부여된 전환청구권의 행사로 인하여 발행할 주식의 발행가액의 합계액은 각 전환사채의 발행가액을 초과할 수 없다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 행사가격 인하조건이 내재된 제1회 사모전환사채의 전환권에 대해서 금융감독원의 질의회신(회제이-00094)에 따라 발행시점에 자본으로 분류하고, 최초 인식시점이후의 공정가액변동은 회계처리 하지 아니하였습니다. 만일 동 질의회신의 내용에 대하여 한국채택국제회계기준 유권해석이 변경될 경우 전환사채와 관련된 회계처리가 변경될 수 있습니다.(*2) 전환가격은 최초 발행 이후 2회에 걸쳐 조정되었습니다. 보고기간 후 제1회 무보증 사모 전환사채 액면가액 전액 상환청구 되었습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="794">

<COLGROUP>
<COL WIDTH="211"></COL>
<COL WIDTH="565"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="574" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제2회 무보증 사모 전환사채(*1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">발행일</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">2021.12.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">액면가액</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">2,350,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">발행가액</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">2,350,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">이자지급방법</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">상환방법</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">만기일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">조기상환청구권</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">본 사채의 발행일로부터 30개월이 되는 날 및 이후 매 3개월에 해당되는 날</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">매도청구권</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">발행일로부터 12개월이 되는 날로부터 본 사채 발행일로부터 30개월이 되는 날까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">전환비율(%)</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">전환가격(*2)</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">17,675</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">전환에 따라 발행할 주식수(*2)</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">132,956</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30" VALIGN="MIDDLE">전환청구기간</TD>
<TD WIDTH="574" HEIGHT="30" VALIGN="MIDDLE">2022.12.30~2026.11.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="720" VALIGN="MIDDLE">전환가액 조정에 관한 사항(*1)</TD>

<TD WIDTH="574" HEIGHT="720">
<P>(1) 본 사채를 소유한 자가 전환청구권 행사를 하기 전에 발행회사가 시가를 하회하는 발행가액으로 유상증자, 무상증자, 주식배당 및 준비금의 자본전입 등을 함으로써 주식을 발행하거나 또는 시가를 하회하는 전환가격 또는 행사가격으로 전환사채 또는 신주인수권부사채를 발행하는 경우에는 아래와 같이 전환가격을 조정한다. </P>
<P> </P>
<P>조정 후 전환가격 = 조정 전 전환가격 × [{기발행주식수+(신발행주식수×1주당 발행가격/시가)} / (기발행주식수+신발행주식수)]</P>
<P> </P>
<P>(2) 합병, 자본의 감소, 주식분할 및 병합 등에 의하여 전환가격의 조정이 필요한 경우에는 당해 사유 발생 직전에 전환청구권이 행사되어 전액 주식으로 전환되었더라면 본 사채의 사채권자가 가질 수 있었던 것과 동일한 효과가 날 수 있도록 조정한다. </P>
<P>(3) 감자 및 주식 병합 등 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합 등으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가격을 조정한다. </P>
<P>(4) 위 (1)호 내지 (3)호와는 별도로 2021년 12월 30일 및 이후 매 3개월이 되는 날을 전환가격 조정일로 하고, 각 전환가격 조정일 전일을 기산일로 하여 그 기산일로부터 소급한 1개월 가중산술평균주가, 1주일 가중산술평균주가 및 기산일 가중산술평균주가를 산술평균한 가액과 기산일 가중산술평균주가 중 높은 가격(이하 본 호 및 (5)호에서 “시가산정액”)이 해당 조정일 직전일 현재의 전환가격보다 낮은 경우 시가산정액을 새로운 전환가격으로 한다. 단, 전환가격의 최저 조정한도는 최초 전환가액의 100분의 70에 해당하는 가액으로 한다.</P>
<P>(5) 위 (4)호에 따라 전환가격을 하향조정한 이후에 위 (4)호에 따라 산정한 시가산정액이 해당 조정일 직전일 현재의 전환가격보다 높게 되는 경우 시가산정액을 새로운 전환가격으로 한다. 단, 전환가격의 최고 조정한도는 최초 전환가액으로 한다.</P>
<P>(6) 위 (1)호 내지 (4)호에 의하여 조정된 전환가격이 주식의 액면가 이하일 경우에는 액면가를 전환가격으로 하며, 각 전환사채에 부여된 전환청구권의 행사로 인하여 발행할 주식의 발행가액의 합계액은 각 전환사채의 발행가액을 초과할 수 없다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 제2회 사모전환사채의 전환권은 상향리픽싱 조항으로 인해 부채로 분류됐습니다.(*2) 전환가격은 최초 발행 이후 2회에 걸쳐 조정되었습니다. </P>

<P>
<SPAN USERMARK=" B">17. 파생상품부채</SPAN>(1) 당분기말과 전기말 현재 파생상품의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="223"></COL>
<COL WIDTH="222"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="232" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="231" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" COLSPAN="3">유동파생상품부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">  전환사채</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,648,076,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" COLSPAN="3">비유동파생상품부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30">  주주간약정</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,815,501,063</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,815,501,063</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당사는 파생상품부채의 공정가치 변동에 대해 포괄손익계산서상 '금융수익 및 금융비용'으로 표시하고 있습니다.</P>
<P>(2) 당분기와 전분기 중 파생상품의 변동내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="540">

<COLGROUP>
<COL WIDTH="207"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="162" HEIGHT="30" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기초잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,463,577,717</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,220,906,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  증감</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  평가손익</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">  기타</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">기말잔액</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,463,577,717</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,220,906,310</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">18. 차입금</SPAN>(1) 당분기말 및 전기말 현재 당사의 차입금의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="896">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="248" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">차입처</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">내역</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">차입일</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">만기일</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">이자율(%)</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당분기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시설자금대출</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.25</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2029.12.15</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4.84</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">산업은행</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시설자금대출</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.24</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2025.01.24</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4.18</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>(*) 상기 차입금과 관련하여 당사의 유형자산 중 토지와 건물을 담보로 제공하고 있습니다(주석30 참조).
<SPAN USERMARK=" B">19. 법인세비용</SPAN>당사는 법인세비용을 전체 회계연도에 대해서 예상되는 최선의 가중평균 연간법인세율의 추정에 기초하여 인식하고 있으며, 당분기와 전분기 중 법인세비용차감전순손실이 발생하여 인식한 법인세비용은 없습니다.
</P>

<P>
<SPAN USERMARK=" B">20. 자본금과 주식발행초과금</SPAN>(1) 당분기말과 전기말 현재 자본금 및 주식발행초과금의 내역은 다음과 같습니다(단위: 원). 
</P>

<TABLE BORDER="1" WIDTH="797" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="154"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="145" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">구   분</TH>
<TH WIDTH="326" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">당분기말</TH>
<TH WIDTH="326" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="163" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">보통주</TH>
<TH WIDTH="163" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">우선주</TH>
<TH WIDTH="163" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">보통주</TH>
<TH WIDTH="163" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">수권주식수</TD>
<TD WIDTH="326" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">50,000,000주</TD>
<TD WIDTH="326" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">50,000,000주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">주당 액면금액</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">발행주식수</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,932,208주</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,940주</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,872,208주</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,940주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">자본금</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,466,104,000</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">248,970,000</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,436,104,000</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">248,970,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">주식발행초과금</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">203,893,635,218</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,527,911,076</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">203,634,970,624</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,527,911,076</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당분기와 전분기 중 자본금과 주식발행초과금의 변동 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="633" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" VALIGN="MIDDLE" HEIGHT="60" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구분</TH>
<TH WIDTH="228" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7" COLSPAN="2" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수(주)</TH>
<TH WIDTH="118" VALIGN="MIDDLE" HEIGHT="60" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">자본금</TH>
<TH WIDTH="134" VALIGN="MIDDLE" HEIGHT="60" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">주식발행초과금</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주</TH>
<TH WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">전기초</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,443,645</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,462,069</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,452,857,000</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">214,356,598,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">  주식선택권 행사</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,000</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                  -</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,000,000</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">308,821,747</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">  전환우선주의 행사</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">413,107</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(289,651)</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">61,728,000</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">499,992,944</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">전분기말</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,878,752</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,172,418</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,525,585,000</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">215,165,412,992</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">당기초</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,872,208 </TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,940</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,685,074,000</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">214,162,881,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">  주식선택권 행사</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,000</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                  -</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">30,000,000</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">258,664,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">당분기말</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,932,208</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,940</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,715,074,000</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">214,421,546,294</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 전환우선주당사가 발행한 전환우선주의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="815">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="579"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">구분</TD>
<TD WIDTH="588" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">발행가액(원)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">33,449,803,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="53">전환조건(*2)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="53">- 전환가격 : 발행가와 동일- 전환비율 : 1 대 1.4262295082</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환청구기간</TD>
<TD WIDTH="588" HEIGHT="30">2022년 11월 19일 ~ 2026년 11월 18일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환으로 발행할 주식의 종류</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">기명식 보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">전환으로 발행할 주식수(*2)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30"> 618,695</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">의결권에 관한 사항</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">우선주 1주당 1의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" VALIGN="MIDDLE" HEIGHT="30">이익배당에 관한 사항</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="30">누적적(액면가 기준 1%), 참가적 우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="99" VALIGN="MIDDLE">기타 약정사항(주주간 약정 및 재무약정 사항 등)</TD>
<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="99">본 주식의 발행일로부터 12개월이 되는 날로부터 본 주식 발행일로부터 30개월이 되는날까지 매 영업일에 본 주식 보유자에게 보유하고 있는 본 주식의 일부를 매수인에게 매도하여 줄 것을 청구할 수 있으며, 본 주식 보유자는 이 청구에 따라 보유하고 있는 본 주식을 매수인에게 매도하여야 한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="973" VALIGN="MIDDLE">전환조건의 조정(*1)</TD>

<TD WIDTH="588" VALIGN="MIDDLE" HEIGHT="973">
<P>가. 인수회사의 본 주식의 1주당 취득가격은 제1조의 납입총액을 본 주식 총수로 나눈 가액으로 한다.</P>
<P>나. 발행회사가 당시 전환가액을 하회하는 가격으로 발행가격 등을 정하여 신주, 상환우선주, 전환우선주, 상환전환우선주, 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우 본 주식의 전환조건 및 1주당 전환되는 보통주식의 수를 정하는 전환비율을 다음과 같이 조정한다.</P>
<P> </P>
<P>조정 후 전환가액 = [(조정 전 전환가액 × 기발행주식수)+(신발행주식수 × 1주당 발행가액)] / (기발행주식수+신발행주식수)</P>
<P> </P>
<P>조정후 전환비율= 본 주식 1주당 취득가액/ 조정 후 전환가액</P>
<P> </P>
<P>다. 발행회사가 시가를 하회하는 발행가액으로 신주, 상환우선주, 전환우선주, 상환전환우선주, 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우에는 다음과 같이 전환가격을 조정한다.</P>
<P></P>
<P>조정 후 전환가액 = 조정 전 전환가액 × {[기발행주식수+(신주발행주식수 × 1주당발행가액/시가)]/(기발행주식수+신발행주식수)}</P>
<P> </P>
<P>조정후 전환비율= 본 주식 1주당 취득가액/ 조정 후 전환가액</P>
<P> </P>
<P>라. 발행회사의 주식을 분할 또는 합병하는 경우 전환조건은 그 분할 및 병합의 비율에 따라 조정된다.</P>
<P> </P>
<P>마. 발행회사의 분할 또는 합병 등이 이루어지는 경우 그 사유가 발생하기 전에 본 주식이 보통주로 전환되었다면 받을 수 있었던 대가가 우선주로서 받을 수 있는 대가보다 큰 경우에는 보통주로 전환되었다면 받을 수 있었던 대가가 보장되도록 본 주식의 전환조건이 조정된다.</P>
<P> </P>
<P>바. 감자 및 주식 병합 등 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가액을 조정한다.</P>
<P> </P>
<P>사. 위의 전환조건 조정과는 별도로 2021년 11월 19일 이후 매 3개월마다 전환가액을 조정하며, 각 조정일의 전일을 기준일로 산정한 보통주의 산술평균가액{(1개월 거래량가중평균주가 + 1주일 거래량 가중평균주가 + 최근일 종가)/3}과 최근일 종가 중 높은 가격으로 조정하되, 조정후 전환가격이 조정전 전환가격보다 높은 경우에는 그 중 낮은 금액으로 전환가격을 조정함. 단, 최초 전환가액(조정일 전에 전환가액을 이미 조정한 경우에는 이를 감안하여 산정한 가액)의 100분의 70에 해당하는 가액 미만으로 조정되지 아니한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 행사가격 인하조건이 내재된 제2회 전환우선주에 대해서 금융감독원의 질의회신(회제이-00094)에 따라 발행시점에 자본으로 분류하였습니다.(*2) 전환가격은 최초 발행 이후 3회에 걸쳐 조정되었습니다.보고기간 후 전환우선주 28,965주가 보통주로 전환청구 되었습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="815">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="579"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="227" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">구분</TD>
<TD WIDTH="588" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">제3회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">발행가액(원)</TD>
<TD WIDTH="588" HEIGHT="30" VALIGN="MIDDLE">4,649,997,750</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="53" VALIGN="MIDDLE">전환조건(*2)</TD>
<TD WIDTH="588" HEIGHT="53" VALIGN="MIDDLE">- 전환가격 : 발행가와 동일- 전환비율 : 1 대 1.4262295082</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">전환청구기간</TD>
<TD WIDTH="588" HEIGHT="30">2022년 12월 30일 ~ 2026년 12월 29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">전환으로 발행할 주식의 종류</TD>
<TD WIDTH="588" HEIGHT="30" VALIGN="MIDDLE">기명식 보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">전환으로 발행할 주식수(*2)</TD>
<TD WIDTH="588" HEIGHT="30" VALIGN="MIDDLE">91,475</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">의결권에 관한 사항</TD>
<TD WIDTH="588" HEIGHT="30" VALIGN="MIDDLE">우선주 1주당 1의결권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">이익배당에 관한 사항</TD>
<TD WIDTH="588" HEIGHT="30" VALIGN="MIDDLE">누적적(액면가 기준 1%), 참가적 우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="99" VALIGN="MIDDLE">기타 약정사항(주주간 약정 및 재무약정 사항 등)</TD>
<TD WIDTH="588" HEIGHT="99" VALIGN="MIDDLE">본 주식의 발행일로부터 12개월이 되는 날로부터 본 주식 발행일로부터 30개월이 되는날까지 매 영업일에 본 주식 보유자에게 보유하고 있는 본 주식의 일부를 매수인에게 매도하여 줄 것을 청구할 수 있으며, 본 주식 보유자는 이 청구에 따라 보유하고 있는 본 주식을 매수인에게 매도하여야 한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="927" VALIGN="MIDDLE">전환조건의 조정(*1)</TD>

<TD WIDTH="588" HEIGHT="927" VALIGN="MIDDLE">
<P>가. 인수회사의 본 주식의 최초 전환가액은 납입총액을 본 주식 총수로 나눈 가액으로 한다. </P>
<P> </P>
<P>나. 발행회사가 당시 전환가액을 하회하는 가격으로 발행가격 등을 정하여 신주(상환우선주, 전환우선주, 상환전환우선주 포함), 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우 본 주식의 전환가액 및 1주당 전환되는 보통주식의 수를 정하는 전환비율을 다음과 같이 조정한다.</P>
<P> </P>
<P>조정 후 전환가액 = [(조정 전 전환가액 × 기발행주식수)+(신발행주식수 × 1주당 발행가액)] / (기발행주식수+신발행주식수) </P>
<P> </P>
<P>조정후 전환비율= 최초 전환가액/ 조정 후 전환가액</P>
<P> </P>
<P>다. 발행회사가 시가를 하회하는 발행가액으로 신주(상환우선주, 전환우선주, 상환전환우선주 포함), 전환사채 또는 신주인수권부사채 등 지분증권 또는 주식관련사채를 발행하는 경우에는 다음과 같이 전환가격 및 전환비율을 조정한다. </P>
<P> </P>
<P>조정 후 전환가액 = 조정 전 전환가액 × {[기발행주식수+(신주발행주식수 × 1주당발행가액/시가)]/(기발행주식수+신발행주식수)}</P>
<P> </P>
<P>조정후 전환비율= 최초 전환가액/ 조정 후 전환가액</P>
<P> </P>
<P>라. 발행회사의 주식을 분할 또는 합병하는 경우 전환조건은 그 분할 및 병합의 비율에 따라 조정된다.</P>
<P> </P>
<P>마. 발행회사의 분할 또는 합병 등이 이루어지는 경우 그 사유가 발생하기 전에 본 주식이 보통주로 전환되었다면 받을 수 있었던 대가가 우선주로서 받을 수 있는 대가보다 큰 경우에는 보통주로 전환되었다면 받을 수 있었던 대가가 보장되도록 본 주식의 전환조건이 조정된다.</P>
<P> </P>
<P>바. 보통주식에 한하여 이루어지는 감자 및 주식 병합 등 본 주식의 주식가치 상승사유가 발생하는 경우 감자 및 주식 병합으로 인한 조정비율만큼 상향하여 반영하는 조건으로 전환가액을 조정한다.</P>
<P> </P>
<P>사. 위의 전환조건 조정과는 별도로 2021년 12월 30일 이후 매 3개월마다 전환가액을 조정하며, 각 조정일의 전일을 기준일로 산정한 보통주의 산술평균가액{(1개월 거래량가중평균주가 + 1주일 거래량 가중평균주가 + 최근일 종가)/3}과 최근일 종가 중 높은 가격으로 조정하되, 조정후 전환가격이 조정전 전환가격보다 높은 경우에는 조정하지 아니함(단, 최초 전환가액(조정일 전에 전환가액을 이미 조정한 경우에는 이를 감안하여 산정한 가액)의 100분의 70에 해당하는 가액 미만으로 조정되지 아니한다). </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 행사가격 인하조건이 내재된 제3회 전환우선주에 대해서 금융감독원의 질의회신(회제이-00094)에 따라 발행시점에 자본으로 분류하였습니다.(*2) 전환가격은 최초 발행 이후 2회에 걸쳐 조정되었습니다.</P>

<P>
<SPAN USERMARK=" B">21. 주식기준보상</SPAN>(1) 당사는 임직원 등에게 주식결제형 주식선택권을 부여하였으며, 그 주요 내용은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1023">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="171"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="171" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차 부여분</TH>
<TH WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">4차 부여분</TH>
<TH WIDTH="171" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5차 부여분</TH>
<TH WIDTH="170" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6차 부여분</TH>
<TH WIDTH="180" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">7차 부여분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여일</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.04.02</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.07.01</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.08.29</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.06.13</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.04.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여수량(주)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">564,065</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">270,034</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,004</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">222,000</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사가격(원)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,522</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,553</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,553</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,119</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,196</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53" VALIGN="MIDDLE">행사가능기간</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2021.04.01~2026.03.31</TD>
<TD WIDTH="173" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.06.30~2027.06.29</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.08.28~2027.08.27</TD>
<TD WIDTH="170" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2023.06.12~2028.06.11</TD>
<TD WIDTH="180" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2023.10.20~2028.10.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="76">가득조건</TD>
<TD WIDTH="171" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년, IPO조건</TD>
<TD WIDTH="173" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년 , 부여 즉시 가득</TD>
<TD WIDTH="171" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년, 부여 즉시 가득</TD>
<TD WIDTH="170" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 3년, 부여 즉시 가득</TD>
<TD WIDTH="180" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 2년6개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여방법</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사한 주식수(주)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">471,026</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">201,026</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,004</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31,500</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">소멸된 주식수(주)(*1)</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">48,000</TD>
<TD WIDTH="173" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">60,007</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="170" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">24,000</TD>
<TD WIDTH="180" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">14,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">변경된 주식수(주)(*2)</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="173" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="171" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="170" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="180" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,635</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미행사 주식수(주)</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,039</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,001</TD>
<TD WIDTH="171" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="170" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">166,500</TD>
<TD WIDTH="180" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">48,635</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="854">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="166"></COL>
<COL WIDTH="167"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="176" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">8차 부여분</TH>
<TH WIDTH="169" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10-1차 부여분</TH>
<TH WIDTH="175" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10-2차 부여분</TH>
<TH WIDTH="176" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">11-1차 부여분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">부여일</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2021.07.21</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.05.18</TD>
<TD WIDTH="175" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.05.18</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.08.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여수량(주)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">110,000</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,000</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,000</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사가격(원)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31,516</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,600</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,600</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="99" VALIGN="MIDDLE">행사가능기간</TD>
<TD WIDTH="176" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2024.01.21~2029.01.20</TD>
<TD WIDTH="169" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2024.05.18~2029.05.17</TD>
<TD WIDTH="175" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2025.05.18~2030.05.17</TD>
<TD WIDTH="176" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2024.08.31~2029.08.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="122">가득조건</TD>
<TD WIDTH="176" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건: 부여일로부터 2년6개월</TD>
<TD WIDTH="169" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건:  부여일로부터 2년</TD>
<TD WIDTH="175" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건:  부여일로부터 3년</TD>
<TD WIDTH="176" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">용역제공조건:  부여일로부터 2년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="53">부여방법</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="175" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
<TD WIDTH="176" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">신주발행교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사한 주식수(주)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">소멸된 주식수(주)(*1)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,000</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,000</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,000</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">변경된 주식수(주)(*2)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,049</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미행사 주식수(주)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">56,049</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="859">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="158" HEIGHT="30">구분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="169" HEIGHT="30">11-2차 부여분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="174" HEIGHT="30">12-1차 부여분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="185" HEIGHT="30">12-2차 부여분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="173" HEIGHT="30">12-3차 부여분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">2022.08.31</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">2023.05.16</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">2023.05.16</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">2023.05.16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여수량(주)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">30,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">56,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사가격(원)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">14,100</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">15,040</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">15,040</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">15,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="53">행사가능기간</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="53">2025.08.31~2030.08.30</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="53">2025.05.16~2030.05.15</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="53">2026.05.16~2031.05.15</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="53">2027.05.16~2032.05.15</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="76">가득조건</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="76">용역제공조건:  부여일로부터 3년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="76">용역제공조건:  부여일로부터 2년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="76">용역제공조건:  부여일로부터 3년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="76">용역제공조건:  부여일로부터 4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">부여방법</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">신주발행교부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">신주발행교부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">신주발행교부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">신주발행교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">행사한 주식수(주)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">소멸된 주식수(주)(*1)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">변경된 주식수(주)(*2)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미행사 주식수(주)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30">30,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="174" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="185" HEIGHT="30">42,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30">56,000</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 직원의 퇴사 등으로 인하여 부여되었던 주식선택권이 소멸되었습니다.(*2) 행사조건 변경 주식수입니다.</P>
<P>(2) 주식선택권의 수량과 가중평균행사가격의 변동은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="619" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="119" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" VALIGN="MIDDLE">
<P>구 분</P>
</TH>

<TH COLSPAN="2" WIDTH="250" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>주식매수선택권 수량(단위: 주)</P>
</TH>

<TH COLSPAN="2" WIDTH="250" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>가중평균행사가격(단위: 원)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="125" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>당분기</P>
</TH>

<TH WIDTH="125" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>전분기</P>
</TH>

<TH WIDTH="125" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>당분기</P>
</TH>

<TH WIDTH="125" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>전분기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30">
<P>기초</P>
</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">609,224</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">614,040</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,975</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,814</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">행사</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(60,000)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,000)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,522</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,553)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30">
<P>소멸</P>
</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(18,000)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(16,600)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="119" HEIGHT="30">
<P>기말</P>
</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">531,224</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">592,040</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,463</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,814</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>보고기간말 현재 유효한 주식선택권의 가중평균잔여만기는 2.37년입니다.</P>
<P>(3) 전기중 부여된 주식선택권의 보상원가를 이항모형을 이용한 공정가치접근법을 적용하여 산정했으며, 보상원가를 산정하기 위한 제반 가정 및 변수는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="557" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" WIDTH="171" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12-1차(*1)</TH>
<TH VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12-2차(*1)</TH>
<TH VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12-3차(*1)</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">부여일 공정가치(원)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3,248</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">4,336</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">5,178</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">부여일의 주가(원)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">11,770</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">11,770</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">11,770</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">주가변동성</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">60.60%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">60.60%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">60.60%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">배당수익률</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">0.00%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">0.00%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">기대만기(년)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">2.0</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3.0</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">4.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30">무위험수익률</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3.37%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">3.28%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">3.28%</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 주가변동성은 부여일 기준 자사 개별종목의 과거 180일 변동성을 반영하였습니다.(4) 당분기와 전분기 중 비용으로 인식한 주식기준보상비용은 각각 41백만원과 271백만원이며, 전액 주식결제형 주식기준보상과 관련된 비용입니다. </P>

<P>
<SPAN USERMARK=" B">22. 고객과의 계약에서 생기는 수익 및 관련 계약자산과 계약부채</SPAN>
</P>
<P></P>
<P>(1) 고객과의 계약에서 생기는 수익① 당분기와 전분기 중 당사는 수익과 관련해 포괄손익계산서에 다음 금액을 인식하였습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="534" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="230"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="239" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>
<TH WIDTH="148" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기</TH>
<TH WIDTH="147" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="239" HEIGHT="30">
<P>고객과의 계약에서 생기는 수익</P>
</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">467,251,645</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">427,102,165</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>
<P>② 고객과의 계약에서 생기는 수익의 구분</P>
<P>당사는 다음의 주요부문에서 재화나 용역을 기간에 걸쳐 이전하거나 한 시점에 이전함으로써 수익을 창출합니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="531">

<COLGROUP>
<COL WIDTH="225"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="234" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="148" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">기술이전</TD>
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">467,251,645</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">427,102,165</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">467,251,645</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">427,102,165</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">지리적 시장</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">  국내</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">460,087,477</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">269,797,633</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">  해외</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,164,168</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">157,304,532</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">467,251,645</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">427,102,165</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">수익인식 시점</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">  한 시점에 인식</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">394,021,163</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">171,877,536</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">  기간에 걸쳐 인식</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,230,482</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">255,224,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">467,251,645</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">427,102,165</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">(2) 고객과의 계약과 관련된 자산과 부채  당분기말과 전기말 현재 당사가 인식하고 있는 계약자산 및 계약부채는 다음과 같습니다(단위: 원).</SPAN>
</P>

<TABLE BORDER="1" WIDTH="504" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="226"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="235" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당분기말</P>
</TH>

<TH WIDTH="134" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30">계약부채 - 기술이전계약</TD>
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,096,566,413</TD>
<TD WIDTH="134" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,169,796,895</TD>
</TR>
</TBODY>
</TABLE>
<P>당사는 기업회계기준서 제1115호에 따라 기업이 고객에게서 이미 받은 대가(또는 지급기일이 된 대가)에 상응하여 고객에게 재화나 용역을 이전하여야 하는 기업의 의무에 해당하는 금액을 계약부채로 계상하였습니다.(3) 당분기 중 원가기준 투입법을 적용하여 진행기준수익을 인식한 계약으로서 계약금액이 전기 매출액의 5% 이상인 주요 계약의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="754">

<COLGROUP>
<COL WIDTH="260"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="269" HEIGHT="60" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">
<P>구분</P>
</TH>
<TH WIDTH="132" HEIGHT="60" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">계약일</TH>
<TH WIDTH="131" HEIGHT="60" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">계약기한</TH>
<TH WIDTH="222" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">진행률</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제 1</TH>
<TH WIDTH="111" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제 2</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" HEIGHT="30">LICENSE AGREEMENT(SPH SINE)(*1)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2021-10-28</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">상업화 후 20년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4.43%</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">80.06%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="269" HEIGHT="30">주식회사 셀트리온(*2)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2022-03-23</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2년(*3)</TD>
<TD WIDTH="222" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM" COLSPAN="2">　42.95%</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 계약기간 동안 계약지역 내 건선 등의 계약적응증 개발 및 상업화에 필요한 지적재산권에 대한 독점적 라이선스 및 업데이트된 지적재산권의 지속적 제공의무가 포함되어 있습니다. 계약금액은 과제 1에 대한 대가와 과제 2에 대한 대가로 구분됩니다. 당사는 기업회계기준서 제1115호에 따라 계약금액을 각 수행의무의 개별 판매가격으로 배분하였으며, 각 수행의무 별 진행률을 측정하였습니다(주석30 참조).(*2) 회사는 2022년 3월 23일에 주식회사 셀트리온과 마이크로바이옴 신약 후보물질 발굴을 위한 공동연구계약을 체결하였습니다(주석31 참조).(*3) 상기 계약기간은 공동연구기간이며 그 진행 현황에 따라 변동가능합니다.</P>

<P>
<SPAN USERMARK=" B">23. 판매비와 관리비</SPAN>당분기와 전분기 중 판매비와 관리비의 내역은 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="216"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="225" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="198" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="198" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">급여</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">261,337,669</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">237,320,453</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">68,060,864</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,736,630</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">복리후생비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,992,000</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,161,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">여비교통비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,230,667</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">58,898,229</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">세금과공과</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,039,000</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,560,610</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">감가상각비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,250,473</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,556,938</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,266,503</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,795,295</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">사용권자산상각비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,353,365</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,707,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">임차료</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">312,820</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">298,020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">보험료</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,120,400</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,696,045</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">차량유지비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,891,132</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,710,960</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,438,851,307</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,853,859,958</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">소모품비</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,398,529</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,293,796</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">지급수수료</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">287,369,461</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">305,558,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">57,219,665</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">146,933,943</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">기타</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,140,935</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">72,244,288</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,320,834,790</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,805,332,532</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">24. 비용의 성격별 분류</SPAN>당분기와 전분기 중 비용의 성격별 분류는 다음과 같습니다(단위: 원).
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="263"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="272" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>
<TH WIDTH="173" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="173" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="BOTTOM">연구관련 재료비 및 소모품비</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">118,532,907</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">133,416,366</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="BOTTOM">종업원 급여</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,215,311,765</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,098,767,101</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="BOTTOM">주식보상비용</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">40,608,768</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">271,133,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="BOTTOM">용역비</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,091,670</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">137,065,430</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="BOTTOM">감가상각비 및 무형자산상각비</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">290,763,564</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">280,518,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="BOTTOM">지급수수료</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">287,369,461</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">305,558,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" VALIGN="BOTTOM">기타 비용</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">740,958,368</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">782,444,566</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="272" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출원가 및 판매비와 관리비 합계</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,722,636,503</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,008,903,276</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">25. 기타수익과 기타비용</SPAN>
</P>
<P>(1) 당분기와 전분기 중 기타수익의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="617" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="283"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="161"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="292" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="155" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="170" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="31">고용지원금</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">1,855,000</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">17,650,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="31">외환차익</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">2,580,624</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">20,155,501</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="31">외화환산이익</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">418,455,188</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="31">리스자산변경이익</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">1,708,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="31">잡이익</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">192,342</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">2,715,817</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="34" ALIGN="CENTER">합계</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="34">4,627,966</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="34">460,684,903</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 기타비용의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="590" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="257"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="266" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">기타의대손상각비</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">585,870,901</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,444,773,555</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">외환차손</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,382,109</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,260,771</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">외화환산손실</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">77,574,275</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30">잡손실</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,100</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,803</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">666,853,385</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,456,119,129</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">26. 금융수익과 금융비용</SPAN>
</P>
<P>(1) 당분기와 전분기 중 금융수익의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="583" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="160" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="160" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">이자수익</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">553,834,080</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,079,189</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 금융비용의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="582" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="248"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="257" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" VALIGN="MIDDLE" HEIGHT="30">이자비용</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">424,879,388</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">359,296,881</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">27. 주당순손실</SPAN>
</P>
<P>기본주당손실은 당사의 보통주분기순손실을 가중평균 유통보통주식수로 나누어 산정했습니다(단위: 원).</P>
<P>(1) 보통주분기순손실</P>

<TABLE BORDER="1" WIDTH="454" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="188" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">당분기순손실</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(2,788,655,585)</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(3,307,453,029)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">가중평균 유통보통주식수</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,874,186</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">17,565,933</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">기본주당순손익</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(148)</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(188)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">희석주당순손익</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(148)</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(188)</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 가중평균 유통보통주식수당분기와 전분기 중 발행보통주식수를 유통기간으로 가중평균하여 산정한 유통보통주식수의 산출내역은 다음과 같습니다.</P>
<P>① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="811">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="219"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="175" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="190" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">기간</TH>
<TH WIDTH="122" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유통주식수</TH>
<TH WIDTH="96" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일수</TH>
<TH WIDTH="228" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균유통보통주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2024-01-01</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2024-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,872,208</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,717,370,928</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권행사</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2024-03-29</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2024-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,000</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">180,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,717,550,928</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">유통일수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">가중평균 유통보통주식수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,874,186</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="811">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="219"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="175" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="190" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">기간</TH>
<TH WIDTH="122" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유통주식수</TH>
<TH WIDTH="96" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일수</TH>
<TH WIDTH="228" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중평균유통보통주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-01-01</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,443,645</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">90</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,569,928,050</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">2CPS 우선주 전환</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-01-26</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">68,849</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">65</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,475,185</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">주식매수선택권행사</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-02-01</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,000</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">59</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,298,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">2CPS 우선주 전환</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-09</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,179</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,431,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">2CPS 우선주 전환</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-22</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,900</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">459,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">2CPS 우선주 전환</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-23</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023-03-31</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,179</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,342,611</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,580,933,963</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">유통일수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="583" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">가중평균 유통보통주식수</TD>
<TD WIDTH="228" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,565,933</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 희석주당순이익</P>
<P>① 당사의 잠재적보통주는 희석화 효과가 없으므로 기본주당손익과 희석주당손익은동일합니다.</P>
<P>② 희석효과가 없어 보통주희석주당손익을 계산할 때 가중평균 보통주식수에서 제외된 잠재적 보통주 내역은 다음과 같습니다(단위: 주).</P>

<TABLE BORDER="1" WIDTH="639" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">전환우선주</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">710,170</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,672,126</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">전환사채</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">755,301</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">755,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">주식선택권</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">549,224</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">592,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,014,695</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,019,467</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">28. 현금흐름표</SPAN>
</P>
<P>(1) 당분기와 전분기 중 영업활동으로 인한 현금흐름은 다음과 같습니다(단위: 원). </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="597">

<COLGROUP>
<COL WIDTH="290"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="147"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="299" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">당분기순손실</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(2,788,655,585)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(3,307,453,029)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">조정</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   이자비용</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">424,879,388</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">359,296,881</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   외화환산손실</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">77,574,275</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   기타의대손상각비</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">585,870,901</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,444,773,555</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   무형자산상각비</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,266,503</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,795,295</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   감가상각비</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">263,143,696</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">252,015,156</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   사용권자산상각비</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,353,365</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,707,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">   주식보상비용</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">40,608,768</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">271,133,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">   외화환산이익</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(418,455,188)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">   이자수익</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(553,834,080)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(629,079,189)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">   리스자산변경이익</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(1,708,397)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소  계</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">865,862,816</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,306,478,740</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">영업 활동관련 자산부채의 변동</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   매출채권의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(123,434,142)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(294,238,649)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   미지급금의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(24,808,712)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">451,821,696</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   미수금의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">36,975,384</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(144,168,102)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   선급금의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(151,320,000)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   선급비용의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(87,218,928)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">102,778,698</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   부가세대급금의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(13,843,279)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(14,508,769)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">   예수금의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(28,622,690)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(29,110)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">   선수금의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(4,125,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">   미지급비용의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(168,174,293)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">65,007,021</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">   계약부채의 증감</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(73,230,482)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(5,224,629)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소  계</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(633,677,142)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">157,313,156</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30">영업으로부터 창출된 현금</TD>
<TD WIDTH="142" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(2,556,469,911)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(1,843,661,133)</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당분기와 전분기 중 현금의 유입ㆍ유출이 없는 거래 중 중요한 사항은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="637" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="318"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="327" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="148" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" HEIGHT="31">사용권자산의 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">31,886,192</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" HEIGHT="31">리스부채의 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">27,260,575</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" HEIGHT="31">계약변경에 따른 사용권자산/리스부채의 감소</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">48,705,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" HEIGHT="31">주식매수선택권의 종속기업투자주식 대체</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">17,027,942</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" HEIGHT="31">전환우선주 행사로 인한 자본 증가</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">-</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">9,162,091,107</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" HEIGHT="30">전환사채의 이자비용 인식</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">354,849,582</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">294,575,338</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 당분기와 전분기 중 재무활동에서 생기는 부채의 조정내용은 다음과 같습니다(단위: 원).① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="705">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="196" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">현금흐름</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비현금거래</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">유동리스부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,453,702</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,608,412)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,608,412</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,453,702</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">비유동리스부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,689,359</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,608,412)</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,080,947</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">전환사채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,633,328,862</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">354,849,582</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,988,178,444</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30">장기차입금</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="704">

<COLGROUP>
<COL WIDTH="189"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="198" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">현금흐름</TH>
<TH WIDTH="126" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비현금거래</TH>
<TH WIDTH="126" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30">유동리스부채</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,005,758</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,679,711)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,423,516)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,902,531</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30">비유동리스부채</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,729,051</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,896,410</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,625,461</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30">전환사채</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,419,641,414</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">294,575,338</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,714,216,752</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30">장기차입금</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,000,000,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">29</SPAN>
<SPAN USERMARK=" B">. 영업부문 정보</SPAN>(1) 부문에 대한 정보당분기말 현재 당사의 영업부문은 단일 영업부문입니다. 당분기와 전분기 중 영업수익(매출액) 정보는 다음과 같습니다(단위: 원).
</P>

<TABLE BORDER="1" WIDTH="507" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="148" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기</TH>
<TH WIDTH="148" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">기술이전</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">467,251,645</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">427,102,165</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 지역에 대한 정보</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="504">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구     분</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전분기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30">국내</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">460,087,477</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">269,797,633</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30">해외</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,164,168</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,304,532</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="212" HEIGHT="30">합계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="146" HEIGHT="30">467,251,645</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="146" HEIGHT="30">427,102,165</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 주요 고객에 대한 정보당분기와 전분기 중 당사 매출액의 10% 이상을 차지하는 외부고객과 관련된 정보는 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="571">

<COLGROUP>
<COL WIDTH="135"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구분 </TD>
<TD COLSPAN="2" WIDTH="214" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당분기</TD>
<TD COLSPAN="2" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전분기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비율</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">A사</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">394,021,163</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84.33%</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">171,877,536</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40.20%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">B사</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,164,168</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.53%</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,304,532</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36.80%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">C사</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,066,314</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14.14%</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,920,097</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23.0%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">30. 우발상황 및 약정사항</SPAN>
</P>
<P>(1) 당분기말과 전기말 현재 사용이 제한된 예금의 내역은 다음과 같습니다(단위: 원).</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="646">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예금종류</TH>
<TH WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="107" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
<TH WIDTH="107" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용제한내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">현금성자산</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">보통예금</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">정부보조금</TD>
</TR>
</TBODY>
</TABLE>

<P>(2) 당사는 전기 이전에 서울대학교 산학협력단과 상표사용허락 계약을 체결 하였습니다. 본 계약을 통해 당사는 계약상표에 대한 사용권리를 확보하였고, 경상 상표사용료를 지급할 의무를 부담하고 있습니다.(3) 당사는 전기 이전에 서울대학교 산학협력단 및 서울대병원과 특허에 대한 기술이전계약(양도 등)을 체결하였습니다. 당사는 향후 동 기술에 대한 임상 진행경과에 따라 총 11,630백만원(경상기술료 별도)의 마일스톤 지급약정을 체결하고 있습니다. 전기 이전에 체결한 기술이전계약의 계약기술은 서울대학교 산학협력단으로부터양도받은 특허에 포함되어 있는 기술이며, 기술이전으로 수취한 기술료 중 일부(최대10%, 부가세 별도)에 대해 서울대학교 산학협력단과 합의된 비율에 따라 배분됩니다.(4)
<SPAN> </SPAN>당사는 2021년 11월 1일에 서울대학교 산학협력단과 '인체 마이크로바이옴 유래분 균주의 면역 항암 효과 검증'을 위한 위탁연구용역 계약을 체결하였습니다. 전기까지 총 연구비 6억원 전액을 납부하였습니다.
</P>

<P>(5) 기술이전계약① 당사가 체결한 주요 기술이전 계약의 내용은 다음과 같습니다.
<SPAN>당사는 2021년 10월 28일에 SPH Sine Pharmaceutical Laboratories Co., Ltd. 와 마이크로바이옴 신약 후보물질에 대한 기술이전 계약을 체결하였습니다. 당사는 계약금(upfront payment) USD 2,500,000 중 USD 1,250,000은 2021년 12월 17일에 수령하였으며, 2022년 12월 20일에 나머지 USD 1,250,000를 수령하였습니다. 동 계약금은 수행의무 이행 기간 동안 진행기준에 따라 수익을 인식합니다. 계약에 따라 향후 임상단계, 허가, 상업화 등 단계별  마일스톤 지급 조건 충족 시 USD 104,750,000(경상기술료(royalty)별도) 규모의 마일스톤 금액(milestone payment)을 추가로 수령할 수 있습니다.</SPAN>
<SPAN>당사는 2022년 4월 15일에 당사의 종속회사인 주식회사 위바이옴과 당사가 보유하고 있는 KBL375, KBL396, KBL409, KBL674, KBL982 균주 및 건강기능식품 관련기술이전 계약을 체결하였습니다. 당사는 동 계약에 따라 해당 균주를 사용한 건강기능식품의 판매액에 대하여 합의된 비율에 따라 경상기술료를 수령하고 있습니다.</SPAN>
<SPAN>② 기술이전계약과 관련된 불확실성 및 기타사항</SPAN>
<SPAN>본 계약을 통한 수익 인식은 개발 및 임상시험과 품목허가 등의 성공 여부에 따라 달라질 수 있습니다. 계약 조건에 따라, 규제기관에 의한 연구-개발의 중단, 품목허가 실패 등 발생시 계약이 해지될 수 있으므로 발생가능성에 불확실성이 내포되어 있습니다.</SPAN>
<SPAN></SPAN>(6) 공동연구개발당사는 2022년 3월 23일에 주식회사 셀트리온과 마이크로바이옴 신약 후보물질 발굴을 위한 공동연구계약을 체결하였습니다. 한편 공동연구계약은 라이선스 옵션 계약을 포함하고 있습니다. 당사는 연구의 결과로 얻어지는 지적재산권에 대하여 독점적 실시권을 취득할 수 있는 권리를 부여하였습니다. (7) 합작투자계약
<SPAN></SPAN>
<SPAN>당사는 전기 중 당사의 종속기업인 주식회사 위바이옴의 지분 49%를 보유한 주식회사 이마트와 주식회사 위바이옴의 소유와 지배구조 등에 대한 합작투자계약서를 체결하였습니다. 동 계약에 따라 각 당사자는 일정 기간 동안 주식처분이 제한되어 있으며, 주식처분제한 기간 이후 거래상대방의 지분 양도 시 회사는 이에 대한 우선매수권을 가집니다. 한편 거래상대방인 주식회사 이마트는 교착상태 또는 합작회사의 설립일로부터 10년이 경과된 경우, 이마트의 보유 지분에 대하여 회사에 매수청구권을 행사할 수 있습니다. 당사가 동 매수청구권의 행사를 거부하는 경우 주식회사 이마트의 주식매도청구권(Penalty Call Option)이 발동됩니다. 당사는 주주간계약에 따른 파생상품 공정가치 1,816백만원을 파생상품부채로 계상하였습니다(주석17 참조).</SPAN>
<SPAN>(8) 위탁균주 생산공정 최적화 및 생산계약</SPAN>
<SPAN>당사는 당사의 종속회사인 주식회사 위바이옴과 KBL981, KBL983 균주와 관련한 위탁 균주 생산공정 최적화 및 위탁 균주 개발에 대한 계약을 체결하였습니다.</SPAN>
</P>
<P>(9) 담보제공내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="893">

<COLGROUP>
<COL WIDTH="884"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="893" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="905">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">담보권자</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">담보제공자산</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">장부금액</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">담보설정액</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">관련 채무</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">채무금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="245" VALIGN="MIDDLE" HEIGHT="60">기업은행</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">분양 토지(토지)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,414,625,766</TD>
<TD ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" HEIGHT="60" ALIGN="RIGHT">3,600,000,000</TD>
<TD ROWSPAN="4" WIDTH="132" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER">장기차입금</TD>
<TD ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" HEIGHT="60" ALIGN="RIGHT">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">판교 사옥(건물)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,388,857,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="245" VALIGN="MIDDLE" HEIGHT="60">산업은행</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">분양 토지(토지)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,414,625,766</TD>
<TD ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" HEIGHT="60" ALIGN="RIGHT">3,600,000,000</TD>
<TD ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" HEIGHT="60" ALIGN="RIGHT">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">판교 사옥(건물)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,388,857,524</TD>
</TR>
</TBODY>
</TABLE>
<P>(10) 당사는 마이크로바이옴 치료제 개발 등에 대하여 창업진흥원 등과의 협약에 따라 정부보조금을 수령하였습니다. 진행중인 과제 포함한 전체 국책과제에 대한 총 수령 보조금은 5,274백만원이며, 기술료 납부 의무가 종료된 과제의 보조금은 3,315백만원입니다. 상환의무가 존재하는 정부보조금의 경우에는 상환의무가 확정되는 시점에 회계추정의 변경으로 처리하고 있습니다.</P>

<P>
<SPAN USERMARK=" B">31. 특수관계자 거래</SPAN>
</P>
<P>(1) 당분기말과 전기말 현재 당사의 특수관계자 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="634">

<COLGROUP>
<COL WIDTH="226"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당분기말</TH>
<TH WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="53" VALIGN="MIDDLE">유의적인 영향력을 행사하는 기업</TD>
<TD WIDTH="200" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
<TD WIDTH="199" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">아이비케이 스톤브릿지 혁신성장 사모투자합자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">종속기업</TD>
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KoBioLabs Australia Pty Ltd</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">주식회사 위바이옴</TD>
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">주식회사 위바이옴</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">기타 특수관계자</TD>
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">주식회사 이마트(*)</TD>
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">주식회사 이마트(*)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="399" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">대표이사 및 주요 경영진</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 전기 중 회사의 종속기업인 주식회사 위바이옴이 주식회사 이마트의 관계기업으로 편입됨에 따라 기타 특수관계자로 분류되었습니다.(2) 매출 및 매입 등 거래당분기와 전분기 중 특수관계자와의 매출 및 매입 등 거래내역은 다음과 같습니다(단위: 원).① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="916">

<COLGROUP>
<COL WIDTH="310"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="319" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>특수관계구분</P>
</TH>
<TH WIDTH="150" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">매출 등</TH>
<TH WIDTH="149" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">매입 등</TH>
<TH WIDTH="149" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">이자수익</TH>
<TH WIDTH="149" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">유형자산 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="319" HEIGHT="30" VALIGN="MIDDLE">주식회사 위바이옴</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">394,021,163</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">44,618,273</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="319" HEIGHT="30" VALIGN="MIDDLE">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>② 전분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="912">

<COLGROUP>
<COL WIDTH="310"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="319" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">
<P>특수관계구분</P>
</TH>
<TH WIDTH="149" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">매출 등</TH>
<TH WIDTH="148" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">매입 등</TH>
<TH WIDTH="148" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">이자수익</TH>
<TH WIDTH="148" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">유형자산 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="319" HEIGHT="30" VALIGN="MIDDLE">주식회사 위바이옴</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">171,877,536</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,632,455</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="319" HEIGHT="30" VALIGN="MIDDLE">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 특수관계자에 대한 채권ㆍ채무의 주요 잔액당분기말과 전기말 현재 특수관계자에 대한 채권ㆍ채무의 주요 내역은 다음과 같습니다(단위: 원).① 당분기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="778">

<COLGROUP>
<COL WIDTH="188"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7" ROWSPAN="2">특수관계 구분</TD>
<TD COLSPAN="2" WIDTH="291" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">채 권</TD>
<TD COLSPAN="2" WIDTH="290" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">채 무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">매출채권</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타채권(*)</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">매입채무</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타채무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30">주식회사 위바이옴</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">433,423,279</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,000,000</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">112,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당분기말 현재의 채권금액은 대손충당금 24,950백만원을 차감한 순액으로 기재되어 있으며, 당분기 중 비용으로 인식된 대손상각비는 586백만원입니다. </P>
<P>② 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="783">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="200" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">특수관계 구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="292" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">채 권</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="291" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">채 무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출채권</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타채권(*)</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매입채무</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타채무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="33" VALIGN="MIDDLE">주식회사 위바이옴</TD>
<TD WIDTH="146" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">309,989,137</TD>
<TD WIDTH="146" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">91,587,254</TD>
<TD WIDTH="146" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">112,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="33" VALIGN="MIDDLE" ALIGN="CENTER">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="146" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="146" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="146" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="33" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 전기말 현재의 채권금액은 대손충당금 24,364백만원을 차감한 순액으로 기재되어 있으며, 전기 중 비용으로 인식된 대손상각비는 5,868백만원입니다.(4) 특수관계자와의 자금 거래당분기와 전기 중 특수관계자와의 자금 거래내역은 다음과 같습니다(단위: 원).</P>
<P>① 당분기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="497">

<COLGROUP>
<COL WIDTH="188"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7" ROWSPAN="2">특수관계 구분</TD>
<TD COLSPAN="2" WIDTH="300" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">자금대여 거래</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">대여</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">회수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">661,385,560</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>② 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="497">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="196" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">특수관계 구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="301" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">자금대여 거래</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대여</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">회수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KoBioLabs Australia Pty Ltd</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,858,313,140</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(5) 당사는 전기까지 종속기업인 주식회사 위바이옴으로의 전출인원에 대한 주식보상비용 전액을 종속기업투자주식으로 인식하였습니다.(6) 전환우선주 및 전환사채의 발행 내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="712">

<COLGROUP>
<COL WIDTH="703"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="712" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="717">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="317" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">발행금액</TH>
<TH ROWSPAN="2" WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">합계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제2회 전환사채</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제3회 전환우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="53">아이비케이 스톤브릿지 혁신성장 사모투자합자회사(*)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,350,000,000</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">4,649,997,750</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">6,999,997,750</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 상세내역은 주석 16 및 20 참조</P>
<P>(7) 당사와 종속기업(KoBioLabs Australia Pty Ltd) 간 체결한 Co-Development Agreement에 따라 종속기업은 당사 개발과제인 KBLP-001, KBLP-002 및 KBLP-007의호주 내 발생비용을 부담하고, 관련 지식재산권에 대해 당사와 공동 소유권을 보유합니다. 단, 호주법인의 지식재산권 사용 권한은 호주지역에 한정됩니다.(8) 당사는 전기 중 당사의 종속기업인 주식회사 위바이옴의 지분 49%를 보유한 주식회사 이마트와 주식회사 위바이옴의 소유와 지배구조 등에 대한 합작투자계약서를체결하였습니다(주석30 참조).</P>
<P>(9) 당기말과 전기말 현재 당사는 차량리스 약정과 법인신용카드와 관련하여 대표이사로부터 연대보증을 제공받고 있습니다.(10) 당사는 전기 이전에 서울대학교 산학협력단(연구책임자 고광표 교수)과 마이크로바이옴 관련 위탁연구용역 계약을 체결하였고, 전기 중 연구용역이 완료되었습니다(주석 30 참조).</P>
<P></P>
<P>(11) 주요 경영진에 대한 보상 주요 경영진은 등기 이사 및 감사를 포함하고 있습니다. 당분기와 전분기 중 주요 경영진에게 지급됐거나 지급될 보상금액은 다음과 같습니다(단위: 원).</P>

<TABLE BORDER="1" WIDTH="508" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">구     분</TH>
<TH WIDTH="143" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">당분기</TH>
<TH WIDTH="147" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">전분기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">급여 및 기타 단기종업원 급여 </TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">167,792,669</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">96,700,249</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">퇴직급여 </TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">61,113,737</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">23,226,602</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">주식기준보상 </TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">64,392,958</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">429,300,226</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">293,299,364</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">549,227,077</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>
</LIBRARY>


<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0" ATOCID="12">6. 배당에 관한 사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-0" ATOCID="13">7. 증권의 발행을 통한 자금조달에 관한 사항</TITLE>
<P></P>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-1" ATOCID="14">7-1. 증권의 발행을 통한 자금조달 실적</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[지분증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">가. 증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="598" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="733" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행(감소)일자</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="158" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)형태</TH>
<TH COLSPAN="5" VALIGN="MIDDLE" WIDTH="438" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당액면가액</TH>
<TH VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행(감소)가액</TH>
<TH VALIGN="MIDDLE" WIDTH="136" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20220407">2022년 04월 07일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">544,960</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">18,350</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">증자비율: 3.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20220630">2022년 06월 30일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">125,010</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">3,553</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20220829">2022년 08월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">90,020</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">3,553</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20221125">2022년 11월 25일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">160,650</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20221206">2022년 12월 06일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">114,749</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20221213">2022년 12월 13일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">91,797</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20221228">2022년 12월 28일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">45,900</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230126">2023년 01월 26일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">68,849</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230201">2023년 02월 01일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">22,000</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">3,553</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230309">2023년 03월 09일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">149,179</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230322">2023년 03월 22일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">45,900</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230323">2023년 03월 23일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">149,179</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230403">2023년 04월 03일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">261,635</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230404">2023년 04월 04일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">163,950</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230405">2023년 04월 05일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">309,832</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230413">2023년 04월 13일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">13,097</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제2회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230419">2023년 04월 19일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">213,442</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">15,250</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">제3회 전환우선주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20230612">2023년 06월 12일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND" ALIGN="CENTER">보통주</TE>
<TE VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT" ALIGN="RIGHT">31,500</TE>
<TE VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT" ALIGN="RIGHT">500</TE>
<TE VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT" ALIGN="RIGHT">10,119</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20240329">2024년 03월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT">60,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">2,522</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<P>
<SPAN USERMARK=" B">나. 미상환 전환사채 발행현황</SPAN>
</P>

<LIBRARY>
<TABLE-GROUP ACLASS="CB" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="685" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="379"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="388" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1313" BORDER="1">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="128" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">종류＼구분</TH>
<TH WIDTH="48" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">회차</TH>
<TH WIDTH="137" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">발행일</TH>
<TH WIDTH="137" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">만기일</TH>
<TH WIDTH="150" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">권면(전자등록)총액</TH>
<TH WIDTH="98" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">전환대상주식의 종류</TH>
<TH WIDTH="138" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">전환청구가능기간</TH>
<TH WIDTH="156" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">전환조건</TH>
<TH WIDTH="273" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">미상환사채</TH>
<TH WIDTH="48" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">전환비율(%)</TH>
<TH WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">전환가액</TH>
<TH WIDTH="150" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">권면(전자등록)총액</TH>
<TH WIDTH="123" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE">전환가능주식수</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="128" HEIGHT="76" ACODE="CB_KND" ALIGN="CENTER" VALIGN="MIDDLE">무기명식 이권부무보증사모 전환사채</TE>
<TE WIDTH="48" HEIGHT="76" ACODE="CB_SEQ" ALIGN="CENTER" VALIGN="MIDDLE">1</TE>
<TU WIDTH="137" HEIGHT="76" AUNIT="CB_DT" AUNITVALUE="20211119" ALIGN="CENTER" VALIGN="MIDDLE">2021년 11월 19일</TU>
<TU WIDTH="137" HEIGHT="76" AUNIT="CB_FDT" AUNITVALUE="20261119" ALIGN="CENTER" VALIGN="MIDDLE">2026년 11월 19일</TU>
<TE WIDTH="150" HEIGHT="76" ACODE="CB_EN" ALIGN="RIGHT" VALIGN="MIDDLE">11,000,000,000</TE>
<TE WIDTH="98" HEIGHT="76" ACODE="CB_KN" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TE>
<TE WIDTH="138" HEIGHT="76" ACODE="CB_PE" ALIGN="CENTER" VALIGN="MIDDLE">2022.11.19~2026.10.19</TE>
<TE WIDTH="78" HEIGHT="76" ACODE="CB_RAT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="78" HEIGHT="76" ACODE="CB_PR" ALIGN="RIGHT" VALIGN="MIDDLE">25,250</TE>
<TE WIDTH="150" HEIGHT="76" ACODE="CB_AMN" ALIGN="RIGHT" VALIGN="MIDDLE">11,000,000,000</TE>
<TE WIDTH="123" HEIGHT="76" ACODE="CB_CN" ALIGN="RIGHT" VALIGN="MIDDLE">435,641</TE>
<TE WIDTH="48" HEIGHT="76" ACODE="NOTE" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="128" HEIGHT="76" ACODE="CB_KND" ALIGN="CENTER" VALIGN="MIDDLE">무기명식 이권부무보증사모 전환사채</TE>
<TE WIDTH="48" HEIGHT="76" ACODE="CB_SEQ" ALIGN="CENTER" VALIGN="MIDDLE">2</TE>
<TU WIDTH="137" HEIGHT="76" AUNIT="CB_DT" AUNITVALUE="20211230" ALIGN="CENTER" VALIGN="MIDDLE">2021년 12월 30일</TU>
<TU WIDTH="137" HEIGHT="76" AUNIT="CB_FDT" AUNITVALUE="20261230" ALIGN="CENTER" VALIGN="MIDDLE">2026년 12월 30일</TU>
<TE WIDTH="150" HEIGHT="76" ACODE="CB_EN" ALIGN="RIGHT" VALIGN="MIDDLE">2,350,000,000</TE>
<TE WIDTH="98" HEIGHT="76" ACODE="CB_KN" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TE>
<TE WIDTH="138" HEIGHT="76" ACODE="CB_PE" ALIGN="CENTER" VALIGN="MIDDLE">2022.12.30~2026.11.30</TE>
<TE WIDTH="78" HEIGHT="76" ACODE="CB_RAT" ALIGN="RIGHT" VALIGN="MIDDLE">100</TE>
<TE WIDTH="78" HEIGHT="76" ACODE="CB_PR" ALIGN="RIGHT" VALIGN="MIDDLE">25,250</TE>
<TE WIDTH="150" HEIGHT="76" ACODE="CB_AMN" ALIGN="RIGHT" VALIGN="MIDDLE">2,350,000,000</TE>
<TE WIDTH="123" HEIGHT="76" ACODE="CB_CN" ALIGN="RIGHT" VALIGN="MIDDLE">93,069</TE>
<TE WIDTH="48" HEIGHT="76" ACODE="NOTE" ALIGN="CENTER" VALIGN="MIDDLE">주2)</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">합 계</TD>
<TD WIDTH="48" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="150" HEIGHT="30" ACODE="CB_ENT" VALIGN="MIDDLE" ALIGN="RIGHT">13,350,000,000</TE>
<TE WIDTH="98" HEIGHT="30" ACODE="CB_KNT" VALIGN="MIDDLE">-</TE>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="78" HEIGHT="30" ACODE="CB_RATT" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="78" HEIGHT="30" ACODE="CB_PRT" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="150" HEIGHT="30" ACODE="CB_AMNT" VALIGN="MIDDLE" ALIGN="RIGHT">13,350,000,000</TE>
<TE WIDTH="123" HEIGHT="30" ACODE="CB_CNT" VALIGN="MIDDLE" ALIGN="RIGHT">528,710</TE>
<TE WIDTH="48" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 당사가 발행한 제1회 전환사채는 2022년 2월 19일을 기산일로 하여 시가 하락에 따른 전환가액이 조정되었으며, 조정후 전환가액은 17,675원, 조정후 전환가능주식수는 622,345주로 변경되었습니다.주2) 당사가 발행한 제2회 전환사채는 2022년 6월 30일을 기산일로 하여 시가 하락에 따른 전환가액이 조정되었으며, 조정후 전환가액은 17,675원, 조정후 전환가능주식수는 132,956주로 변경되었습니다.</P>
</LIBRARY>

<P></P>

<P>
<SPAN USERMARK=" B">다. 미상환 신주인수권부사채 등 발행현황</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK=" B">라. 미상환 전환형 조건부자본증권 등 발행현황</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[채무증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">가. 채무증권 발행실적</P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="1">(단위 : 원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1122" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="40"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="251"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">발행회사</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">증권종류</TH>
<TH WIDTH="49" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">발행방법</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">발행일자</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="57" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">이자율</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">평가등급(평가기관)</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">만기일</TH>
<TH WIDTH="66" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">상환여부</TH>
<TH WIDTH="260" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACODE="BSS_PIS_CMPY">주식회사고바이오랩</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUNIT="BSS_PIS_STC" AUNITVALUE="2">사모</TU>
<TU WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUNIT="BSS_PIS_DAT" AUNITVALUE="20211119">2021년 11월 19일</TU>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="99" ACODE="BSS_PIS_MON">11,000,000,000</TE>
<TE WIDTH="57" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="99" ACODE="BSS_PIS_RATE">0</TE>
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="99" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUNIT="BSS_PIS_LAS" AUNITVALUE="20261119">2026년 11월 19일</TU>
<TE WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="260" VALIGN="MIDDLE" HEIGHT="99" ACODE="BSS_PIS_SUC" ALIGN="CENTER">뉴딜익스텐션신기술투자조합1호스마트코리아 컴퍼니케이 언택트펀드씨케이피-KIS2020 투자조합메리츠에셋원신기술금융조합 제1호</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_CMPY">주식회사고바이오랩</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_STC" AUNITVALUE="2">사모</TU>
<TU WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_DAT" AUNITVALUE="20211230">2021년 12월 30일</TU>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_MON">2,350,000,000</TE>
<TE WIDTH="57" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_RATE">0</TE>
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_LAS" AUNITVALUE="20261230">2026년 12월 30일</TU>
<TE WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="260" VALIGN="MIDDLE" HEIGHT="53" ACODE="BSS_PIS_SUC" ALIGN="CENTER">아이비케이 스톤브릿지 혁신성장사모투자합자회사</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_CMPY">주식회사위바이옴</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_STC" AUNITVALUE="2">사모</TU>
<TU WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_DAT" AUNITVALUE="20220408">2022년 04월 08일</TU>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_MON">60,000,000</TE>
<TE WIDTH="57" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_RATE">0</TE>
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_LAS" AUNITVALUE="20250408">2025년 04월 08일</TU>
<TE WIDTH="66" VALIGN="MIDDLE" HEIGHT="53" ACODE="BSS_PIS_REC" ALIGN="CENTER">상환 주)</TE>
<TE WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_SUC">서울대학교 기술지주㈜</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="153" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSS_PIS_MONT" ALIGN="RIGHT">13,410,000,000</TE>
<TE WIDTH="57" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주) 위바이옴은 2023년 01월 18일 발행한 전환사채를 전부 상환하였습니다.
<SPAN USERMARK=" B">나. 기업어음증권 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK=" B">다. 단기사채 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK=" B">라. 회사채 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="835" BORDER="1">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="146" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="76" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="121" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="71" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="121" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">13,350,000,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">13,350,000,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">13,350,000,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">13,350,000,000</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>- 2024년 05월 19일부터 매 3개월 단위로 행사가능한 조기상환청구권은 11,000,000,000원이며, 2024년 06월 30일부터 매 3개월 단위로 행사가능한 조기상환청구권은 2,350,000,000원입니다.
<SPAN USERMARK=" B">마. 신종자본증권 미상환 잔액</SPAN>
<SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK=" B">바. 조건부자본증권 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK=" B">사. 조건부자본증권 미상환 잔액</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
</P>

<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-2" ATOCID="15">7-2. 증권의 발행을 통해 조달된 자금의 사용실적</TITLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">가. 공모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1120" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="224"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="224"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="60"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="158" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH VALIGN="MIDDLE" WIDTH="354" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의 자금사용 계획</TH>
<TH VALIGN="MIDDLE" WIDTH="354" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용 내역</TH>
<TH VALIGN="MIDDLE" WIDTH="69" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="233" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH VALIGN="MIDDLE" WIDTH="233" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="158" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 상장공모</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">1회</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20201112">2020년 11월 12일</TU>
<TE ALIGN="CENTER" WIDTH="233" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">신약 임상 비용</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">25,657,680,000</TE>
<TE ALIGN="CENTER" WIDTH="233" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">신약 임상 비용</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">11,466,100,821</TE>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="158" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 상장공모</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">1회</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20201112">2020년 11월 12일</TU>
<TE ALIGN="CENTER" WIDTH="233" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">생산설비 확보 및 연구시설 확충</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">3,429,000,000</TE>
<TE ALIGN="CENTER" WIDTH="233" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">생산설비 확보 및 연구시설 확충</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">3,429,000,000</TE>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="158" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 상장공모</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">1회</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20201112">2020년 11월 12일</TU>
<TE ALIGN="CENTER" WIDTH="233" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">발행제비용</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">1,813,320,000</TE>
<TE ALIGN="CENTER" WIDTH="233" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">발행제비용</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">1,545,000,000</TE>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주2)</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P>주1) 당사는 2020년 11월 코스닥시장 공모를 통해 동 공모자금을 조달 하였으며, 2024년까지 25,658백만원을 신약 임상 비용으로 사용할 것이라 계획했습니다. 보고서 작성기준일 현재 자금 사용 계획 상의 시기 미도래와 2021년 제3자배정 유상증자로 인해 조달된 자금을 선사용하여 차이가 발생합니다. 미사용 잔액은 은행 예적금 및 금융상품에 나누어 보관되어 있습니다.주2) 발행제비용 금액은 신주 상장에 따른 인수수수료, 등록세, 교육세, 기타비용(IR비용 등 제반비용)으로 기타비용(IR비용 등 제반비용) 부분 등에서 예상보다 작은 비용이 사용되어 차이가 발생하였습니다. 미사용 잔액은 은행 예적금 및 금융상품에 나누어 보관되어 있습니다.</P>

<LIBRARY>
<P USERMARK=" B">나. 사모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1112" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="239"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="239"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="105" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH VALIGN="MIDDLE" WIDTH="369" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의 자금사용 계획</TH>
<TH VALIGN="MIDDLE" WIDTH="369" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용 내역</TH>
<TH VALIGN="MIDDLE" WIDTH="84" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="248" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH VALIGN="MIDDLE" WIDTH="248" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="76" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자(전환우선주)</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="MO_SEQ" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20211118">2021년 11월 18일</TU>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="76" ACODE="PLA_USE" VALIGN="MIDDLE">비임상/임상 및 연구개발 비용,시설투자비 등 기타 운영자금 용도</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="76" ACODE="PLA_AMT" VALIGN="MIDDLE">33,449,803,500</TE>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="76" ACODE="BRK_CON" VALIGN="MIDDLE">비임상/임상 및 연구개발 비용,시설투자비 등 기타 운영자금 용도</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="76" ACODE="BRK_AMT" VALIGN="MIDDLE">20,436,907,405</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="76" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">전환사채</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20211119">2021년 11월 19일</TU>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">비임상/임상 및 연구개발 비용,시설투자비 등 기타 운영자금 용도</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">11,000,000,000</TE>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="76" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자(전환우선주)</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="MO_SEQ" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20211229">2021년 12월 29일</TU>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="76" ACODE="PLA_USE" VALIGN="MIDDLE">타법인 증권취득자금</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="76" ACODE="PLA_AMT" VALIGN="MIDDLE">4,649,997,750</TE>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="76" ACODE="BRK_CON" VALIGN="MIDDLE">건강기능식품자회사 설립 출자</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="76" ACODE="BRK_AMT" VALIGN="MIDDLE">4,649,997,750</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="76" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">전환사채</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20211230">2021년 12월 30일</TU>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">타법인 증권취득자금</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">2,350,000,000</TE>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">건강기능식품자회사 설립 출자</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">904,986,250</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주2)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="105" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">24</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20220406">2022년 04월 06일</TU>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">타법인 증권취득자금</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">10,000,016,000</TE>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">건강기능식품자회사 설립 출자</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">10,000,016,000</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P>주1) 예치중인 운용 상품의 만기에 따라 전환우선주 금액을 자금사용 계획에 맞춰 먼저 사용중입니다. 미사용 자금은 자금사용 계획에 따라 사용될 예정이며 현재 남은 잔액은 은행 예적금 및 금융상품에 나누어 보관되어 있습니다.주2) 건강기능식품 자회사 설립 출자액이 예상대비 감소하여 차이가 발생하였습니다. 미사용 잔액은 은행 예적금 및 금융상품에 나누어 보관되어 있습니다.</P>

<LIBRARY>
<P USERMARK=" B">다. 미사용자금의 운용내역</P>

<TABLE-GROUP ACLASS="UNS_HIY" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="598" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="231"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="240" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="707" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH VALIGN="MIDDLE" WIDTH="210" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">운용상품명</TH>
<TH VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">운용금액</TH>
<TH VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약기간</TH>
<TH VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">실투자기간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,979,949,589</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202405" VALIGN="MIDDLE">2024년 03월 ~ 2024년 05월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,979,949,590</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202406" VALIGN="MIDDLE">2024년 03월 ~ 2024년 06월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,500,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202409" VALIGN="MIDDLE">2024년 03월 ~ 2024년 09월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202401-202407" VALIGN="MIDDLE">2024년 01월 ~ 2024년 07월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">2,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202401-202410" VALIGN="MIDDLE">2024년 01월 ~ 2024년 10월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">2개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">2,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202401-202501" VALIGN="MIDDLE">2024년 01월 ~ 2025년 01월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">2개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">4,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202503" VALIGN="MIDDLE">2024년 03월 ~ 2025년 03월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,945,013,750</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202405" VALIGN="MIDDLE">2024년 03월 ~ 2024년 05월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">7,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202406" VALIGN="MIDDLE">2024년 03월 ~ 2024년 06월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,513,028,345</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202312-202404" VALIGN="MIDDLE">2023년 12월 ~ 2024년 04월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">3,999,955,500</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202409" VALIGN="MIDDLE">2024년 03월 ~ 2024년 09월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">3,999,912,500</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202501" VALIGN="MIDDLE">2024년 03월 ~ 2025년 01월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202312-202412" VALIGN="MIDDLE">2023년 12월 ~ 2024년 12월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">4개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="C" VALIGN="MIDDLE">채권</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">중소기업금융채권(기업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">1,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202403-202503" VALIGN="MIDDLE">2024년 03월 ~ 2025년 03월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">정기예금(산업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">4,000,000,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202401-202404" VALIGN="MIDDLE">2024년 01월 ~ 2024년 04월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">정기예금(산업은행)</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">999,999,750</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202401-202404" VALIGN="MIDDLE">2024년 01월 ~ 2024년 04월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="288" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="UNS_MNY_SUM" VALIGN="MIDDLE">39,917,809,024</TE>
<TD ALIGN="CENTER" WIDTH="298" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-8-0" ATOCID="16">8. 기타 재무에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 재무제표 재작성 등의 유의사항</SPAN>1) 재무제표 재작성당사는 보고서 작성기준일 현재 해당사항 없습니다.2) 합병, 분할, 자산양수도, 영업양수도당사는 보고서 작성기준일 현재 해당사항 없습니다.3) 자산유동화와 관련한 자산매각의 회계처리 및 우발채무 등에 관한 사항우발채무 등에 관한 사항은「III. 재무에 관한 사항 → 3. 연결재무제표 주석 → 31. 우발상황 및 약정사항」을 참조하시기 바랍니다.나. 대손충당금 설정현황당사는 연결재무제표 기준 대손충당금 설정내역 해당사항이 없습니다. 별도재무제표 기준 대손충당금 설정내역은 하기와 같습니다.1) 최근 3사업연도의 계정과목별 대손충당금 설정내역
</P>

<TABLE WIDTH="516" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="507"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="516" HEIGHT="30">(단위 : 원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="518" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="55"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="64" USERMARK=" BC0XD7D7D7" HEIGHT="53" VALIGN="MIDDLE">
<P>구분</P>
</TD>

<TD ALIGN="CENTER" WIDTH="119" USERMARK=" BC0XD7D7D7" HEIGHT="53" VALIGN="MIDDLE">
<P>계정과목</P>
</TD>

<TD ALIGN="CENTER" WIDTH="121" USERMARK=" BC0XD7D7D7" HEIGHT="53" VALIGN="MIDDLE">

<P>채권총액
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
</TD>

<TD ALIGN="CENTER" WIDTH="121" USERMARK=" BC0XD7D7D7" HEIGHT="53" VALIGN="MIDDLE">
<P>대손충당금 주)</P>
</TD>

<TD ALIGN="CENTER" WIDTH="93" USERMARK=" BC0XD7D7D7" HEIGHT="53" VALIGN="MIDDLE">
<P>대손충당금설정율</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" ALIGN="CENTER" WIDTH="64" VALIGN="MIDDLE" HEIGHT="120">
<P>제11기1분기</P>
</TD>

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>매출채권</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">433,423,279</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>미수금</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">63,361,870</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>장기대여금 주)</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,950,265,412</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,950,265,412</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>합계</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">25,447,050,561</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,950,265,412</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">98.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" ALIGN="CENTER" WIDTH="64" VALIGN="MIDDLE" HEIGHT="120">
<P>제10기</P>
</TD>

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>매출채권</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">309,989,137</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>미수금</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">100,337,254</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>장기대여금 주)</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,364,394,511</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,364,394,511</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>합계</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,774,720,902</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,364,394,511</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">98.3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" ALIGN="CENTER" WIDTH="64" VALIGN="MIDDLE" HEIGHT="120">
<P>제9기</P>
</TD>

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>매출채권</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">199,825,426</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>미수금</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">39,323,798</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>장기대여금 주)</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">19,939,006,314</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">18,496,617,550</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">92.8</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">
<P>합계</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">20,178,155,538</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">18,496,617,550</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="30">91.7</TD>
</TR>
</TBODY>
</TABLE>

<P>주) 자회사 호주법인에 대한 장기대여금 및 대손충당금 입니다.
<SPAN></SPAN>
</P>
<P>2) 최근 3사업연도의 대손충당금 변동현황</P>
<P USERMARK="F-16"></P>

<TABLE WIDTH="550" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="541"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="550" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="551" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="196" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>구분</P>
</TD>

<TD ALIGN="CENTER" WIDTH="121" USERMARK=" BC0XD7D7D7" HEIGHT="30">

<P>제11기
<SPAN> 1분기</SPAN>
</P>
</TD>

<TD ALIGN="CENTER" WIDTH="121" USERMARK=" BC0XD7D7D7" HEIGHT="30">

<P>제10기
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>제9기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" HEIGHT="30">
<P>1.기초충당금잔액합계</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,364,394,511</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">18,496,617,550</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">12,900,993,777</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" HEIGHT="30">
<P>2.순대손처리액</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" HEIGHT="30">
<P> ①대손처리액</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" HEIGHT="30">
<P> ②상각채권회수액</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" HEIGHT="30">
<P> ③기타증감액</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" HEIGHT="30">
<P>3.대손상각비계상(환입)액</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">585,870,901</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">5,867,776,961</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">5,595,623,773</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" HEIGHT="30">
<P>4.기말대손충당금잔액합계</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,950,265,412</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">24,364,394,511</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">18,496,617,550</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-16">
<SPAN USERMARK="F-12">3) 매출채권관련 대손충당금 설정방침매출채권은 공정가치로 인식할 때에 유의적인 금융요소를 포함하는 않는 경우에는 무조건적인 대가의 금액으로 최초 인식합니다. 매출채권은 후속적으로 유효이자율법을 적용한 상각후원가에 손실충당금을 차감하여 측정됩니다.</SPAN>
</P>
<P>4) 당분기말 현재 경과기간별 매출채권잔액별도재무제표의 매출채권의 합계액이 10억원 미만이므로 기재를 생략하였습니다.</P>
<P></P>

<P USERMARK=" B">다. 재고자산 현황 등
<SPAN USERMARK=" !B">1) 최근 3사업연도의 재고자산 보유현황</SPAN>
</P>

<TABLE WIDTH="668" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="659"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="668" HEIGHT="30">(단위 : 원,%,회)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="653" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="176"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="185" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>구분</P>
</TD>

<TD ALIGN="CENTER" WIDTH="138" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>계정과목</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>제11기 1분기</P>
</TD>

<TD ALIGN="CENTER" WIDTH="113" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>제10기</P>
</TD>

<TD ALIGN="CENTER" WIDTH="104" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>제9기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="185" HEIGHT="210" VALIGN="MIDDLE" ROWSPAN="7">건강기능식품</TD>

<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">
<P>제품</P>
</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,351,903,999</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">1,489,085,993</TD>
<TD ALIGN="RIGHT" WIDTH="104" HEIGHT="30" VALIGN="MIDDLE">985,042,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">제품평가충당금</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(14,606,475)</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(59,722,519)</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(68,624,202)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">66,805,754</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">23,279,336</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">45,539,133</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">부재료</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10,309,511</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">9,793,755</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">9,297,997</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">반품자산</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">8,794,707</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,259,612</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">6,214,072</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">반제품</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">213,224,962</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">21,075,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">반제품평가충당금</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(69,452,105)</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(21,075,550)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="323" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2">합계</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,566,980,353</TD>
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,466,696,177</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">977,469,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ALIGN="CENTER" WIDTH="323" HEIGHT="53">
<P>총자산대비재고자산구성비율(%)</P>
<P>[재고자산합계÷기말자산총계X100]</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="53" VALIGN="MIDDLE">1.32</TD>
<TD ALIGN="RIGHT" WIDTH="113" VALIGN="MIDDLE" HEIGHT="53">1.28</TD>
<TD ALIGN="RIGHT" WIDTH="104" VALIGN="MIDDLE" HEIGHT="53">0.79</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ALIGN="CENTER" WIDTH="323" HEIGHT="53">
<P>재고자산회전율(회수)</P>
<P>[연환산매출원가÷{(기초재고+기말재고)÷2}]</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="53" VALIGN="MIDDLE">12.87</TD>
<TD ALIGN="RIGHT" WIDTH="113" VALIGN="MIDDLE" HEIGHT="53">6.86</TD>
<TD ALIGN="RIGHT" WIDTH="104" VALIGN="MIDDLE" HEIGHT="53">5.04</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-16">
<SPAN USERMARK="F-12">2) 재고자산의 실사가) 실사내역매반기 실사 실시나) 실사일자 및 장소</SPAN>
</P>

<TABLE BORDER="1" WIDTH="518" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="239"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="179" USERMARK=" BC0XD7D7D7" HEIGHT="30"> 일 자</TD>
<TD ALIGN="CENTER" WIDTH="91" USERMARK=" BC0XD7D7D7" HEIGHT="30"> 내 용</TD>
<TD ALIGN="CENTER" WIDTH="248" USERMARK=" BC0XD7D7D7" HEIGHT="30">장 소</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="179" HEIGHT="30">2022.12.28.</TD>
<TD ALIGN="CENTER" WIDTH="91" HEIGHT="30">제품</TD>
<TD ALIGN="CENTER" WIDTH="248" HEIGHT="30">군포 물류창고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="179" HEIGHT="30">2023.06.30.</TD>
<TD ALIGN="CENTER" WIDTH="91" HEIGHT="30">제품</TD>
<TD ALIGN="CENTER" WIDTH="248" HEIGHT="30">군포 물류창고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="179" HEIGHT="30">2023.12.29</TD>
<TD ALIGN="CENTER" WIDTH="91" HEIGHT="30">제품</TD>
<TD ALIGN="CENTER" WIDTH="248" HEIGHT="30">안성 물류창고</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-16">
<SPAN USERMARK="F-12">주) 삼일회계법인의 입회하에 2022년 및 2023년 기말 재고조사를 실시하였습니다.다) 장기체화 재고 등 현황</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12">재고자산은 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고 있습니다. 순실현가능가치는 정상적인 영업과정의 예상 판매가격에서 예상되는 추가 완성원가와 판매비용을 차감한 금액으로서 매 후속기간에 순실현가능가치를  재평가하고 있습니다.</SPAN>
</P>

<TABLE WIDTH="562" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="553"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="562" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="564" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="107" USERMARK=" BC0XD7D7D7" HEIGHT="30">구분</TD>

<TD ALIGN="CENTER" WIDTH="107" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>취득원가</P>
</TD>

<TD ALIGN="CENTER" WIDTH="120" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>평가손실충당금</P>
</TD>

<TD ALIGN="CENTER" WIDTH="109" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>기말잔액</P>
</TD>
<TD ALIGN="CENTER" WIDTH="121" USERMARK=" BC0XD7D7D7" HEIGHT="30">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="107" VALIGN="MIDDLE" HEIGHT="30">
<P>제품</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">1,351,903,999</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">14,606,475</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">1,337,297,524</TD>
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="107" VALIGN="MIDDLE" HEIGHT="30">원재료</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">66,805,754</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">66,805,754</TD>
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="107" VALIGN="MIDDLE" HEIGHT="30">
<P>부재료</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">10,309,511</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">10,309,511</TD>
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="107" VALIGN="MIDDLE" HEIGHT="30">반품자산</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">8,794,707</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">8,794,707</TD>
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="107" VALIGN="MIDDLE" HEIGHT="30">반제품</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">213,224,962</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">69,452,105</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">143,772,857</TD>
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="107" VALIGN="MIDDLE" HEIGHT="30">
<P>합계</P>
</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">1,651,038,933</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">84,058,580</TD>
<TD ALIGN="RIGHT" WIDTH="109" HEIGHT="30" VALIGN="MIDDLE">1,566,980,353</TD>
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-16"></P>
<P>라) 기타 재고자산의 담보제공여부등당사는 보고서 작성기준일 현재 해당사항 없습니다.</P>

<P USERMARK="F-16">
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12 B">라. 수주계약 현황</SPAN>
<SPAN USERMARK="F-12"></SPAN>
</P>

<P>당사는 보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK=" B">마. 공정가치평가 내역</SPAN>공정가치평가 내역공정가치 평가방법 및 내역은 「Ⅲ. 재무에 관한 사항 → 3. 연결재무제표 주석」 을 참조하시기 바랍니다.
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0" ATOCID="17">IV. 이사의 경영진단 및 분석의견</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0" ATOCID="18">V. 회계감사인의 감사의견 등</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-1-0" ATOCID="19">1. 외부감사에 관한 사항</TITLE>
<P></P>
<LIBRARY>
<P USERMARK=" B">가. 회계감사인의 명칭 및 감사의견</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="730" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="274"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH VALIGN="MIDDLE" WIDTH="283" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제11기 1분기(당분기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="OPN_AUR1" VALIGN="MIDDLE">삼정회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_CMT1" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_EMP1" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="283" HEIGHT="53" ACODE="OPN_POT1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제10기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="OPN_AUR2" VALIGN="MIDDLE">삼일회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_EMP2" VALIGN="MIDDLE">-</TE>
<TE WIDTH="283" HEIGHT="53" ACODE="OPN_POT2" VALIGN="MIDDLE">(1) 라이선스 수익인식(2) 제품매출 수익인식의 발생사실</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제9기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="OPN_AUR3" VALIGN="MIDDLE">삼일회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="OPN_EMP3" VALIGN="MIDDLE">-</TE>
<TE WIDTH="283" HEIGHT="53" ACODE="OPN_POT3" VALIGN="MIDDLE">(1) 라이선스 수익인식(2) 주식회사 위바이옴에 대한 지분투자</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 감사용역 체결현황</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="903" BORDER="1">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="315"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="46"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="159" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH VALIGN="MIDDLE" WIDTH="324" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH VALIGN="MIDDLE" WIDTH="156" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH VALIGN="MIDDLE" WIDTH="156" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제11기 1분기(당분기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">삼정회계법인</TE>
<TE ALIGN="CENTER" WIDTH="324" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE">반기 재무제표 검토, 연결/별도 재무제표 감사</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">85,000천원</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">851</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">30,000천원</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="159" HEIGHT="30" ACODE="SIGK_YEAR2" VALIGN="MIDDLE" ALIGN="CENTER">제10기(당기)</TE>
<TE WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR2" VALIGN="MIDDLE" ALIGN="CENTER">삼일회계법인</TE>
<TE WIDTH="324" HEIGHT="30" ACODE="SIGK_CNT2" VALIGN="MIDDLE" ALIGN="CENTER">반기 재무제표 검토, 연결/별도 재무제표 감사</TE>
<TE WIDTH="101" HEIGHT="30" ACODE="SIGK_CPAY2" VALIGN="MIDDLE" ALIGN="RIGHT">160,000천원</TE>
<TE WIDTH="55" HEIGHT="30" ACODE="SIGK_CTIM2" VALIGN="MIDDLE" ALIGN="RIGHT">1,600</TE>
<TE WIDTH="101" HEIGHT="30" ACODE="SIGK_FPAY2" VALIGN="MIDDLE" ALIGN="RIGHT">160,000천원</TE>
<TE WIDTH="55" HEIGHT="30" ACODE="SIGK_FTIM2" VALIGN="MIDDLE" ALIGN="RIGHT">1,543</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="159" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE" ALIGN="CENTER">제9기(당기)</TE>
<TE WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE" ALIGN="CENTER">삼일회계법인</TE>
<TE WIDTH="324" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE" ALIGN="CENTER">반기 재무제표 검토, 연결/별도 재무제표 감사</TE>
<TE WIDTH="101" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE" ALIGN="RIGHT">160,000천원</TE>
<TE WIDTH="55" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE" ALIGN="RIGHT">1,770</TE>
<TE WIDTH="101" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE" ALIGN="RIGHT">160,000천원</TE>
<TE WIDTH="55" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE" ALIGN="RIGHT">1,615</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">다. 회계감사인과의 비감사용역 계약체결 현황</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" ROWSPAN="2">제11기 1분기(당분기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">제10기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="2">제9기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK=" B">라. 내부감사기구가 회계감사인과 논의한 결과</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1085" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="286"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="515"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH VALIGN="MIDDLE" WIDTH="295" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH VALIGN="MIDDLE" WIDTH="81" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH VALIGN="MIDDLE" WIDTH="524" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20220314" VALIGN="MIDDLE">2022년 03월 14일</TU>
<TE ALIGN="CENTER" WIDTH="295" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 : 내부감사 외 1명감사인 : 업무수행이사 외 1명</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="524" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">감사에서의 유의적 발견사항, 핵심감사사항 및 그 결과, 감사인의 독립성 등 감사종결보고</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="61" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="61" AUNIT="DIS_DATE" AUNITVALUE="20221207" VALIGN="MIDDLE">2022년 12월 07일</TU>

<TE ALIGN="CENTER" WIDTH="295" HEIGHT="61" ACODE="DIS_ATT" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 회사측 : 감사위원회 위원 3명,CFO 1명감사인 : 업무수행이사 외 1명</P>
</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="61" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="524" HEIGHT="61" ACODE="DIS_CONT" VALIGN="MIDDLE">경영진 및 감사인의 책임, 감사인의 독립성, 핵심감사사항, 내부회계관리제도 감사 진행경과 등 감사계획보고</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="61" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="61" AUNIT="DIS_DATE" AUNITVALUE="20230214" VALIGN="MIDDLE">2023년 02월 14일</TU>

<TE ALIGN="CENTER" WIDTH="295" HEIGHT="61" ACODE="DIS_ATT" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 회사측 : 감사위원회 위원 3명,CFO 1명감사인 : 업무수행이사 외 1명</P>
</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="61" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="524" HEIGHT="61" ACODE="DIS_CONT" VALIGN="MIDDLE">감사에서의 유의적 발견사항, 핵심감사사항 및 그 결과, 그룹감사 관련 사항, 내부회계관리제도 감사 진행경과 등 감사수행보고</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="61" ACODE="DIS_DIV" VALIGN="MIDDLE">4</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="61" AUNIT="DIS_DATE" AUNITVALUE="20230320" VALIGN="MIDDLE">2023년 03월 20일</TU>

<TE ALIGN="CENTER" WIDTH="295" HEIGHT="61" ACODE="DIS_ATT" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 회사측 : 감사위원회 위원 3명,CFO 1명감사인 : 업무수행이사 외 1명</P>
</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="61" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="524" HEIGHT="61" ACODE="DIS_CONT" VALIGN="MIDDLE">핵심감사사항 및 그 결과, 감사인의 독립성, 경영진서면진술 등 감사종결보고</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">5</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20231213" VALIGN="MIDDLE">2023년 12월 13일</TU>
<TE ALIGN="CENTER" WIDTH="295" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE"> 회사측 : 감사위원회 위원 3명,CFO 1명감사인 : 업무수행이사 외 1명</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="524" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">경영진 및 감사인의 책임, 감사인의 독립성, 핵심감사사항 등 감사계획보고</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="61" ACODE="DIS_DIV" VALIGN="MIDDLE">6</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="61" AUNIT="DIS_DATE" AUNITVALUE="20240214" VALIGN="MIDDLE">2024년 02월 14일</TU>

<TE ALIGN="CENTER" WIDTH="295" HEIGHT="61" ACODE="DIS_ATT" VALIGN="MIDDLE" USERMARK=" 0X0000FF">

<P USERMARK="F-GL11 0X0000FF"> 
<SPAN USERMARK=" 0X000000">회사측 : 감사위원회 위원 3명,CFO 1명감사인 : 업무수행이사 외 1명</SPAN>
</P>
</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="61" ACODE="DIS_WAY" VALIGN="MIDDLE">화상회의</TE>
<TE ALIGN="CENTER" WIDTH="524" HEIGHT="61" ACODE="DIS_CONT" VALIGN="MIDDLE">감사에서의 유의적 발견사항, 핵심감사사항 및 그 결과, 그룹감사 관련 사항, 내부회계관리제도 감사 진행경과 등 감사수행보고</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">7</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20240319" VALIGN="MIDDLE">2024년 03월 19일</TU>
<TE ALIGN="CENTER" WIDTH="295" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 : 감사위원회 위원 3명,CFO 1명감사인 : 업무수행이사 외 1명</TE>
<TE ALIGN="CENTER" WIDTH="81" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="524" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">핵심감사사항 및 그 결과, 그룹감사와 관련한 사항, 감사인의 독립성, 경영진서면진술, 감사 수정사항 및 미수정 왜곡표시 등 감사종결보고</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<P USERMARK=" B">마. 조정협의회내용 및 재무제표 불일치 정보
<SPAN USERMARK=" !B">당사는 보고서 작성기준일 현재 해당사항 없습니다.</SPAN>
<SPAN>바. 회계감사인의 변경 </SPAN>
<SPAN USERMARK=" !B">제11기(2024.01.01.~2024.12.31.)부터 제13기(2026.01.01.~2026.12.31.)까지 연속하는 3개 사업연도에 대해서는 2024년 2월 14일 삼정회계법인과 감사계약을 체결하였습니다.</SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-2-0" ATOCID="20">2. 내부통제에 관한 사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" ATOCID="21">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0" ATOCID="22">1. 이사회에 관한 사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0" ATOCID="23">2. 감사제도에 관한 사항</TITLE>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0" ATOCID="24">3. 주주총회 등에 관한 사항</TITLE>
<P></P>

<P USERMARK=" B">가. 투표제도 현황
<SPAN USERMARK=" !B"></SPAN>
<SPAN USERMARK=" !B">당사는 정관상 서면투표제를 채택하고 있으며, 집중투표제 및 전자투표제는 채택하고 있지 않습니다.</SPAN>
</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="359"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30">2024년 3월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="368" HEIGHT="30">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="508" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">투표제도 종류</TD>
<TD WIDTH="93" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">집중투표제</TD>
<TD WIDTH="209" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서면투표제</TD>
<TD WIDTH="93" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전자투표제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30">도입여부</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">배제</TD>
<TD ALIGN="CENTER" WIDTH="209" HEIGHT="30">도입</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">미도입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30">실시여부</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" WIDTH="209" HEIGHT="30">제8기(21년도) 정기주주총회</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 당사 정관 제29조(의결권의 대리행사)에서 서면에 의한 의결권 행사를 채택하고 있습니다(2020.06.10. 개정).</P>

<P>
<SPAN USERMARK=" B">나. 소수주주권</SPAN>
<SPAN></SPAN>
<SPAN>당사는 공시대상 기간 중 소수주주권이 행사된 경우가 없습니다.</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">다. 경영권 경쟁</SPAN>
<SPAN>당사는 공시대상 기간 중 회사의 경영지배권에 관하여 경쟁이 있었던 경우가 없습니다.</SPAN>
</P>
<P USERMARK=" B">라. 의결권 현황</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30">2024년 3월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구     분</TD>
<TD WIDTH="93" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식의 종류</TD>
<TD WIDTH="145" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식수</TD>
<TD WIDTH="124" USERMARK=" BC0XDCDCDC" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" WIDTH="238" VALIGN="MIDDLE" HEIGHT="60">발행주식총수(A)</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30">18,932,208</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30">497,940</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" WIDTH="238" VALIGN="MIDDLE" HEIGHT="60">의결권없는 주식수(B)</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" WIDTH="238" VALIGN="MIDDLE" HEIGHT="60">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" WIDTH="238" VALIGN="MIDDLE" HEIGHT="60">기타 법률에 의하여의결권 행사가 제한된 주식수(D)</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" WIDTH="238" VALIGN="MIDDLE" HEIGHT="60">의결권이 부활된 주식수(E)</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" WIDTH="238" VALIGN="MIDDLE" HEIGHT="60">의결권을 행사할 수 있는 주식수(F = A - B - C - D + E)</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30">18,932,208</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="145" HEIGHT="30">497,940</TD>
<TD ALIGN="CENTER" WIDTH="124" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">마. 주식사무</SPAN>
</P>

<TABLE BORDER="1" WIDTH="911" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="473"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="157" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" HEIGHT="444">
<P>정관상</P>
<P>신주인수권의 내용</P>
</TD>

<TD COLSPAN="3" WIDTH="754" HEIGHT="444">
<P>제10조 (신주인수권)</P>
<P>① 주주는 그가 소유한 주식의 수에 비례하여 신주의 배정을 받을 권리를 갖는다.② 회사는 제 1 항의 규정에도 불구하고 다음 각 호의 어느 하나에 해당하는 경우 이사회의 결의로 주주외의 자에게 신주를 배정할 수 있다.1. 발행주식총수의 100분의 30 을 초과하지 않는 범위 내에서 「자본시장과 금융투자업에 관한 법률」 제 165조의 6 에 따라 일반공모증자 방식으로 신주를 발행하는 경우2. 「상법」 제 542조의 3에 따른 주식매수선택권의 행사로 인하여 신주를 발행하는 경우3. 발행하는 주식총수의 100 분의 20 범위 내에서 우리사주조합원에게 주식을 우선배정하는 경우4. 「근로복지기본법」제 39조의 규정에 의한 우리사주매수선택권의 행사로 인하여 신주를 발행하는 경우5. 발행주식총수의 100분의 20 을 초과하지 않는 범위 내에서 긴급한 자금조달을 위하여 국내외 투자자에게 신주를 발핸하는 경우6. 발행주식총수의 100 분의 20 을 초과화지 않는 범위 내에서 사업상 중요한 기술도입 ·연구개발 ·생산 ·판매 ·자본제휴를 위하여 그 상대방에게 신주를 발행하는 경우7. 발행주식총수의 100 분의 40 을 초과하지 않는 범위 내에서 주권을 코스닥시장 또는 유가증권시장에 신규 상장하기 위하여 신주를 모집하거나 인수인에게 인수하게 하는 경우③ 제 2 항 각 호 중 어느 하나의 규정에 의해 신주를 발행할 경우 발행할 주식의 종류와 수 및 발행가격 등은 이사회의 결의로 정한다.④ 신주인수권의 포기 또는 상실에 따른 주식과 신주배정에서 발행한 단주에 대한 처리방법은 이사회의 결의로 정한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="157" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>결 산 일</P>
</TD>

<TD VALIGN="MIDDLE" WIDTH="136" ALIGN="CENTER" HEIGHT="30">
<P>12월 31일</P>
</TD>

<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30">

<P>정기

<SPAN>
<SPAN>주주총회</SPAN>
</SPAN>
</P>
</TD>

<TD WIDTH="482" HEIGHT="30">
<P>매사업연도 종료 후 3월 이내</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="157" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>주주명부폐쇄시기</P>
</TD>

<TD COLSPAN="3" WIDTH="754" HEIGHT="30">
<P>매년 1월 1일 ~ 1월 15일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="157" USERMARK=" BC0XD7D7D7" HEIGHT="53">
<P>공고방법</P>
</TD>
<TD COLSPAN="3" WIDTH="754" HEIGHT="53">고바이오랩 홈페이지(전산장애 또는 그 밖의 부득이한 사유가 있을 경우는 서울특별시에서 발행되는 일간 한국경제신문에 게재)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="157" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>주식사무대행기관</P>
</TD>
<TD COLSPAN="3" WIDTH="754" HEIGHT="30">주식회사 국민은행</TD>
</TR>
</TBODY>
</TABLE>

<P>

<SPAN USERMARK=" B">바.
<SPAN> </SPAN>

<SPAN>
<SPAN>주주총회</SPAN>
</SPAN>
<SPAN> 의사록 요약</SPAN>
</SPAN>
</P>

<TABLE BORDER="1" WIDTH="1020" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="390"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="310"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="123" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>주총일자</P>
</TD>

<TD ALIGN="CENTER" WIDTH="399" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>안건</P>
</TD>

<TD ALIGN="CENTER" WIDTH="179" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>결의내용</P>
</TD>
<TD ALIGN="CENTER" WIDTH="319" USERMARK=" BC0XD7D7D7" HEIGHT="30">주요 논의내용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" VALIGN="MIDDLE" HEIGHT="352">재8기정기주주총회(2022.03.29.)</TD>
<TD WIDTH="399" HEIGHT="352">1) 제8기 재무제표 승인의 건2) 정관 일부 개정의 건3) 이사 선임의 건3-1) 사내이사 강윤경 선임의 건3-2) 사내이사 이형진 선임의 건3-3) 사외이사 정성구 선임의 건3-4) 사외이사 정세운 선임의 건4) 감사위원회위원이 되는 사외이사 선임의 건4-1) 감사위원회 위원이 되는 사외이사 김준범 선임의 건4-2) 감사위원회 위원이 되는 사외이사 정성구 선임의 건4-3) 감사위원회 위원이 되는 사외이사 정세운 선임의 건5) 이사 보수한도 승인의 건6) 이사회 기부여 주식매수선택권 승인의 건</TD>
<TD WIDTH="179" HEIGHT="352">▷원안대로 가결▷원안대로 가결▷원안대로 가결▷일신상의 사유로 중도사임하여 해당 안건은 상정하지 않기로 결정▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결</TD>
<TD WIDTH="319" HEIGHT="352">- 주주제안: 없음- 결의과정 중 질의응답, 찬반토론: 없음- 안건 수정사항: 제3-1호 의안 후보자가 일신상의 사유로 중도사임하여 해당 안건은 상정하지 않기로 결정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" VALIGN="MIDDLE" HEIGHT="214">제9기 정기주주총회(2023.03.29.)</TD>
<TD WIDTH="399" HEIGHT="214">1) 제9기 재무제표 승인의 건2) 이사 선임의 건2-1) 사내이사 고광표 선임의 건2-2) 사내이사 이한승 선임의 건2-3) 사외이사 김준범 선임의 건3) 사외이사인 감사위원 선임의 건3-1) 감사위원 김준범 선임의 건4) 이사 보수 한도 승인의 건5) 이사회 기부여 주식매수선택권 승인의 건</TD>
<TD WIDTH="179" HEIGHT="214">▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결▷원안대로 가결</TD>
<TD WIDTH="319" HEIGHT="214">- 주주제안: 없음- 결의과정 중 질의응답, 찬반토론: 없음- 안건 수정사항: 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" VALIGN="MIDDLE" HEIGHT="99">제10기 정기주주총회(2024.03.28.)</TD>
<TD WIDTH="399" VALIGN="MIDDLE" HEIGHT="99">1) 제10기 재무제표 승인의 건2) 이사 보수 한도 승인의 건3) 주식매수선택권 승인의 건</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="99">▷원안대로 가결▷원안대로 가결▷원안대로 가결</TD>
<TD WIDTH="319" VALIGN="MIDDLE" HEIGHT="99">- 주주제안: 없음- 결의과정 중 질의응답, 찬반토론: 없음- 안건 수정사항: 없음</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0" ATOCID="25">VII. 주주에 관한 사항</TITLE>
<P></P>

<P USERMARK=" 0XFF1200 B">
<SPAN USERMARK="F-16">1. 최대주주 및 특수관계인의 주식소유 현황</SPAN>
<SPAN USERMARK=" 0X000000">가. 최대주주 및 특수관계인의 주식소유 현황</SPAN>
</P>
<P></P>

<LIBRARY>
<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="619" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="308" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="762" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" VALIGN="MIDDLE" WIDTH="173" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" VALIGN="MIDDLE" WIDTH="165" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의종류</TH>
<TH COLSPAN="4" VALIGN="MIDDLE" WIDTH="313" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">고광표</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">본인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">5,062,237</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">26.13</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">5,062,237</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">26.05</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">고재윤</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">240,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">1.24</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">240,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">1.24</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">고재아</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">240,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">1.24</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">240,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">1.24</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">주형준</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">105,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.54</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">105,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.54</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">고재경</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">35,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.18</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">35,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.18</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">주소은</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">10,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">10,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">주성현</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">45,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.23</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">45,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.23</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">고재희</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">18,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.09</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">18,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.09</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">고재은</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">10,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">10,000</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">정성구</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인(등기임원)</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">15,002</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.08</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">15,002</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.08</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">김준범</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계인(등기임원)</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">200</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">200</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="173" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE" ALIGN="CENTER">주식회사 에이치앤철강</TE>
<TE WIDTH="165" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE" ALIGN="CENTER">특수관계법인</TE>
<TE VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND" ALIGN="CENTER">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">43,500</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.22</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">43,500</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.22</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">5,823,939</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">30.07</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">5,823,939</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">29.97</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
<P USERMARK=" B">나. 최대주주의 주요경력 및 개요</P>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="562" BORDER="1">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="412"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">
<P>성명</P>
</TD>

<TD WIDTH="78" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">
<P>직책</P>
</TD>

<TD WIDTH="421" HEIGHT="30" USERMARK=" BC0XD7D7D7" ALIGN="CENTER">
<P>주요 경력</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="145" ALIGN="CENTER">고광표</TD>
<TD WIDTH="78" HEIGHT="145" ALIGN="CENTER">대표이사</TD>

<TD WIDTH="421" HEIGHT="145">
<P>- 서울대학교 미생물학과 학/석사- 하버드대학교 석/박사- University of North Carolina at Chapel Hill 연구원- University of Texas at Houston 조교수- 現 서울대학교 보건대학원 교수 및 마이크로바이옴 센터장- 現 고바이오랩 대표이사</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">다. 사업현황 등 회사 경영 안정성에 영향을 미칠 수 있는 주요 내용</SPAN>당사는 보고서 작성기준일  현재 해당사항이 없습니다.
</P>
<P></P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">2. 최</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">대주주의 변동내역</SPAN>
<SPAN>당사는 설립 이후 보고서 작성기준일 현재까지 최대주주가 변동된 사실이 없습니다.</SPAN>
</P>

<P></P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">3. 주</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">식의 분포</SPAN>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">4. 주</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">가 및 주식거래실적</SPAN>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" ATOCID="26">VIII. 임원 및 직원 등에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0" ATOCID="27">1. 임원 및 직원 등의 현황</TITLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">가. 임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="931" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20240331">2024년 03월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="591" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1455" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="371"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="101" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원여부</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근여부</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="163" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당업무</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="380" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의관계</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="84" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권있는 주식</TH>
<TH VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_NM_T" VALIGN="MIDDLE">고광표</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="145" AUNIT="SH5_BIH" AUNITVALUE="197001" VALIGN="MIDDLE">1970년 01월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_LEV" VALIGN="MIDDLE">사장</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="145" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="145" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="145" ACODE="SH5_OBJ" VALIGN="MIDDLE">대표이사</TE>
<TE WIDTH="380" HEIGHT="145" ACODE="SH5_SKL" VALIGN="MIDDLE">- 서울대학교 보건대학원 교수- University of Texas at Houston 조교수- Harvard University 이학박사(미생물학)- Harvard University 이학석사(미생물학)- 서울대학교 분자바이러스학 석사- 서울대학교 미생물학 학사</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="145" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">5,062,237</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="145" ACODE="SH5_RLTN" VALIGN="MIDDLE">본인</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="145" ACODE="SH5_PER" VALIGN="MIDDLE">9년 7개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="145" AUNIT="SH5_FIH" AUNITVALUE="20260330" VALIGN="MIDDLE">2026년 03월 30일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="191" ACODE="SH5_NM_T" VALIGN="MIDDLE">이한승</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="191" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="191" AUNIT="SH5_BIH" AUNITVALUE="196809" VALIGN="MIDDLE">1968년 09월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="191" ACODE="SH5_LEV" VALIGN="MIDDLE">부사장</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="191" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="191" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="191" ACODE="SH5_OBJ" VALIGN="MIDDLE">COO</TE>
<TE WIDTH="380" HEIGHT="191" ACODE="SH5_SKL" VALIGN="MIDDLE">- 와이바이오로직스 개발본부장 부사장- LG화학 바이오시밀러 사업부장- LG생명과학 HA사업부장- LG생명과학 히알루론산 연구팀장- LG생명과학 배양공정 연구팀장- University of California Irvine 생물화학공학 박사- University of California Irvine 생물화학공학 석사- 서울대학교 화학공학 학사</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="191" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="191" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="191" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="191" ACODE="SH5_PER" VALIGN="MIDDLE">1년 3개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="191" AUNIT="SH5_FIH" AUNITVALUE="20260328" VALIGN="MIDDLE">2026년 03월 28일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_NM_T" VALIGN="MIDDLE">이형진</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="145" AUNIT="SH5_BIH" AUNITVALUE="197810" VALIGN="MIDDLE">1978년 10월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_LEV" VALIGN="MIDDLE">전무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="145" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="145" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="145" ACODE="SH5_OBJ" VALIGN="MIDDLE">전략기획본부장</TE>
<TE WIDTH="380" HEIGHT="145" ACODE="SH5_SKL" VALIGN="MIDDLE">- ㈜위바이옴 대표이사- 테크노와이시스템㈜ 대표이사- 아산나눔재단 사무국장- 골드만삭스 Corporate Treasury 부장- MIT Sloan 경영학 석사(MBA)- 서울대학교 경제학 학사</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="145" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="145" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="145" ACODE="SH5_PER" VALIGN="MIDDLE">2년 8개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="145" AUNIT="SH5_FIH" AUNITVALUE="20250328" VALIGN="MIDDLE">2025년 03월 28일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_NM_T" VALIGN="MIDDLE">김준범</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="145" AUNIT="SH5_BIH" AUNITVALUE="196906" VALIGN="MIDDLE">1969년 06월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_LEV" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="145" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="145" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="145" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사 및 감사위원</TE>
<TE WIDTH="380" HEIGHT="145" ACODE="SH5_SKL" VALIGN="MIDDLE">- 서울대학교 경영학과 부교수- 홍콩과학기술대학 조/부교수- Georgia Institute of Technology 조교수- UCLA 경영학 박사- MIT 기계공학 박사- 서울대학교 항공우주공학 학사</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="145" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">200</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="145" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="145" ACODE="SH5_PER" VALIGN="MIDDLE">3년 7개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="145" AUNIT="SH5_FIH" AUNITVALUE="20260328" VALIGN="MIDDLE">2026년 03월 28일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">정성구</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="197202" VALIGN="MIDDLE">1972년 02월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사 및 감사위원</TE>
<TE WIDTH="380" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">- EQBR Networks Pte. Ltd. 대표이사- 김·장 법률사무소 변호사- 콜롬비아대학교 로스쿨 석사- 서울대학교 공법학 학사</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">15,002</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2년</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20250328" VALIGN="MIDDLE">2025년 03월 28일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">정세운</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="197901" VALIGN="MIDDLE">1979년 01월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사 및 감사위원</TE>
<TE WIDTH="380" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">- 정인회계법인 회계사- KPMG 삼정회계법인 회계사- 고려대학교 경영학과 학사</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2년</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="20250328" VALIGN="MIDDLE">2025년 03월 28일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">신용원</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="197312" VALIGN="MIDDLE">1973년 12월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">전무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">CMC/임상개발본부장</TE>
<TE WIDTH="380" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">- 녹십자 정제팀 팀장, CMC팀장, Project Leader- 녹십자 정제공정개발팀 책임연구원- 경희대학교 의과학 박사- 경북대학교 유전공학 학/석사</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE"> 21,003</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">4년 8개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="168" ACODE="SH5_NM_T" VALIGN="MIDDLE">임상균</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="168" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="168" AUNIT="SH5_BIH" AUNITVALUE="197601" VALIGN="MIDDLE">1976년 01월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="168" ACODE="SH5_LEV" VALIGN="MIDDLE">전무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="168" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="168" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="168" ACODE="SH5_OBJ" VALIGN="MIDDLE">연구소장</TE>
<TE WIDTH="380" HEIGHT="168" ACODE="SH5_SKL" VALIGN="MIDDLE">- Kanaph Therapeutics 상무이사- Vivid Biosciences 수석연구원- Harvard Medical School 책임연구원- UT Southwestern Medical Center Instructor- UT Southwestern Medical Center Postdoctoral Fellow- University of Wisconsin-Madison 종양생물학 박사- 서울대학교 미생물학 학사</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="168" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="168" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="168" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="168" ACODE="SH5_PER" VALIGN="MIDDLE">10개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="168" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="168" ACODE="SH5_NM_T" VALIGN="MIDDLE">임현규</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="168" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="168" AUNIT="SH5_BIH" AUNITVALUE="198005" VALIGN="MIDDLE">1980년 05월</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="168" ACODE="SH5_LEV" VALIGN="MIDDLE">상무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="168" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="168" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="168" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영지원본부장</TE>
<TE WIDTH="380" HEIGHT="168" ACODE="SH5_SKL" VALIGN="MIDDLE">- 대주회계법인 품질관리 위원- ㈜셀트리온 재무기획팀 팀장- ㈜셀트리온 자금팀 팀장- ㈜셀트리온 회계팀/자금팀- KPMG삼정회계법인 공인회계사- 성균관대학교 경영학 석사- 성균관대학교 경영학 학사</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="168" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="168" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="168" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="168" ACODE="SH5_PER" VALIGN="MIDDLE">1년 3개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="168" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<P>
<SPAN USERMARK=" B">나. 등기임원 선임 후보자 및 해임 대상자 현황</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>당사는 보고서 작성기준일  현재 해당사항이 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK=" B">다. 직원 등 현황</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK=" B">라. 미등기임원 보수 현황</SPAN>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
<SPAN USERMARK=" B"></SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0" ATOCID="28">2. 임원의 보수 등</TITLE>
<P></P>

<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0" ATOCID="29">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0" ATOCID="30">X. 대주주 등과의 거래내용</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">1. 대주주등에 대한 신용공여 등</SPAN>
<SPAN USERMARK=" B">가. 자기급금 및 대여금(증권대여 포함)</SPAN>
</P>

<TABLE WIDTH="794" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="785"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="794" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="809" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="42"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="63" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>구분</P>
</TD>

<TD ALIGN="CENTER" WIDTH="201" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>법인명</P>
</TD>

<TD ALIGN="CENTER" WIDTH="97" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>대여일자</P>
</TD>
<TD ALIGN="CENTER" WIDTH="48" USERMARK=" BC0XD7D7D7" HEIGHT="30">통화</TD>

<TD ALIGN="CENTER" WIDTH="105" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>대여금액</P>
</TD>

<TD ALIGN="CENTER" WIDTH="133" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>원화</P>
</TD>
<TD ALIGN="CENTER" WIDTH="111" USERMARK=" BC0XD7D7D7" HEIGHT="30">환율</TD>

<TD ALIGN="CENTER" WIDTH="51" USERMARK=" BC0XD7D7D7" HEIGHT="30">
<P>비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" ALIGN="CENTER" WIDTH="63" VALIGN="MIDDLE" HEIGHT="90">
<P>대여금</P>
</TD>

<TD ROWSPAN="3" ALIGN="CENTER" WIDTH="201" VALIGN="MIDDLE" HEIGHT="90">
<P>KoBioLabs Australia Pty Ltd</P>
</TD>
<TD ALIGN="CENTER" WIDTH="97" VALIGN="MIDDLE" HEIGHT="30">2024.01.16</TD>
<TD ALIGN="CENTER" WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">AUD</TD>
<TD ALIGN="RIGHT" WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">380,000.00</TD>
<TD ALIGN="RIGHT" WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">334,920,600</TD>
<TD ALIGN="RIGHT" WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">881.37</TD>
<TD ALIGN="CENTER" WIDTH="51" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="97" VALIGN="MIDDLE" HEIGHT="30">2024.01.30</TD>
<TD ALIGN="CENTER" WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">AUD</TD>
<TD ALIGN="RIGHT" WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">371,000.00</TD>
<TD ALIGN="RIGHT" WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">326,914,070</TD>
<TD ALIGN="RIGHT" WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">881.17</TD>
<TD ALIGN="CENTER" WIDTH="51" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="250" HEIGHT="30">계</TD>
<TD ALIGN="RIGHT" WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">661,834,670</TD>
<TD ALIGN="CENTER" WIDTH="111" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" WIDTH="51" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">나. 담</SPAN>
<SPAN USERMARK=" B">보제공 내역</SPAN>대주주 등과의 영업거래에 관한 사항은「III. 재무에 관한 사항 → 3. 연결재무제표 주석 → 31. 우발상황 및 약정사항」을 참조하시기 바랍니다.
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">다. 채</SPAN>
<SPAN USERMARK=" B">무보증 내역</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK="F-16 0XFF1200 B">2. 대주주와의 자산양수도 등</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">3. 대주주와</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">의 영업거래</SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN></SPAN>
<SPAN>대주주 등과의 영업거래에 관한 사항은「III. 재무에 관한 사항 → 3. 연결재무제표 주석 → 32. 특수관계자 거래」을 참조하시기 바랍니다.</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">4. 대주주 이</SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">외의 이해관계자의 영업거래</SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>당사는 보고서 작성기준일 </SPAN>
<SPAN>현재 해당사항 없습니다.</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0" ATOCID="31">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-1-0" ATOCID="32">1. 공시내용 진행 및 변경사항</TITLE>
<P>당사는 보고서 작성기준일 현재 해당사항 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-2-0" ATOCID="33">2. 우발부채 등에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 중요한 소송사건 등</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK=" B">나. 견질 또는 담보용 어음ㆍ수표 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK=" B">다. 채무보증 현황</SPAN>채무보증 현황에 관한 사항은「III. 재무에 관한 사항 → 3. 연결재무제표 주석 → 31. 우발상황 및 약정사항」을 참조하시기 바랍니다.
<SPAN USERMARK=" B">라. 채무인수약정 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK=" B">마. 그 밖의 우발채무 등</SPAN>그 밖의 우발채무 등에 관한 사항은「III. 재무에 관한 사항 → 3. 연결재무제표 주석 → 31. 우발상황 및 약정사항」을 참조하시기 바랍니다.
</P>
<P></P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-3-0" ATOCID="34">3. 제재 등과 관련된 사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-4-0" ATOCID="35">4. 작성기준일 이후 발생한 주요사항 등 기타사항</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
<P></P>

<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_APPENDIX" ATOCID="36">XII. 상세표</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" ATOCID="37">1. 연결대상 종속회사 현황(상세)</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" ATOCID="38">2. 계열회사 현황(상세)</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" ATOCID="39">3. 타법인출자 현황(상세)</TITLE>
<P></P>

<P>당사는 기업공시서식 작성기준 및 작성지침에 따라 분기보고서에는 본 항목을 기재하지 않습니다. 관련 내용은 
<A REFNO="20240320002022" REFTYPE="DARTURL">2024. 03. 20에 제출된 2023년도 사업보고서</A>를 참고하시기 바랍니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="" ATOCID="50">4. 지적재산권 상세</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="II. 사업의 내용|ADX-1|NEF-1">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" ACLASS="NORMAL" AFIXTABLE="N" WIDTH="854">

<COLGROUP>
<COL WIDTH="28"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="248"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>번호</SPAN>
</P>
</TD>

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>구분</SPAN>
</P>
</TD>

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="257">

<P>
<SPAN>내용</SPAN>
</P>
</TD>

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>권리자</SPAN>
</P>
</TD>

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>출원일 및 각국진입일</SPAN>
</P>
</TD>

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록일</SPAN>
</P>
</TD>

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>적용제품</SPAN>
</P>
</TD>

<TD HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>출원국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>1</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>장내 세균의 군집과 기능의 </SPAN>
<SPAN>변화를 이용한 대사성 및 </SPAN>
<SPAN>염증성 질환의 조기 진단</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2014.03.28.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2014.09.22.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>2</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2015.01.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>3</SPAN>
</P>
</TD>

<TD ROWSPAN="5" HEIGHT="150" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="5" HEIGHT="150" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 균주</SPAN>
</P>
</TD>

<TD ROWSPAN="5" HEIGHT="150" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2016.02.25.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.05.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>4</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.03.31.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.06.05.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>5</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.01.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.05.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>6</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2016.03.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>7</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.09.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>8</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>전용실시권</SPAN>
<SPAN>)</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>항 노로바이러스 활성을 갖는 락토바실러스 속 균주 및 이를 포함하는 항바이러스 조성물 </SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교 산학협력단</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2015.11.18.</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.07.31.</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>9</SPAN>
</P>
</TD>

<TD ROWSPAN="4" HEIGHT="120" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>전용실시권</SPAN>
<SPAN>)</SPAN>
</P>
</TD>

<TD ROWSPAN="4" HEIGHT="120" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>구강 세균의 군집을 이용한 대사성 질환 진단용 바이오 마커</SPAN>
</P>
</TD>

<TD ROWSPAN="4" HEIGHT="120" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교 산학협력단</SPAN>
<SPAN>, </SPAN>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2016.07.25.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2017.12.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>10</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.07.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>11</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.07.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.06.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>12</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.07.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>13</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>전용실시권</SPAN>
<SPAN>)</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>질 내 미생물을 포함하는 조성물</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교 산학협력단</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2016.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.04.05.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>14</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.18.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>15</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>클로스트리디움 디피실레 성장 억제효과를 갖는 클로스트리디움 신덴스 균주</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.22.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.11.03.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>16</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.02.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>17</SPAN>
</P>
</TD>

<TD ROWSPAN="3" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>전용실시권</SPAN>
<SPAN>)</SPAN>
</P>
</TD>

<TD ROWSPAN="3" HEIGHT="90" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>클로스트리디움 디피실레 성장 억제효과를 갖는 락토바실러스 균주</SPAN>
</P>
</TD>

<TD ROWSPAN="3" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교 산학협력단</SPAN>
<SPAN>, </SPAN>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.01.05.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>18</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.02.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>19</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.01.05.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>20</SPAN>
</P>
</TD>

<TD ROWSPAN="9" HEIGHT="270" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="9" HEIGHT="270" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물</SPAN>
</P>
</TD>

<TD ROWSPAN="9" HEIGHT="270" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.09.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.01.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>21</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.09.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>22</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.03.26.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.03.02.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>23</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.05.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.11.03.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>24</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.03.18.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.11.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>25</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.10.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2024.02.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>26</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.04.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>27</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.03.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>28</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.03.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.05.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-009</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>29</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>전용실시권</SPAN>
<SPAN>)</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 퍼멘텀 </SPAN>
<SPAN>KBL 375 </SPAN>
<SPAN>균주 및 그 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교 산학협력단</SPAN>
<SPAN>, </SPAN>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.11.24.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2019.09.18.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>30</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.11.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>31</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 플란타럼 </SPAN>
<SPAN>KBL 396 </SPAN>
<SPAN>균주 및 그 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.02.07.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.06.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>32</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.02.07.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>33</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.17.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.03.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>34</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>35</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.06.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>36</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.31.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>37</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>브라질</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>38</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>멕시코</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>39</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.31.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.12.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>40</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.12.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>41</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.08.05.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.01.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>42</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.07.08.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-010</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>홍콩</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>43</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>전용실시권</SPAN>
<SPAN>)</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>신규한 </SPAN>
<SPAN>Bacteroides vulgatus </SPAN>
<SPAN>균주 및 이를 유효 성분으로 하는 면역 및 대사성 질환 예방 또는 치료용 조성물</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교산학협력단</SPAN>
<SPAN>,</SPAN>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.04.19.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.03.04.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>44</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.04.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>45</SPAN>
</P>
</TD>

<TD ROWSPAN="28" HEIGHT="932" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="28" HEIGHT="932" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 파라카제이 균주 및 그 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="28" HEIGHT="932" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.05.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.12.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>46</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.12.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.07.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>47</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.12.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.02.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>48</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.02.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.09.26.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>49</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.05.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>50</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.04.05.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>51</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.02.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>52</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.06.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.10.03.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>53</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>54</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.06.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.08.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>55</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.12.25.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>56</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.03.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.09.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>57</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.05.17.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>홍콩</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>58</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.12.08.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>베트남</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>59</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.01.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>베트남</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>60</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.06.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>필리핀</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>61</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.30.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.05.31.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>인도네시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>62</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.06.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.08.26.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>말레이시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>63</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.05.25.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>말레이시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>64</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.08.24.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>말레이시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>65</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.03.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>싱가포르</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>66</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.10.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>싱가포르</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>67</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.04.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.02.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>68</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.02.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>69</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.02.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>70</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.06.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>멕시코</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>71</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>브라질</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>72</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-006</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>인도</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>73</SPAN>
</P>
</TD>

<TD ROWSPAN="15" HEIGHT="450" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="15" HEIGHT="450" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 가세리 </SPAN>
<SPAN>KBL 697 </SPAN>
<SPAN>균주 및 그 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="15" HEIGHT="450" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.05.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.07.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>74</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.05.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>75</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.07.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>76</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>브라질</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>77</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>뉴질랜드</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>78</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.03.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>79</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.02.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.11.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>80</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>81</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.01.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2024.01.12.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>82</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.06.13.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>83</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>84</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.12.04.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.06.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>85</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>멕시코</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>86</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.06.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>홍콩</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>87</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.02.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-001</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>마카오</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>88</SPAN>
</P>
</TD>

<TD ROWSPAN="15" HEIGHT="450" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="15" HEIGHT="450" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 크리스파투스 </SPAN>
<SPAN>KBL 693 </SPAN>
<SPAN>균주 및 그 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="15" HEIGHT="450" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.05.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.07.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>89</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.05.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>90</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.07.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>91</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>브라질</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>92</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>뉴질랜드</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>93</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.10.12.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>94</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.09.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.04.25.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>95</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>96</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.12.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2024.01.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>97</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2024.02.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>98</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>99</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.12.03.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.03.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>100</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.11.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>멕시코</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>101</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.06.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>홍콩</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>102</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.02.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-002</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>마카오</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>103</SPAN>
</P>
</TD>

<TD ROWSPAN="13" HEIGHT="390" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="13" HEIGHT="390" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>아커만시아 뮤시니필라 균주 및 이를 포함하는 식욕 억제 및 대사성 질환 예방</SPAN>
<SPAN>, </SPAN>
<SPAN>개선</SPAN>
<SPAN>, </SPAN>
<SPAN>완화 및 치료용 조성물</SPAN>
</P>
</TD>

<TD ROWSPAN="13" HEIGHT="390" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.10.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.12.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>104</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.10.11.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>105</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.03.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>106</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>107</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.06.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2024.02.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>108</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.11.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>109</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.05.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.10.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>110</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>111</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.08.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>112</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.11.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.03.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>113</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.08.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>멕시코</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>114</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.09.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>브라질</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>115</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.10.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>홍콩</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>116</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>비알코올성 지방간 질환의 예측 또는 진단용 키트</SPAN>
<SPAN>, </SPAN>
<SPAN>및 진단방법</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.05.02.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>117</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>118</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.12.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>119</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>120</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>멕시코</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>121</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>브라질</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>122</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>123</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.02.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>124</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.31.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.07.18.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>125</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>126</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.02.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>127</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.05.31.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>홍콩</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>128</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>간 손상 예방</SPAN>
<SPAN>, </SPAN>
<SPAN>개선</SPAN>
<SPAN>, </SPAN>
<SPAN>또는 치료용 조성물</SPAN>
</P>
</TD>

<TD ROWSPAN="12" HEIGHT="360" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.05.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>129</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.07.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>130</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.12.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>131</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>캐나다</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>132</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.19.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>멕시코</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>133</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>브라질</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>134</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.06.26.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>135</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.02.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.12.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>러시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>136</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.01.30.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2023.12.08.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>137</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.02.22.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>호주</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>138</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.02.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>139</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.05.31.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>홍콩</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>140</SPAN>
</P>
</TD>

<TD ROWSPAN="9" HEIGHT="293" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="9" HEIGHT="293" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 애시도필러스 </SPAN>
<SPAN>KBL409 </SPAN>
<SPAN>균주 및 그 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="9" HEIGHT="293" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.10.02.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2021.05.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>141</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2020.09.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>142</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.04.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>143</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.03.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2024.01.05.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>144</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.04.05.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2024.01.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>몽골</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>145</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.04.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>베트남</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>146</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.05.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>147</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.04.27.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>등록결정</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>인도네시아</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>148</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.05.02.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>인도</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>149</SPAN>
</P>
</TD>

<TD ROWSPAN="5" HEIGHT="150" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="5" HEIGHT="150" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>GLP-1 </SPAN>
<SPAN>유도 활성을 갖는 단백질 변이체 및 이의 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="5" HEIGHT="150" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>150</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.04.21.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>151</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.10.24</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>152</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.11.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>153</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.12.16.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-004</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>154</SPAN>
</P>
</TD>

<TD ROWSPAN="8" HEIGHT="240" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="8" HEIGHT="240" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>피칼리박테리움 프라우스니치이 균주 및 그 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="8" HEIGHT="240" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.08.12.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>155</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.11.08.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>156</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.08.12.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>157</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.08.13.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>대만</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>158</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.02.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>159</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.02.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>중국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>160</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.03.13.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>유럽</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>161</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.02.13.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>일본</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>162</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 애시도필러스 </SPAN>
<SPAN>KBL402 </SPAN>
<SPAN>또는 </SPAN>
<SPAN>KBL409 </SPAN>
<SPAN>균주를 포함하는 장 질환 개선</SPAN>
<SPAN>, </SPAN>
<SPAN>예방 또는 치료용 조성물</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교산학협력단</SPAN>
<SPAN>, </SPAN>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.10.08.</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLF-004</SPAN>
</P>
</TD>

<TD HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>163</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>항암 활성을 갖는 베일로넬라 파르불라 균주를 이용한 암의 완화</SPAN>
<SPAN>, </SPAN>
<SPAN>예방 또는 치료용 조성물</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교산학협력단</SPAN>
<SPAN>,</SPAN>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.10.20.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-005</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>164</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.10.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-005</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>165</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>항암 활성을 갖는 신규 박테리아 균주 및 이를 이용한 암의 완화</SPAN>
<SPAN>, </SPAN>
<SPAN>예방 또는 치료용 조성물</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>서울대학교산학협력단</SPAN>
<SPAN>,</SPAN>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.10.20.</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-005</SPAN>
</P>
</TD>

<TD HEIGHT="46" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>166</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2022.10.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>KBLP-005</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>167</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>리모실락토바실러스 루테리 균주 및 이의 면역 증진 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.02.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>168</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.02.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>169</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락티카제이바실러스 람노서스 균주 및 이의 면역 증진 용도</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.02.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>170</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.02.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>PCT</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>171</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>락토바실러스 가세리 균주에서 유래한 당지질</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.07.07.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>172</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>히스타민 분해능을 가지는 락티플란티바실러스 플란타룸 균주</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2023.10.20.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>173</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>비피도박테리움 롱검 아종 수일럼균주 및 이의 면역 증진 용도</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.01.26.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>174</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>특허권</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>비피도박테리움 롱검 아종 인판티스 균주 및 이의 면역 증진 용도</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2024.01.26.</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>-</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미정</SPAN>
</P>
</TD>

<TD HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>175</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>디자인권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>포장용 상자</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.07.25.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2019.03.18.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>176</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>서비스권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>KOBIOLABS </SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2015.08.04.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2016.04.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>177</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>서비스권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>KOBIOLABS </SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2015.08.04.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2016.04.29.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>178</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>KOBIOLABS </SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2015.08.04.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2016.07.01.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>179</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>KOBIOLABS </SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.11.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2019.07.02.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>180</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>비오비오</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.26.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.09.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>181</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>VioBio</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.26.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.09.14.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>182</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>엔트로비오</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.08.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>183</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>Ntrobio</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.08.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>184</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>구티마</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.07.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>185</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>Gutima</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.07.10.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>186</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>베네비옴</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.03.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>187</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>Benebiome</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.03.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>188</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>비비옴</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.08.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>189</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>Vibiome </SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2017.09.27.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2018.08.23.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>190</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>CUREbiotics</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.03.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2019.06.07.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>191</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.09.17.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.02.18.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>192</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>CAREbiotics</SPAN>
</P>
</TD>

<TD ROWSPAN="2" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.03.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2019.06.07.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>193</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2018.09.17.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.02.18.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>미국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>194</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>SMARTiome</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.10.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.05.06.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>195</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>BaxData</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.10.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.12.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>196</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>BaxBank</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.10.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.12.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>197</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>BaxPlore</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2019.10.24.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2020.12.28.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>198</SPAN>
</P>
</TD>

<TD ROWSPAN="3" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113">

<P>
<SPAN>상표권</SPAN>
</P>
</TD>

<TD ROWSPAN="3" HEIGHT="90" VALIGN="MIDDLE" WIDTH="257">

<P>
<SPAN>ABELARBOR</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>제 </SPAN>
<SPAN>1</SPAN>
<SPAN>류</SPAN>
<SPAN>, 3</SPAN>
<SPAN>류</SPAN>
<SPAN>, 5</SPAN>
<SPAN>류</SPAN>
<SPAN>)</SPAN>
</P>
</TD>

<TD ROWSPAN="3" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="106">

<P>
<SPAN>㈜</SPAN>
<SPAN>고바이오랩</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.01.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.06.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>199</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.01.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.06.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="37">

<P>
<SPAN>200</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="89">

<P>
<SPAN>2021.01.15.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="92">

<P>
<SPAN>2022.06.20.</SPAN>
</P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">
<P>  </P>
</TD>

<TD HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80">

<P>
<SPAN>한국</SPAN>
</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" ATOCID="40">【 전문가의 확인 】</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0" ATOCID="41">1. 전문가의 확인</TITLE>
<P></P>
<P>당사는 보고서 작성기준일 현재 해당사항 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0" ATOCID="42">2. 전문가와의 이해관계</TITLE>
<P></P>
<P>당사는 보고서 작성기준일 현재 해당사항 없습니다.</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>